# publications

journal: EClinicalMedicine
publication_date: 2022-12-27
doi: 10.1016/j.eclinm.2022.101809
pubmed_id: 36636296
source_url: https://doi.org/10.1016/j.eclinm.2022.101809
source_record_id: PMID:36636296
substance_tags: psilocybin
topic_tags: Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Adverse Events
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1016/j.eclinm.2022.101809
text_rights_status: unverified_not_redistributed
title:
Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial

authors:
Robin von Rotz, Eva Maria Schindowski, Johannes Jungwirth, Anna Schuldt, Nathalie M. Rieser, Katharina Zahoranszky, Erich Seifritz, Albina Nowak, Peter J.C.M. Nowak, Lutz Jäncke, Katrin H. Preller, Franz X. Vollenweider

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36636296","source_url":"https://doi.org/10.1016/j.eclinm.2022.101809","doi":"10.1016/j.eclinm.2022.101809","pmid":"36636296","publication_date":"2022-12-27","importer_version":"2.1.3","text_redistributed":false}


title: 5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines
journal: ACS Chemical Neuroscience
publication_date: 2023-01-10
doi: 10.1021/acschemneuro.2c00718
pubmed_id: 36630260
source_url: https://doi.org/10.1021/acschemneuro.2c00718
source_record_id: PMID:36630260
substance_tags: psilocybin
topic_tags: Pharmacology,Receptor Pharmacology,Safety
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 06:34:46
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1021/acschemneuro.2c00718
text_rights_status: unverified_not_redistributed
authors:
Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, Eden V. Barragan, Hannah N. Saeger, Hunter T. Warren, Winston L. Chow, J.A. Gray, David E. Olson

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36630260","source_url":"https://doi.org/10.1021/acschemneuro.2c00718","doi":"10.1021/acschemneuro.2c00718","pmid":"36630260","publication_date":"2023-01-10","importer_version":"2.1.3","text_redistributed":false}


journal: Comprehensive Psychoneuroendocrinology
publication_date: 2022-12-05
doi: 10.1016/j.cpnec.2022.100163
pubmed_id: 36545240
source_url: https://doi.org/10.1016/j.cpnec.2022.100163
source_record_id: PMID:36545240
substance_tags: psilocybin
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1016/j.cpnec.2022.100163
text_rights_status: unverified_not_redistributed
title:
Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation

authors:
Daniel Burmester, M. Madsen, Attila Szabó, Sanjay S. Aripaka, Dea Siggaard Stenbæk, Vibe G. Frøkjær, Betina Elfving, Jens D. Mikkelsen, Gitte M. Knudsen, Patrick M. Fisher

topic_tags:
Depression,Pharmacology,Receptor Pharmacology,Biomarkers,Observational Study,Healthy Volunteers,Toxicity,Inflammation

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36545240","source_url":"https://doi.org/10.1016/j.cpnec.2022.100163","doi":"10.1016/j.cpnec.2022.100163","pmid":"36545240","publication_date":"2022-12-05","importer_version":"2.1.3","text_redistributed":false}


authors: Hang Wang, Ying Wang
journal: Analytical and Bioanalytical Chemistry
publication_date: 2022-12-01
doi: 10.1007/s00216-022-04467-9
pubmed_id: 36459169
source_url: https://doi.org/10.1007/s00216-022-04467-9
source_record_id: PMID:36459169
substance_tags: psilocybin
topic_tags: Brain Imaging,Aging,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
title:
Matrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36459169","source_url":"https://doi.org/10.1007/s00216-022-04467-9","doi":"10.1007/s00216-022-04467-9","pmid":"36459169","publication_date":"2022-12-01","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis.
authors: Ko K, Kopra EI, Cleare AJ, Rucker JJ.
publication_date: 2022-10-06
doi: 10.1016/j.jad.2022.09.168
pubmed_id: 36209780
source_url: https://doi.org/10.1016/j.jad.2022.09.168
source_record_id: PMID:36209780
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jad.2022.09.168
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36209780","source_url":"https://doi.org/10.1016/j.jad.2022.09.168","doi":"10.1016/j.jad.2022.09.168","pmid":"36209780","publication_date":"2022-10-06","importer_version":"2.1.3","text_redistributed":false}


title: Novel antidepressant drugs: Beyond monoamine targets.
authors: Gonda X, Dome P, Neill JC, Tarazi FI.
publication_date: 2021-09-29
doi: 10.1017/s1092852921000791
pubmed_id: 34588093
source_url: https://doi.org/10.1017/s1092852921000791
source_record_id: PMID:34588093
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1017/s1092852921000791
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34588093","source_url":"https://doi.org/10.1017/s1092852921000791","doi":"10.1017/s1092852921000791","pmid":"34588093","publication_date":"2021-09-29","importer_version":"2.1.3","text_redistributed":false}


title: Classic psychedelics do not affect T cell and monocyte immune responses
authors: Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, Carsten Gründemann
journal: Frontiers in Psychiatry
publication_date: 2023-01-19
doi: 10.3389/fpsyt.2023.1042440
pubmed_id: 36741125
source_url: https://doi.org/10.3389/fpsyt.2023.1042440
source_record_id: PMID:36741125
substance_tags: psilocin
topic_tags: End-of-Life Distress,Pharmacology,Receptor Pharmacology,In Vitro Study,Safety,Immune Function
study_type: In Vitro Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3389/fpsyt.2023.1042440
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36741125","source_url":"https://doi.org/10.3389/fpsyt.2023.1042440","doi":"10.3389/fpsyt.2023.1042440","pmid":"36741125","publication_date":"2023-01-19","importer_version":"2.1.3","text_redistributed":false}


authors: Stokłosa I, Więckiewicz G, Stokłosa M, Piegza M, Pudlo R, Gorczyca P.
publication_date: 2023-01-18
doi: 10.3390/ijerph20031870
pubmed_id: 36767234
source_url: https://doi.org/10.3390/ijerph20031870
source_record_id: PMID:36767234
substance_tags: psilocybin
topic_tags: Clinical Trial,Review Article
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ijerph20031870
text_rights_status: unverified_not_redistributed
title:
Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36767234","source_url":"https://doi.org/10.3390/ijerph20031870","doi":"10.3390/ijerph20031870","pmid":"36767234","publication_date":"2023-01-18","importer_version":"2.1.3","text_redistributed":false}


title: Is psilocybin an effective antidepressant and what is its Mechanism of action?
authors: Mann JJ.
publication_date: 2022-12-31
doi: 10.1016/j.xcrm.2022.100906
pubmed_id: 36652915
source_url: https://doi.org/10.1016/j.xcrm.2022.100906
source_record_id: PMID:36652915
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:01
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.xcrm.2022.100906
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36652915","source_url":"https://doi.org/10.1016/j.xcrm.2022.100906","doi":"10.1016/j.xcrm.2022.100906","pmid":"36652915","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Natalie Gukasyan
journal: Med
publication_date: 2022-12-31
doi: 10.1016/j.medj.2022.12.003
pubmed_id: 36640755
source_url: https://doi.org/10.1016/j.medj.2022.12.003
source_record_id: PMID:36640755
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression,Safety
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
title:
On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36640755","source_url":"https://doi.org/10.1016/j.medj.2022.12.003","doi":"10.1016/j.medj.2022.12.003","pmid":"36640755","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Berlowitz I, García Torres E, Maake C, Wolf U, Martin-Soelch C.
publication_date: 2023-01-09
doi: 10.3390/plants12020346
pubmed_id: 36679060
source_url: https://doi.org/10.3390/plants12020346
source_record_id: PMID:36679060
substance_tags: psilocybin
topic_tags: Anxiety,Addiction,Wellbeing
study_type: Qualitative Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-11 19:28:11
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/plants12020346
text_rights_status: unverified_not_redistributed
title:
Indigenous-Amazonian Traditional Medicine's Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36679060","source_url":"https://doi.org/10.3390/plants12020346","doi":"10.3390/plants12020346","pmid":"36679060","publication_date":"2023-01-09","importer_version":"2.1.3","text_redistributed":false}


title: The association between naturalistic use of psychedelics and co-occurring substance use disorders
authors: Jonina Rabinowitz, Shaul Lev-Ran, Raz Gross
journal: Frontiers in Psychiatry
publication_date: 2023-01-09
doi: 10.3389/fpsyt.2022.1066369
pubmed_id: 36704738
source_url: https://doi.org/10.3389/fpsyt.2022.1066369
source_record_id: PMID:36704738
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Observational Study,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3389/fpsyt.2022.1066369
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36704738","source_url":"https://doi.org/10.3389/fpsyt.2022.1066369","doi":"10.3389/fpsyt.2022.1066369","pmid":"36704738","publication_date":"2023-01-09","importer_version":"2.1.3","text_redistributed":false}


title: The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology.
publication_date: 2023-01-09
doi: 10.3390/ijms24021329
pubmed_id: 36674849
source_url: https://doi.org/10.3390/ijms24021329
source_record_id: PMID:36674849
substance_tags: psilocybin,psilocin
topic_tags: Depression,PTSD,OCD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ijms24021329
text_rights_status: unverified_not_redistributed
authors:
Mastinu A, Anyanwu M, Carone M, Abate G, Bonini SA, Peron G, Tirelli E, Pucci M, Ribaudo G, Oselladore E, Premoli M, Gianoncelli A, Uberti DL, Memo M.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36674849","source_url":"https://doi.org/10.3390/ijms24021329","doi":"10.3390/ijms24021329","pmid":"36674849","publication_date":"2023-01-09","importer_version":"2.1.3","text_redistributed":false}


title: When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s.
authors: Martinovic J.
journal: História Ciências Saúde-Manguinhos
publication_date: 2023-01-05
doi: 10.1590/s0104-59702022000500007
pubmed_id: 36629673
source_url: https://doi.org/10.1590/s0104-59702022000500007
source_record_id: PMID:36629673
substance_tags: psilocybin
topic_tags: Pharmacology,Consciousness
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1590/s0104-59702022000500007
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36629673","source_url":"https://doi.org/10.1590/s0104-59702022000500007","doi":"10.1590/s0104-59702022000500007","pmid":"36629673","publication_date":"2023-01-05","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin sex-dependently reduces alcohol consumption in C57BL/6J mice
authors: Kenneth Alper, Janelle Cange, Ria Sah, Deanna Schreiber-Gregory, Henry Sershen, K. Yaragudri Vinod
journal: Frontiers in Pharmacology
publication_date: 2023-01-03
doi: 10.3389/fphar.2022.1074633
pubmed_id: 36686713
source_url: https://doi.org/10.3389/fphar.2022.1074633
source_record_id: PMID:36686713
substance_tags: psilocybin
topic_tags: Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Drug Interactions
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3389/fphar.2022.1074633
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36686713","source_url":"https://doi.org/10.3389/fphar.2022.1074633","doi":"10.3389/fphar.2022.1074633","pmid":"36686713","publication_date":"2023-01-03","importer_version":"2.1.3","text_redistributed":false}


title: Editorial: Old and new psychoactive substances: Pharmacology and potential applications.
authors: Mayer FP, Luethi D, Areal LB, Sitte HH
journal: Frontiers in psychiatry
publication_date: 2021-12-31
doi: 10.3389/fpsyt.2022.1087005
pubmed_id: 36684007
source_url: https://pubmed.ncbi.nlm.nih.gov/36684007/
source_record_id: PMID:36684007
substance_tags: psilocybin
topic_tags: PTSD,Pharmacology
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36684007","source_url":"https://pubmed.ncbi.nlm.nih.gov/36684007/","doi":"10.3389/fpsyt.2022.1087005","pmid":"36684007","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment
authors: Gail A. Edelsohn, Dominic Sisti
journal: Perspectives in biology and medicine
publication_date: 2022-12-31
doi: 10.1353/pbm.2023.0007
pubmed_id: 38662012
source_url: https://doi.org/10.1353/pbm.2023.0007
source_record_id: PMID:38662012
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1353/pbm.2023.0007
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,PTSD,Addiction,Personality Change,Clinical Trial,Adolescents,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:38662012","source_url":"https://doi.org/10.1353/pbm.2023.0007","doi":"10.1353/pbm.2023.0007","pmid":"38662012","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Efficacy and Safety of Psychedelics in Treating Anxiety Disorders
authors: Leah Feulner, Thanpicha Sermchaiwong, Nathan Rodland, David Galarneau
journal: Ochsner Journal
publication_date: 2022-12-31
doi: 10.31486/toj.23.0076
pubmed_id: 38143548
source_url: https://doi.org/10.31486/toj.23.0076
source_record_id: PMID:38143548
substance_tags: psilocybin
topic_tags: Anxiety,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.31486/toj.23.0076
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:38143548","source_url":"https://doi.org/10.31486/toj.23.0076","doi":"10.31486/toj.23.0076","pmid":"38143548","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Ahmed H, Mushahid H, Arshad T.
publication_date: 2022-12-31
pubmed_id: 37992112
source_url: https://europepmc.org/article/MED/37992112
source_record_id: PMID:37992112
substance_tags: psilocybin
topic_tags: Depression,Cancer Patients
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
text_rights_status: not_applicable_no_text
title:
UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:37992112","source_url":"https://europepmc.org/article/MED/37992112","doi":"","pmid":"37992112","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Biological embedding of early trauma: the role of higher prefrontal synaptic strength.
authors: Tamman AJF, Jiang L, Averill CL, Mason GF, Averill LA, Abdallah CG.
publication_date: 2022-12-30
doi: 10.1080/20008066.2023.2246338
pubmed_id: 37642398
source_url: https://doi.org/10.1080/20008066.2023.2246338
source_record_id: PMID:37642398
substance_tags: psilocybin
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-11 19:28:11
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/20008066.2023.2246338
text_rights_status: unverified_not_redistributed
topic_tags:
PTSD,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Safety,Toxicity

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:37642398","source_url":"https://doi.org/10.1080/20008066.2023.2246338","doi":"10.1080/20008066.2023.2246338","pmid":"37642398","publication_date":"2022-12-30","importer_version":"2.1.3","text_redistributed":false}


authors: Unzueta-Larrinaga P, Urigüen L.
publication_date: 2022-12-30
doi: 10.1007/978-1-0716-3307-6_5
pubmed_id: 37464162
source_url: https://doi.org/10.1007/978-1-0716-3307-6_5
source_record_id: PMID:37464162
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-11 19:28:11
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/978-1-0716-3307-6_5
text_rights_status: unverified_not_redistributed
title:
Evaluation of Sensorimotor Gating Deficits in Mice Through Prepulse Inhibition (PPI) of the Startle Response.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:37464162","source_url":"https://doi.org/10.1007/978-1-0716-3307-6_5","doi":"10.1007/978-1-0716-3307-6_5","pmid":"37464162","publication_date":"2022-12-30","importer_version":"2.1.3","text_redistributed":false}


title: The Resurgence of Hallucinogen Drugs in Clinical Research.
authors: Rivera-García MT, Cruz SL.
publication_date: 2022-12-31
doi: 10.24875/ric.23000108
pubmed_id: 37441761
source_url: https://doi.org/10.24875/ric.23000108
source_record_id: PMID:37441761
substance_tags: psilocin
topic_tags: Receptor Pharmacology,Review Article,Animal Study
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.24875/ric.23000108
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:37441761","source_url":"https://doi.org/10.24875/ric.23000108","doi":"10.24875/ric.23000108","pmid":"37441761","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Next generation antidepressants with novel mechanisms for treatment resistant depression.
authors: Chen MH, Tu PC, Su TP.
publication_date: 2023-03-08
doi: 10.1016/bs.pbr.2023.02.005
pubmed_id: 37414491
source_url: https://doi.org/10.1016/bs.pbr.2023.02.005
source_record_id: PMID:37414491
substance_tags: psilocybin
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-11 19:28:10
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/bs.pbr.2023.02.005
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:37414491","source_url":"https://doi.org/10.1016/bs.pbr.2023.02.005","doi":"10.1016/bs.pbr.2023.02.005","pmid":"37414491","publication_date":"2023-03-08","importer_version":"2.1.3","text_redistributed":false}


title: Functional MRI markers for treatment-resistant depression: Insights and challenges.
authors: Kotoula V, Evans JW, Punturieri C, Johnson SC, Zarate CA
journal: Progress in brain research
publication_date: 2022-12-31
doi: 10.1016/bs.pbr.2023.04.001
pubmed_id: 37414490
source_url: https://pubmed.ncbi.nlm.nih.gov/37414490/
source_record_id: PMID:37414490
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Biomarkers,Aging,Treatment-Resistant Depression
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/37414490/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:37414490","source_url":"https://pubmed.ncbi.nlm.nih.gov/37414490/","doi":"10.1016/bs.pbr.2023.04.001","pmid":"37414490","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Ezeaka UC, Kim HJJ, Laprairie RB.
publication_date: 2022-12-31
doi: 10.2174/1568026623666230705151922
pubmed_id: 37409550
source_url: https://doi.org/10.2174/1568026623666230705151922
source_record_id: PMID:37409550
substance_tags: psilocybin,psilocin
topic_tags: Depression,Anxiety,Addiction,Pharmacology,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:00
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.2174/1568026623666230705151922
text_rights_status: unverified_not_redistributed
title:
Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent Models.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:37409550","source_url":"https://doi.org/10.2174/1568026623666230705151922","doi":"10.2174/1568026623666230705151922","pmid":"37409550","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin in Palliative Care: An Update.
authors: Whinkin E, Opalka M, Watters C, Jaffe A, Aggarwal S.
publication_date: 2023-04-13
doi: 10.1007/s13670-023-00383-7
pubmed_id: 37305379
source_url: https://doi.org/10.1007/s13670-023-00383-7
source_record_id: PMID:37305379
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Aging,Emotional Processing,Spirituality,Review Article,Safety,Inflammation
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:01
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s13670-023-00383-7
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:37305379","source_url":"https://doi.org/10.1007/s13670-023-00383-7","doi":"10.1007/s13670-023-00383-7","pmid":"37305379","publication_date":"2023-04-13","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Psychopharmacology
publication_date: 2022-12-31
doi: 10.1177/02698811221146356
pubmed_id: 36601974
source_url: https://doi.org/10.1177/02698811221146356
source_record_id: PMID:36601974
substance_tags: psilocybin
topic_tags: Addiction,Pharmacology,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/02698811221146356
text_rights_status: unverified_not_redistributed
title:
Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness

authors:
Matthias Forstmann, Hannes Kettner, Christina Sagioglou, Alexander Irvine, Sam Gandy, Robin Carhart-Harris, David Luke

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36601974","source_url":"https://doi.org/10.1177/02698811221146356","doi":"10.1177/02698811221146356","pmid":"36601974","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith
journal: Journal of Psychopharmacology
publication_date: 2022-12-31
doi: 10.1177/02698811221140004
pubmed_id: 36588452
source_url: https://doi.org/10.1177/02698811221140004
source_record_id: PMID:36588452
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/02698811221140004
text_rights_status: unverified_not_redistributed
title:
Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective

topic_tags:
Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Adverse Events,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36588452","source_url":"https://doi.org/10.1177/02698811221140004","doi":"10.1177/02698811221140004","pmid":"36588452","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Meccia J, Lopez J, Bagot RC.
publication_date: 2022-12-23
doi: 10.1007/s00213-022-06297-0
pubmed_id: 36564671
source_url: https://doi.org/10.1007/s00213-022-06297-0
source_record_id: PMID:36564671
substance_tags: psilocybin
topic_tags: Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Aging,Review Article,Animal Study
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-022-06297-0
text_rights_status: unverified_not_redistributed
title:
Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36564671","source_url":"https://doi.org/10.1007/s00213-022-06297-0","doi":"10.1007/s00213-022-06297-0","pmid":"36564671","publication_date":"2022-12-23","importer_version":"2.1.3","text_redistributed":false}


authors: Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley
journal: Journal of Psychopharmacology
publication_date: 2022-12-13
doi: 10.1177/02698811221131997
pubmed_id: 36515370
source_url: https://doi.org/10.1177/02698811221131997
source_record_id: PMID:36515370
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/02698811221131997
text_rights_status: unverified_not_redistributed
title:
Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36515370","source_url":"https://doi.org/10.1177/02698811221131997","doi":"10.1177/02698811221131997","pmid":"36515370","publication_date":"2022-12-13","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Drug Legislative Reform and Legalization in the US
authors: Joshua S. Siegel, James E. Daily, Demetrius A. Perry, Ginger E. Nicol
journal: JAMA Psychiatry
publication_date: 2022-12-06
doi: 10.1001/jamapsychiatry.2022.4101
pubmed_id: 36477830
source_url: https://doi.org/10.1001/jamapsychiatry.2022.4101
source_record_id: PMID:36477830
substance_tags: psilocybin
topic_tags: Aging,Review Article,Older Adults,Adolescents,Toxicity,Contraindications
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1001/jamapsychiatry.2022.4101
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36477830","source_url":"https://doi.org/10.1001/jamapsychiatry.2022.4101","doi":"10.1001/jamapsychiatry.2022.4101","pmid":"36477830","publication_date":"2022-12-06","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome
journal: Psychopharmacology
publication_date: 2022-12-04
doi: 10.1007/s00213-022-06286-3
pubmed_id: 36469097
source_url: https://doi.org/10.1007/s00213-022-06286-3
source_record_id: PMID:36469097
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Personality Change,Animal Study
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
authors:
Valeria Buzzelli, Emilia Carbone, Antonia Manduca, Sara Schiavi, Alessandro Feo, Julia V. Perederiy, Kyle Ambert, M Hausman, Viviana Trezza

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36469097","source_url":"https://doi.org/10.1007/s00213-022-06286-3","doi":"10.1007/s00213-022-06286-3","pmid":"36469097","publication_date":"2022-12-04","importer_version":"2.1.3","text_redistributed":false}


authors: Shukuroglou M, Roseman L, Wall M, Nutt D, Kaelen M, Carhart-Harris R.
journal: Journal of Psychopharmacology
publication_date: 2022-11-25
doi: 10.1177/02698811221125354
pubmed_id: 36433778
source_url: https://doi.org/10.1177/02698811221125354
source_record_id: PMID:36433778
substance_tags: psilocybin
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811221125354
text_rights_status: unverified_not_redistributed
title:
Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.

topic_tags:
Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36433778","source_url":"https://doi.org/10.1177/02698811221125354","doi":"10.1177/02698811221125354","pmid":"36433778","publication_date":"2022-11-25","importer_version":"2.1.3","text_redistributed":false}


title: Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.
authors: Kious B, Schwartz Z, Lewis B
journal: Journal of psychopharmacology (Oxford, England)
publication_date: 2022-12-31
doi: 10.1177/02698811221133461
pubmed_id: 36377548
source_url: https://pubmed.ncbi.nlm.nih.gov/36377548/
source_record_id: PMID:36377548
substance_tags: psilocybin
topic_tags: PTSD,Clinical Trial
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36377548/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36377548","source_url":"https://pubmed.ncbi.nlm.nih.gov/36377548/","doi":"10.1177/02698811221133461","pmid":"36377548","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Body mass index (BMI) does not predict responses to psilocybin.
journal: Journal of Psychopharmacology
publication_date: 2022-11-13
doi: 10.1177/02698811221131994
pubmed_id: 36373934
source_url: https://doi.org/10.1177/02698811221131994
source_record_id: PMID:36373934
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Wellbeing,Emotional Processing,Mystical Experience
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811221131994
text_rights_status: unverified_not_redistributed
authors:
Spriggs MJ, Giribaldi B, Lyons T, Rosas FE, Kärtner LS, Buchborn T, Douglass HM, Roseman L, Timmermann C, Erritzoe D, Nutt DJ, Carhart-Harris RL.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36373934","source_url":"https://doi.org/10.1177/02698811221131994","doi":"10.1177/02698811221131994","pmid":"36373934","publication_date":"2022-11-13","importer_version":"2.1.3","text_redistributed":false}


title: Psilocin - The "real deal" or an extraction byproduct.
authors: Gutman O, Tenne D, Bretler U.
publication_date: 2022-11-03
doi: 10.1111/1556-4029.15167
pubmed_id: 36333836
source_url: https://doi.org/10.1111/1556-4029.15167
source_record_id: PMID:36333836
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:01
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1111/1556-4029.15167
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36333836","source_url":"https://doi.org/10.1111/1556-4029.15167","doi":"10.1111/1556-4029.15167","pmid":"36333836","publication_date":"2022-11-03","importer_version":"2.1.3","text_redistributed":false}


authors: Jones GM.
journal: Journal of Psychopharmacology
publication_date: 2022-10-30
doi: 10.1177/02698811221127304
pubmed_id: 36314881
source_url: https://doi.org/10.1177/02698811221127304
source_record_id: PMID:36314881
substance_tags: psilocybin
topic_tags: Depression,Observational Study,Drug Interactions
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811221127304
text_rights_status: unverified_not_redistributed
title:
Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36314881","source_url":"https://doi.org/10.1177/02698811221127304","doi":"10.1177/02698811221127304","pmid":"36314881","publication_date":"2022-10-30","importer_version":"2.1.3","text_redistributed":false}


title: Mescaline: The forgotten psychedelic.
authors: Vamvakopoulou IA, Narine KAD, Campbell I, Dyck JRB, Nutt DJ.
publication_date: 2022-10-13
doi: 10.1016/j.neuropharm.2022.109294
pubmed_id: 36252614
source_url: https://doi.org/10.1016/j.neuropharm.2022.109294
source_record_id: PMID:36252614
substance_tags: psilocybin
topic_tags: Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Review Article,Animal Study
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neuropharm.2022.109294
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36252614","source_url":"https://doi.org/10.1016/j.neuropharm.2022.109294","doi":"10.1016/j.neuropharm.2022.109294","pmid":"36252614","publication_date":"2022-10-13","importer_version":"2.1.3","text_redistributed":false}


title: The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.
authors: Johnston CB, Mangini M, Grob C, Anderson B.
publication_date: 2022-09-05
doi: 10.1016/j.jagp.2022.08.007
pubmed_id: 36184377
source_url: https://doi.org/10.1016/j.jagp.2022.08.007
source_record_id: PMID:36184377
substance_tags: psilocybin
topic_tags: PTSD,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jagp.2022.08.007
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36184377","source_url":"https://doi.org/10.1016/j.jagp.2022.08.007","doi":"10.1016/j.jagp.2022.08.007","pmid":"36184377","publication_date":"2022-09-05","importer_version":"2.1.3","text_redistributed":false}


title: Towards an understanding of psychedelic-induced neuroplasticity.
authors: Calder AE, Hasler G.
publication_date: 2022-09-18
doi: 10.1038/s41386-022-01389-z
pubmed_id: 36123427
source_url: https://doi.org/10.1038/s41386-022-01389-z
source_record_id: PMID:36123427
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41386-022-01389-z
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Mechanism of Action,Microdosing,Review Article

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36123427","source_url":"https://doi.org/10.1038/s41386-022-01389-z","doi":"10.1038/s41386-022-01389-z","pmid":"36123427","publication_date":"2022-09-18","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-08-16
doi: 10.1177/07067437221111371
pubmed_id: 35975555
source_url: https://doi.org/10.1177/07067437221111371
source_record_id: PMID:35975555
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/07067437221111371
text_rights_status: unverified_not_redistributed
title:
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.

authors:
Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V.

topic_tags:
Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35975555","source_url":"https://doi.org/10.1177/07067437221111371","doi":"10.1177/07067437221111371","pmid":"35975555","publication_date":"2022-08-16","importer_version":"2.1.3","text_redistributed":false}


title: Sustained effects of single doses of classical psychedelics in humans.
authors: Knudsen GM.
publication_date: 2022-06-20
doi: 10.1038/s41386-022-01361-x
pubmed_id: 35729252
source_url: https://doi.org/10.1038/s41386-022-01361-x
source_record_id: PMID:35729252
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41386-022-01361-x
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Aging,Personality Change,Emotional Processing,Review Article

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35729252","source_url":"https://doi.org/10.1038/s41386-022-01361-x","doi":"10.1038/s41386-022-01361-x","pmid":"35729252","publication_date":"2022-06-20","importer_version":"2.1.3","text_redistributed":false}


title: How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?
authors: Earleywine M, Low F, Altman BR, De Leo J.
journal: Journal of Psychoactive Drugs
publication_date: 2022-03-22
doi: 10.1080/02791072.2022.2047842
pubmed_id: 35318904
source_url: https://doi.org/10.1080/02791072.2022.2047842
source_record_id: PMID:35318904
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/02791072.2022.2047842
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35318904","source_url":"https://doi.org/10.1080/02791072.2022.2047842","doi":"10.1080/02791072.2022.2047842","pmid":"35318904","publication_date":"2022-03-22","importer_version":"2.1.3","text_redistributed":false}


authors: Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC.
publication_date: 2022-02-27
doi: 10.1080/02791072.2022.2044096
pubmed_id: 35225726
source_url: https://doi.org/10.1080/02791072.2022.2044096
source_record_id: PMID:35225726
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Clinical Trial,Systematic Review,Review Article,Safety
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/02791072.2022.2044096
text_rights_status: unverified_not_redistributed
title:
The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35225726","source_url":"https://doi.org/10.1080/02791072.2022.2044096","doi":"10.1080/02791072.2022.2044096","pmid":"35225726","publication_date":"2022-02-27","importer_version":"2.1.3","text_redistributed":false}


title: Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.
authors: Glynos NG, Pierce J, Davis AK, McAfee J, Boehnke KF.
journal: Journal of Psychoactive Drugs
publication_date: 2022-01-09
doi: 10.1080/02791072.2021.2022817
pubmed_id: 35001856
source_url: https://doi.org/10.1080/02791072.2021.2022817
source_record_id: PMID:35001856
substance_tags: psilocybin
topic_tags: Chronic Pain,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/02791072.2021.2022817
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35001856","source_url":"https://doi.org/10.1080/02791072.2021.2022817","doi":"10.1080/02791072.2021.2022817","pmid":"35001856","publication_date":"2022-01-09","importer_version":"2.1.3","text_redistributed":false}


authors: Hadar A, David J, Shalit N, Roseman L, Gross R, Sessa B, Lev-Ran S
journal: Journal of psychoactive drugs
publication_date: 2022-12-31
doi: 10.1080/02791072.2021.2022254
pubmed_id: 35000572
source_url: https://pubmed.ncbi.nlm.nih.gov/35000572/
source_record_id: PMID:35000572
substance_tags: psilocybin
topic_tags: Chronic Pain,Healthcare Workers
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35000572/
text_rights_status: unverified_not_redistributed
title:
The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35000572","source_url":"https://pubmed.ncbi.nlm.nih.gov/35000572/","doi":"10.1080/02791072.2021.2022254","pmid":"35000572","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.
authors: Simonsson O, Goldberg SB
journal: Journal of psychoactive drugs
publication_date: 2022-12-31
doi: 10.1080/02791072.2021.2022816
pubmed_id: 35000559
source_url: https://pubmed.ncbi.nlm.nih.gov/35000559/
source_record_id: PMID:35000559
substance_tags: psilocybin
topic_tags: Randomized Controlled Trial,Observational Study,Safety
study_type: Randomized Controlled Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35000559/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35000559","source_url":"https://pubmed.ncbi.nlm.nih.gov/35000559/","doi":"10.1080/02791072.2021.2022816","pmid":"35000559","publication_date":"2022-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
journal: Pharmaceuticals
publication_date: 2022-12-30
doi: 10.3390/ph16010068
pubmed_id: 36678564
source_url: https://doi.org/10.3390/ph16010068
source_record_id: PMID:36678564
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3390/ph16010068
text_rights_status: unverified_not_redistributed
authors:
Antonio Munafò, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, Giuseppina Cantarella

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36678564","source_url":"https://doi.org/10.3390/ph16010068","doi":"10.3390/ph16010068","pmid":"36678564","publication_date":"2022-12-30","importer_version":"2.1.3","text_redistributed":false}


title: A Review of Synthetic Access to Therapeutic Compounds Extracted from.
authors: Serreau R, Amirouche A, Benyamina A, Berteina-Raboin S
journal: Pharmaceuticals (Basel, Switzerland)
publication_date: 2022-12-27
doi: 10.3390/ph16010040
pubmed_id: 36678537
source_url: https://pubmed.ncbi.nlm.nih.gov/36678537/
source_record_id: PMID:36678537
substance_tags: psilocybin,psilocin
topic_tags: Review Article
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36678537/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36678537","source_url":"https://pubmed.ncbi.nlm.nih.gov/36678537/","doi":"10.3390/ph16010040","pmid":"36678537","publication_date":"2022-12-27","importer_version":"2.1.3","text_redistributed":false}


journal: Applied and Environmental Microbiology
publication_date: 2022-11-28
doi: 10.1128/aem.01498-22
pubmed_id: 36445079
source_url: https://doi.org/10.1128/aem.01498-22
source_record_id: PMID:36445079
substance_tags: psilocybin
topic_tags: Depression,PTSD,End-of-Life Distress,Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1128/aem.01498-22
text_rights_status: unverified_not_redistributed
title:
DNA Authentication and Chemical Analysis of Psilocybe Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites

authors:
Alexander J. Bradshaw, Talia Backman, Virginia Ramírez-Cruz, Dale L. Forrister, Jaclyn M. Winter, Laura Guzmán-Dávalos, Giuliana Furci, Paul Stamets, Bryn T. M. Dentinger

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36445079","source_url":"https://doi.org/10.1128/aem.01498-22","doi":"10.1128/aem.01498-22","pmid":"36445079","publication_date":"2022-11-28","importer_version":"2.1.3","text_redistributed":false}


authors: Grant Jones, Diego Arias, Matthew K. Nock
journal: Scientific Reports
publication_date: 2022-12-18
doi: 10.1038/s41598-022-25658-5
pubmed_id: 36535992
source_url: https://doi.org/10.1038/s41598-022-25658-5
source_record_id: PMID:36535992
substance_tags: psilocybin
topic_tags: Observational Study,Adolescents,Toxicity
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1038/s41598-022-25658-5
text_rights_status: unverified_not_redistributed
title:
Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36535992","source_url":"https://doi.org/10.1038/s41598-022-25658-5","doi":"10.1038/s41598-022-25658-5","pmid":"36535992","publication_date":"2022-12-18","importer_version":"2.1.3","text_redistributed":false}


title: Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis.
authors: Schäfer T, Kramer K, Werten S, Rupp B, Hoffmeister D.
journal: ChemBioChem
publication_date: 2022-11-21
doi: 10.1002/cbic.202200551
pubmed_id: 36327140
source_url: https://doi.org/10.1002/cbic.202200551
source_record_id: PMID:36327140
substance_tags: psilocybin
topic_tags: Depression,In Vitro Study
study_type: In Vitro Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/cbic.202200551
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36327140","source_url":"https://doi.org/10.1002/cbic.202200551","doi":"10.1002/cbic.202200551","pmid":"36327140","publication_date":"2022-11-21","importer_version":"2.1.3","text_redistributed":false}


journal: PLoS ONE
publication_date: 2022-12-13
doi: 10.1371/journal.pone.0279073
pubmed_id: 36516137
source_url: https://doi.org/10.1371/journal.pone.0279073
source_record_id: PMID:36516137
substance_tags: psilocybin
topic_tags: Depression,Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1371/journal.pone.0279073
text_rights_status: unverified_not_redistributed
title:
“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use

authors:
Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley, Erin E. Michalak

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36516137","source_url":"https://doi.org/10.1371/journal.pone.0279073","doi":"10.1371/journal.pone.0279073","pmid":"36516137","publication_date":"2022-12-13","importer_version":"2.1.3","text_redistributed":false}


title: Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report
journal: Heliyon
publication_date: 2022-11-30
doi: 10.1016/j.heliyon.2022.e12135
pubmed_id: 36536916
source_url: https://doi.org/10.1016/j.heliyon.2022.e12135
source_record_id: PMID:36536916
substance_tags: psilocybin
topic_tags: OCD,Receptor Pharmacology,Emotional Processing,Case Report
study_type: Case Report
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1016/j.heliyon.2022.e12135
text_rights_status: unverified_not_redistributed
authors:
Benjamin Kelmendi, Stephen A. Kichuk, Giuliana DePalmer, Gayle Maloney, Terence H. W. Ching, Alexander Belser, Christopher Pittenger

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36536916","source_url":"https://doi.org/10.1016/j.heliyon.2022.e12135","doi":"10.1016/j.heliyon.2022.e12135","pmid":"36536916","publication_date":"2022-11-30","importer_version":"2.1.3","text_redistributed":false}


title: The economics of psychedelic-assisted therapies: A research agenda.
authors: Marseille E, Bertozzi S, Kahn JG
journal: Frontiers in psychiatry
publication_date: 2021-12-31
doi: 10.3389/fpsyt.2022.1025726
pubmed_id: 36545038
source_url: https://pubmed.ncbi.nlm.nih.gov/36545038/
source_record_id: PMID:36545038
substance_tags: psilocybin
topic_tags: Depression,PTSD,Addiction
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36545038/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36545038","source_url":"https://pubmed.ncbi.nlm.nih.gov/36545038/","doi":"10.3389/fpsyt.2022.1025726","pmid":"36545038","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Błażej D. Pędzich, Mireia Medrano, An Buckinx, Ilse Smolders, Dimitri De Bundel
journal: International Journal of Molecular Sciences
publication_date: 2022-12-03
doi: 10.3390/ijms232315284
pubmed_id: 36499610
source_url: https://doi.org/10.3390/ijms232315284
source_record_id: PMID:36499610
substance_tags: psilocybin
topic_tags: Depression,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3390/ijms232315284
text_rights_status: unverified_not_redistributed
title:
Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36499610","source_url":"https://doi.org/10.3390/ijms232315284","doi":"10.3390/ijms232315284","pmid":"36499610","publication_date":"2022-12-03","importer_version":"2.1.3","text_redistributed":false}


title: Lower-dose psycholytic therapy - A neglected approach.
authors: Passie T, Guss J, Krähenmann R.
publication_date: 2022-12-01
doi: 10.3389/fpsyt.2022.1020505
pubmed_id: 36532196
source_url: https://doi.org/10.3389/fpsyt.2022.1020505
source_record_id: PMID:36532196
substance_tags: psilocybin
topic_tags: Personality Change,Mystical Experience,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2022.1020505
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36532196","source_url":"https://doi.org/10.3389/fpsyt.2022.1020505","doi":"10.3389/fpsyt.2022.1020505","pmid":"36532196","publication_date":"2022-12-01","importer_version":"2.1.3","text_redistributed":false}


title: Therapeutic use of psilocybin: Practical considerations for dosing and administration.
authors: MacCallum CA, Lo LA, Pistawka CA, Deol JK.
publication_date: 2022-11-30
doi: 10.3389/fpsyt.2022.1040217
pubmed_id: 36532184
source_url: https://doi.org/10.3389/fpsyt.2022.1040217
source_record_id: PMID:36532184
substance_tags: psilocybin
topic_tags: Pharmacology,Review Article,Safety,Adverse Events,Drug Interactions,Contraindications
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:01
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2022.1040217
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36532184","source_url":"https://doi.org/10.3389/fpsyt.2022.1040217","doi":"10.3389/fpsyt.2022.1040217","pmid":"36532184","publication_date":"2022-11-30","importer_version":"2.1.3","text_redistributed":false}


authors: Gregory Barber, Charles B. Nemeroff, Steven Siegel
journal: American Journal of Psychiatry
publication_date: 2022-11-30
doi: 10.1176/appi.ajp.22010073
pubmed_id: 36453037
source_url: https://doi.org/10.1176/appi.ajp.22010073
source_record_id: PMID:36453037
substance_tags: psilocybin
topic_tags: Depression,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
title:
A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:36453037","source_url":"https://doi.org/10.1176/appi.ajp.22010073","doi":"10.1176/appi.ajp.22010073","pmid":"36453037","publication_date":"2022-11-30","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic-Assisted Therapy for People with Eating Disorders.
authors: Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS
journal: Current psychiatry reports
publication_date: 2022-11-30
doi: 10.1007/s11920-022-01394-5
pubmed_id: 36374357
source_url: https://pubmed.ncbi.nlm.nih.gov/36374357/
source_record_id: PMID:36374357
substance_tags: psilocybin
topic_tags: Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36374357/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36374357","source_url":"https://pubmed.ncbi.nlm.nih.gov/36374357/","doi":"10.1007/s11920-022-01394-5","pmid":"36374357","publication_date":"2022-11-30","importer_version":"2.1.3","text_redistributed":false}


journal: NeuroImage
publication_date: 2022-10-26
doi: 10.1016/j.neuroimage.2022.119716
pubmed_id: 36341951
source_url: https://doi.org/10.1016/j.neuroimage.2022.119716
source_record_id: PMID:36341951
substance_tags: psilocybin,psilocin
topic_tags: Brain Imaging,Consciousness,Aging,Personality Change
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neuroimage.2022.119716
text_rights_status: unverified_not_redistributed
title:
Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects.

authors:
Olsen AS, Lykkebo-Valløe A, Ozenne B, Madsen MK, Stenbæk DS, Armand S, Mørup M, Ganz M, Knudsen GM, Fisher PM.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36341951","source_url":"https://doi.org/10.1016/j.neuroimage.2022.119716","doi":"10.1016/j.neuroimage.2022.119716","pmid":"36341951","publication_date":"2022-10-26","importer_version":"2.1.3","text_redistributed":false}


authors: Strauss D, Ghosh S, Murray Z, Gryzenhout M.
publication_date: 2022-11-03
doi: 10.1007/s13205-022-03355-4
pubmed_id: 36340802
source_url: https://doi.org/10.1007/s13205-022-03355-4
source_record_id: PMID:36340802
substance_tags: psilocybin,psilocin
topic_tags: Receptor Pharmacology,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:00
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s13205-022-03355-4
text_rights_status: unverified_not_redistributed
title:
Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36340802","source_url":"https://doi.org/10.1007/s13205-022-03355-4","doi":"10.1007/s13205-022-03355-4","pmid":"36340802","publication_date":"2022-11-03","importer_version":"2.1.3","text_redistributed":false}


journal: Contemporary Clinical Trials
publication_date: 2022-11-01
doi: 10.1016/j.cct.2022.106976
pubmed_id: 36332827
source_url: https://doi.org/10.1016/j.cct.2022.106976
source_record_id: PMID:36332827
substance_tags: psilocybin
topic_tags: Addiction,Receptor Pharmacology,Randomized Controlled Trial,Safety
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.cct.2022.106976
text_rights_status: unverified_not_redistributed
title:
Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.

authors:
O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36332827","source_url":"https://doi.org/10.1016/j.cct.2022.106976","doi":"10.1016/j.cct.2022.106976","pmid":"36332827","publication_date":"2022-11-01","importer_version":"2.1.3","text_redistributed":false}


title: Set and setting in microdosing: an oft-overlooked principle.
authors: Hartogsohn I, Petranker R
journal: Psychopharmacology
publication_date: 2022-11-30
doi: 10.1007/s00213-022-06249-8
pubmed_id: 36289109
source_url: https://pubmed.ncbi.nlm.nih.gov/36289109/
source_record_id: PMID:36289109
substance_tags: psilocybin
topic_tags: Microdosing,Clinical Trial
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36289109/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36289109","source_url":"https://pubmed.ncbi.nlm.nih.gov/36289109/","doi":"10.1007/s00213-022-06249-8","pmid":"36289109","publication_date":"2022-11-30","importer_version":"2.1.3","text_redistributed":false}


title: Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002-2019.
authors: Walsh CA, Livne O, Shmulewitz D, Stohl M, Hasin DS.
journal: Addictive Behaviors Reports
publication_date: 2022-09-05
doi: 10.1016/j.abrep.2022.100454
pubmed_id: 36119808
source_url: https://doi.org/10.1016/j.abrep.2022.100454
source_record_id: PMID:36119808
substance_tags: psilocybin
topic_tags: Observational Study,Healthcare Workers
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.abrep.2022.100454
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36119808","source_url":"https://doi.org/10.1016/j.abrep.2022.100454","doi":"10.1016/j.abrep.2022.100454","pmid":"36119808","publication_date":"2022-09-05","importer_version":"2.1.3","text_redistributed":false}


title: The psychedelic renaissance: the next trip for psychiatry?
authors: Kelly JR, Baker A, Babiker M, Burke L, Brennan C, O'Keane V.
publication_date: 2019-09-22
doi: 10.1017/ipm.2019.39
pubmed_id: 31543078
source_url: https://doi.org/10.1017/ipm.2019.39
source_record_id: PMID:31543078
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1017/ipm.2019.39
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Neuroplasticity,Default Mode Network,Randomized Controlled Trial,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:31543078","source_url":"https://doi.org/10.1017/ipm.2019.39","doi":"10.1017/ipm.2019.39","pmid":"31543078","publication_date":"2019-09-22","importer_version":"2.1.3","text_redistributed":false}


title: Classic psychedelics, health behavior, and physical health.
authors: Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB
journal: Therapeutic advances in psychopharmacology
publication_date: 2021-12-31
doi: 10.1177/20451253221135363
pubmed_id: 36465958
source_url: https://pubmed.ncbi.nlm.nih.gov/36465958/
source_record_id: PMID:36465958
substance_tags: psilocybin
topic_tags: Addiction
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36465958/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36465958","source_url":"https://pubmed.ncbi.nlm.nih.gov/36465958/","doi":"10.1177/20451253221135363","pmid":"36465958","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.
authors: Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J.
publication_date: 2022-11-21
doi: 10.7759/cureus.31796
pubmed_id: 36569662
source_url: https://doi.org/10.7759/cureus.31796
source_record_id: PMID:36569662
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:01
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.7759/cureus.31796
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,OCD,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36569662","source_url":"https://doi.org/10.7759/cureus.31796","doi":"10.7759/cureus.31796","pmid":"36569662","publication_date":"2022-11-21","importer_version":"2.1.3","text_redistributed":false}


title: Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.
authors: Messell C, Summer L, Bonde LO, Beck BD, Stenbæk DS.
journal: Frontiers in Psychology
publication_date: 2022-11-16
doi: 10.3389/fpsyg.2022.873455
pubmed_id: 36467212
source_url: https://doi.org/10.3389/fpsyg.2022.873455
source_record_id: PMID:36467212
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyg.2022.873455
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36467212","source_url":"https://doi.org/10.3389/fpsyg.2022.873455","doi":"10.3389/fpsyg.2022.873455","pmid":"36467212","publication_date":"2022-11-16","importer_version":"2.1.3","text_redistributed":false}


authors: Shahar O, Botvinnik A, Esh-Zuntz N, Brownstien M, Wolf R, Lotan A, Wolf G, Lerer B, Lifschytz T.
journal: International Journal of Molecular Sciences
publication_date: 2022-11-15
doi: 10.3390/ijms232214148
pubmed_id: 36430623
source_url: https://doi.org/10.3390/ijms232214148
source_record_id: PMID:36430623
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ijms232214148
text_rights_status: unverified_not_redistributed
title:
Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36430623","source_url":"https://doi.org/10.3390/ijms232214148","doi":"10.3390/ijms232214148","pmid":"36430623","publication_date":"2022-11-15","importer_version":"2.1.3","text_redistributed":false}


title: Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.
authors: Gotvaldová K, Borovička J, Hájková K, Cihlářová P, Rockefeller A, Kuchař M.
journal: International Journal of Molecular Sciences
publication_date: 2022-11-14
doi: 10.3390/ijms232214068
pubmed_id: 36430546
source_url: https://doi.org/10.3390/ijms232214068
source_record_id: PMID:36430546
substance_tags: psilocybin,psilocin
topic_tags: Microdosing,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ijms232214068
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36430546","source_url":"https://doi.org/10.3390/ijms232214068","doi":"10.3390/ijms232214068","pmid":"36430546","publication_date":"2022-11-14","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-08-12
doi: 10.1016/j.neuropharm.2022.109214
pubmed_id: 35973601
source_url: https://doi.org/10.1016/j.neuropharm.2022.109214
source_record_id: PMID:35973601
substance_tags: psilocybin
topic_tags: Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neuropharm.2022.109214
text_rights_status: unverified_not_redistributed
title:
Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines.

authors:
Belouin SJ, Averill LA, Henningfield JE, Xenakis SN, Donato I, Grob CS, Berger A, Magar V, Danforth AL, Anderson BT.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35973601","source_url":"https://doi.org/10.1016/j.neuropharm.2022.109214","doi":"10.1016/j.neuropharm.2022.109214","pmid":"35973601","publication_date":"2022-08-12","importer_version":"2.1.3","text_redistributed":false}


journal: ACS Pharmacology & Translational Science
publication_date: 2022-11-01
doi: 10.1021/acsptsci.2c00177
pubmed_id: 36407948
source_url: https://doi.org/10.1021/acsptsci.2c00177
source_record_id: PMID:36407948
substance_tags: psilocybin,psilocin
topic_tags: Receptor Pharmacology,Animal Study,In Vitro Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1021/acsptsci.2c00177
text_rights_status: unverified_not_redistributed
title:
Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.

authors:
Glatfelter GC, Pottie E, Partilla JS, Sherwood AM, Kaylo K, Pham DNK, Naeem M, Sammeta VR, DeBoer S, Golen JA, Hulley EB, Stove CP, Chadeayne AR, Manke DR, Baumann MH.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36407948","source_url":"https://doi.org/10.1021/acsptsci.2c00177","doi":"10.1021/acsptsci.2c00177","pmid":"36407948","publication_date":"2022-11-01","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin in Treatment-Resistant Depression.
authors: Madras BK.
publication_date: 2022-10-31
doi: 10.1056/nejme2210975
pubmed_id: 36322849
source_url: https://doi.org/10.1056/nejme2210975
source_record_id: PMID:36322849
substance_tags: psilocybin
topic_tags: Depression,Treatment-Resistant Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36322849","source_url":"https://doi.org/10.1056/nejme2210975","doi":"10.1056/nejme2210975","pmid":"36322849","publication_date":"2022-10-31","importer_version":"2.1.3","text_redistributed":false}


title: Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.
journal: New England Journal of Medicine
publication_date: 2022-10-31
doi: 10.1056/nejmoa2206443
pubmed_id: 36322843
source_url: https://doi.org/10.1056/nejmoa2206443
source_record_id: PMID:36322843
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1056/nejmoa2206443
text_rights_status: unverified_not_redistributed
authors:
Goodwin GM, Aaronson ST, Alvarez O, Arden PC, Baker A, Bennett JC, Bird C, Blom RE, Brennan C, Brusch D, Burke L, Campbell-Coker K, Carhart-Harris R, Cattell J, Daniel A, DeBattista C, Dunlop BW, Eisen K, Feifel D, Forbes M, Haumann HM, Hellerstein DJ, Hoppe AI, Husain MI, Jelen LA, Kamphuis J, Kawasaki J, Kelly JR, Key RE, Kishon R, Knatz Peck S, Knight G, Koolen MHB, Lean M, Licht RW, Maples-Keller JL, Mars J, Marwood L, McElhiney MC, Miller TL, Mirow A, Mistry S, Mletzko-Crowe T, Modlin LN, Nielsen RE, Nielson EM, Offerhaus SR, O'Keane V, Páleníček T, Printz D, Rademaker MC, van Reemst A, Reinholdt F, Repantis D, Rucker J, Rudow S, Ruffell S, Rush AJ, Schoevers RA, Seynaeve M, Shao S, Soares JC, Somers M, Stansfield SC, Sterling D, Strockis A, Tsai J, Visser L, Wahba M, Williams S, Young AH, Ywema P, Zisook S, Malievskaia E.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36322843","source_url":"https://doi.org/10.1056/nejmoa2206443","doi":"10.1056/nejmoa2206443","pmid":"36322843","publication_date":"2022-10-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin reduces symptoms in treatment resistant depression, trial results show.
authors: Iacobucci G.
journal: BMJ
publication_date: 2022-11-01
doi: 10.1136/bmj.o2623
pubmed_id: 36411539
source_url: https://doi.org/10.1136/bmj.o2623
source_record_id: PMID:36411539
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36411539","source_url":"https://doi.org/10.1136/bmj.o2623","doi":"10.1136/bmj.o2623","pmid":"36411539","publication_date":"2022-11-01","importer_version":"2.1.3","text_redistributed":false}


title: [Treatment-resistant depression. From classification to new therapies.]
authors: Paganin W, Signorini S, Signorini S, Leccese V, Sciarretta A.
journal: Rivista di psichiatria
publication_date: 2022-10-31
doi: 10.1708/3922.39072
pubmed_id: 36503940
source_url: https://doi.org/10.1708/3922.39072
source_record_id: PMID:36503940
substance_tags: psilocybin
topic_tags: Depression,Aging,Treatment-Resistant Depression,Healthcare Workers,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1708/3922.39072
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36503940","source_url":"https://doi.org/10.1708/3922.39072","doi":"10.1708/3922.39072","pmid":"36503940","publication_date":"2022-10-31","importer_version":"2.1.3","text_redistributed":false}


journal: Headache The Journal of Head and Face Pain
publication_date: 2022-11-22
doi: 10.1111/head.14420
pubmed_id: 36416492
source_url: https://doi.org/10.1111/head.14420
source_record_id: PMID:36416492
substance_tags: psilocybin
topic_tags: Headache / Migraine,Adverse Events
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1111/head.14420
text_rights_status: unverified_not_redistributed
title:
Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.

authors:
Schindler EAD, Sewell RA, Gottschalk CH, Luddy C, Flynn LT, Zhu Y, Lindsey H, Pittman BP, Cozzi NV, D'Souza DC.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36416492","source_url":"https://doi.org/10.1111/head.14420","doi":"10.1111/head.14420","pmid":"36416492","publication_date":"2022-11-22","importer_version":"2.1.3","text_redistributed":false}


authors: Patchett-Marble R, O'Sullivan S, Tadwalkar S, Hapke E.
journal: Canadian Family Physician
publication_date: 2022-10-31
doi: 10.46747/cfp.6811823
pubmed_id: 36376043
source_url: https://doi.org/10.46747/cfp.6811823
source_record_id: PMID:36376043
substance_tags: psilocybin
topic_tags: End-of-Life Distress
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
title:
Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36376043","source_url":"https://doi.org/10.46747/cfp.6811823","doi":"10.46747/cfp.6811823","pmid":"36376043","publication_date":"2022-10-31","importer_version":"2.1.3","text_redistributed":false}


title: Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies.
authors: Calleja-Conde J, Morales-García JA, Echeverry-Alzate V, Bühler KM, Giné E, López-Moreno JA.
publication_date: 2022-10-31
doi: 10.1111/adb.13229
pubmed_id: 36301215
source_url: https://doi.org/10.1111/adb.13229
source_record_id: PMID:36301215
substance_tags: psilocybin
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1111/adb.13229
text_rights_status: unverified_not_redistributed
topic_tags:
Addiction,Mechanism of Action,Receptor Pharmacology,Consciousness,Systematic Review,Review Article,Animal Study

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36301215","source_url":"https://doi.org/10.1111/adb.13229","doi":"10.1111/adb.13229","pmid":"36301215","publication_date":"2022-10-31","importer_version":"2.1.3","text_redistributed":false}


title: Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.
authors: Balon R.
publication_date: 2022-10-15
doi: 10.1097/jcp.0000000000001610
pubmed_id: 36251379
source_url: https://doi.org/10.1097/jcp.0000000000001610
source_record_id: PMID:36251379
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36251379","source_url":"https://doi.org/10.1097/jcp.0000000000001610","doi":"10.1097/jcp.0000000000001610","pmid":"36251379","publication_date":"2022-10-15","importer_version":"2.1.3","text_redistributed":false}


authors: Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI.
publication_date: 2022-10-02
doi: 10.1097/jcp.0000000000001608
pubmed_id: 36193898
source_url: https://doi.org/10.1097/jcp.0000000000001608
source_record_id: PMID:36193898
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1097/jcp.0000000000001608
text_rights_status: unverified_not_redistributed
title:
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.

topic_tags:
Depression,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36193898","source_url":"https://doi.org/10.1097/jcp.0000000000001608","doi":"10.1097/jcp.0000000000001608","pmid":"36193898","publication_date":"2022-10-02","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-08-16
doi: 10.1016/j.neuropharm.2022.109220
pubmed_id: 35987353
source_url: https://doi.org/10.1016/j.neuropharm.2022.109220
source_record_id: PMID:35987353
substance_tags: psilocybin
topic_tags: Mechanism of Action,Consciousness,Spirituality,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neuropharm.2022.109220
text_rights_status: unverified_not_redistributed
title:
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.

authors:
Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35987353","source_url":"https://doi.org/10.1016/j.neuropharm.2022.109220","doi":"10.1016/j.neuropharm.2022.109220","pmid":"35987353","publication_date":"2022-08-16","importer_version":"2.1.3","text_redistributed":false}


journal: Psychopharmacology
publication_date: 2022-08-07
doi: 10.1007/s00213-022-06187-5
pubmed_id: 35939083
source_url: https://doi.org/10.1007/s00213-022-06187-5
source_record_id: PMID:35939083
substance_tags: psilocybin
topic_tags: Depression,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Observational Study
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-022-06187-5
text_rights_status: unverified_not_redistributed
title:
The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.

authors:
Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L, Timmermann C, Nour MM, Kaelen M, Nutt D, Carhart-Harris R, Roseman L.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35939083","source_url":"https://doi.org/10.1007/s00213-022-06187-5","doi":"10.1007/s00213-022-06187-5","pmid":"35939083","publication_date":"2022-08-07","importer_version":"2.1.3","text_redistributed":false}


authors: Berens N, Kim SY.
publication_date: 2022-07-10
doi: 10.1016/j.jagp.2022.07.003
pubmed_id: 35927119
source_url: https://doi.org/10.1016/j.jagp.2022.07.003
source_record_id: PMID:35927119
substance_tags: psilocybin
topic_tags: Depression,End-of-Life Distress,Case Report,Healthcare Workers
study_type: Case Report
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jagp.2022.07.003
text_rights_status: unverified_not_redistributed
title:
Rapid-Response Treatments for Depression and Requests for Physician-Assisted Death: An Ethical Analysis.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35927119","source_url":"https://doi.org/10.1016/j.jagp.2022.07.003","doi":"10.1016/j.jagp.2022.07.003","pmid":"35927119","publication_date":"2022-07-10","importer_version":"2.1.3","text_redistributed":false}


authors: Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM, Ursano RJ, Canales JJ, Johnson LR.
publication_date: 2022-04-26
doi: 10.1016/j.pharmthera.2022.108195
pubmed_id: 35489438
source_url: https://doi.org/10.1016/j.pharmthera.2022.108195
source_record_id: PMID:35489438
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Animal Study
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.pharmthera.2022.108195
text_rights_status: unverified_not_redistributed
title:
Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35489438","source_url":"https://doi.org/10.1016/j.pharmthera.2022.108195","doi":"10.1016/j.pharmthera.2022.108195","pmid":"35489438","publication_date":"2022-04-26","importer_version":"2.1.3","text_redistributed":false}


authors: Altman BR, Earleywine M, De Leo J.
journal: Journal of Psychoactive Drugs
publication_date: 2022-01-02
doi: 10.1080/02791072.2021.2020382
pubmed_id: 34979875
source_url: https://doi.org/10.1080/02791072.2021.2020382
source_record_id: PMID:34979875
substance_tags: psilocybin
topic_tags: Depression,Healthcare Workers,Adverse Events
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/02791072.2021.2020382
text_rights_status: unverified_not_redistributed
title:
Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34979875","source_url":"https://doi.org/10.1080/02791072.2021.2020382","doi":"10.1080/02791072.2021.2020382","pmid":"34979875","publication_date":"2022-01-02","importer_version":"2.1.3","text_redistributed":false}


authors: Mohamed A, Touheed S, Ahmed M, Hor M, Fatima S
journal: Cureus
publication_date: 2022-09-30
doi: 10.7759/cureus.30919
pubmed_id: 36465766
source_url: https://pubmed.ncbi.nlm.nih.gov/36465766/
source_record_id: PMID:36465766
substance_tags: psilocybin
topic_tags: PTSD,Aging,Review Article
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36465766/
text_rights_status: unverified_not_redistributed
title:
The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36465766","source_url":"https://pubmed.ncbi.nlm.nih.gov/36465766/","doi":"10.7759/cureus.30919","pmid":"36465766","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Li SN, Xu F, Long P, Liu F, Zhang P, Fan YG, Chen ZH.
journal: Frontiers in Microbiology
publication_date: 2022-10-30
doi: 10.3389/fmicb.2022.1021583
pubmed_id: 36386664
source_url: https://doi.org/10.3389/fmicb.2022.1021583
source_record_id: PMID:36386664
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fmicb.2022.1021583
text_rights_status: unverified_not_redistributed
title:
Five new species of Inosperma from China: Morphological characteristics, phylogenetic analyses, and toxin detection.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36386664","source_url":"https://doi.org/10.3389/fmicb.2022.1021583","doi":"10.3389/fmicb.2022.1021583","pmid":"36386664","publication_date":"2022-10-30","importer_version":"2.1.3","text_redistributed":false}


title: Electrical spiking of psilocybin fungi.
authors: Gandia A, Adamatzky A.
journal: Communicative & Integrative Biology
publication_date: 2022-10-23
doi: 10.1080/19420889.2022.2136118
pubmed_id: 36311546
source_url: https://doi.org/10.1080/19420889.2022.2136118
source_record_id: PMID:36311546
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/19420889.2022.2136118
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36311546","source_url":"https://doi.org/10.1080/19420889.2022.2136118","doi":"10.1080/19420889.2022.2136118","pmid":"36311546","publication_date":"2022-10-23","importer_version":"2.1.3","text_redistributed":false}


authors: Gaddis A, Lidstone DE, Nebel MB, Griffiths RR, Mostofsky SH, Mejia AF, Barrett FS.
journal: NeuroImage
publication_date: 2022-07-01
doi: 10.1016/j.neuroimage.2022.119434
pubmed_id: 35792293
source_url: https://doi.org/10.1016/j.neuroimage.2022.119434
source_record_id: PMID:35792293
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neuroimage.2022.119434
text_rights_status: unverified_not_redistributed
title:
Psilocybin induces spatially constrained alterations in thalamic functional organizaton and connectivity.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35792293","source_url":"https://doi.org/10.1016/j.neuroimage.2022.119434","doi":"10.1016/j.neuroimage.2022.119434","pmid":"35792293","publication_date":"2022-07-01","importer_version":"2.1.3","text_redistributed":false}


authors: Jensen ME, Jensen ME, Stenbæk DS, Juul TS, Fisher PM, Ekstrøm CT, Knudsen GM, Fink-Jensen A.
journal: BMJ Open
publication_date: 2022-10-13
doi: 10.1136/bmjopen-2022-066019
pubmed_id: 36241352
source_url: https://doi.org/10.1136/bmjopen-2022-066019
source_record_id: PMID:36241352
substance_tags: psilocybin,psilocin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1136/bmjopen-2022-066019
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial).

topic_tags:
Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Review Article

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36241352","source_url":"https://doi.org/10.1136/bmjopen-2022-066019","doi":"10.1136/bmjopen-2022-066019","pmid":"36241352","publication_date":"2022-10-13","importer_version":"2.1.3","text_redistributed":false}


title: Potential Therapeutic Effects of Psilocybin: A Systematic Review.
authors: Goel DB, Zilate S.
publication_date: 2022-10-11
doi: 10.7759/cureus.30214
pubmed_id: 36381758
source_url: https://doi.org/10.7759/cureus.30214
source_record_id: PMID:36381758
substance_tags: psilocybin
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.7759/cureus.30214
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Spirituality,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Contraindications

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36381758","source_url":"https://doi.org/10.7759/cureus.30214","doi":"10.7759/cureus.30214","pmid":"36381758","publication_date":"2022-10-11","importer_version":"2.1.3","text_redistributed":false}


authors: Sottile RJ, Vida T.
publication_date: 2022-10-11
doi: 10.3389/fpsyt.2022.991753
pubmed_id: 36311515
source_url: https://doi.org/10.3389/fpsyt.2022.991753
source_record_id: PMID:36311515
substance_tags: psilocybin
topic_tags: Anxiety,PTSD,Mechanism of Action,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2022.991753
text_rights_status: unverified_not_redistributed
title:
A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36311515","source_url":"https://doi.org/10.3389/fpsyt.2022.991753","doi":"10.3389/fpsyt.2022.991753","pmid":"36311515","publication_date":"2022-10-11","importer_version":"2.1.3","text_redistributed":false}


authors: Jones GM, Nock MK.
journal: Scientific Reports
publication_date: 2022-10-09
doi: 10.1038/s41598-022-18645-3
pubmed_id: 36216840
source_url: https://doi.org/10.1038/s41598-022-18645-3
source_record_id: PMID:36216840
substance_tags: psilocybin
topic_tags: Observational Study,Drug Interactions
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41598-022-18645-3
text_rights_status: unverified_not_redistributed
title:
Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36216840","source_url":"https://doi.org/10.1038/s41598-022-18645-3","doi":"10.1038/s41598-022-18645-3","pmid":"36216840","publication_date":"2022-10-09","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin: a revolution in psychedelic medicines in the US?
authors: Silberner J.
journal: BMJ
publication_date: 2022-10-05
doi: 10.1136/bmj.o2178
pubmed_id: 36202403
source_url: https://doi.org/10.1136/bmj.o2178
source_record_id: PMID:36202403
substance_tags: psilocybin
topic_tags: Emotional Processing
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36202403","source_url":"https://doi.org/10.1136/bmj.o2178","doi":"10.1136/bmj.o2178","pmid":"36202403","publication_date":"2022-10-05","importer_version":"2.1.3","text_redistributed":false}


authors: Søndergaard A, Madsen MK, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS.
journal: Frontiers in Psychology
publication_date: 2022-10-04
doi: 10.3389/fpsyg.2022.948729
pubmed_id: 36275302
source_url: https://doi.org/10.3389/fpsyg.2022.948729
source_record_id: PMID:36275302
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Mystical Experience,Healthy Volunteers
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyg.2022.948729
text_rights_status: unverified_not_redistributed
title:
Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36275302","source_url":"https://doi.org/10.3389/fpsyg.2022.948729","doi":"10.3389/fpsyg.2022.948729","pmid":"36275302","publication_date":"2022-10-04","importer_version":"2.1.3","text_redistributed":false}


title: Chinese Cordyceps: Bioactive Components, Antitumor Effects and Underlying Mechanism-A Review.
authors: Liu Y, Guo ZJ, Zhou XW
journal: Molecules (Basel, Switzerland)
publication_date: 2022-10-03
doi: 10.3390/molecules27196576
pubmed_id: 36235111
source_url: https://pubmed.ncbi.nlm.nih.gov/36235111/
source_record_id: PMID:36235111
substance_tags: psilocybin
topic_tags: Mechanism of Action,Review Article,Immune Function
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 06:54:13
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36235111/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36235111","source_url":"https://pubmed.ncbi.nlm.nih.gov/36235111/","doi":"10.3390/molecules27196576","pmid":"36235111","publication_date":"2022-10-03","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Treatment of Alcohol Use Disorder.
authors: Slomski A.
journal: JAMA
publication_date: 2022-09-30
doi: 10.1001/jama.2022.15436
pubmed_id: 36194230
source_url: https://doi.org/10.1001/jama.2022.15436
source_record_id: PMID:36194230
substance_tags: psilocybin
topic_tags: Addiction
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36194230","source_url":"https://doi.org/10.1001/jama.2022.15436","doi":"10.1001/jama.2022.15436","pmid":"36194230","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-10-02
doi: 10.3389/fpsyt.2022.990405
pubmed_id: 36262632
source_url: https://doi.org/10.3389/fpsyt.2022.990405
source_record_id: PMID:36262632
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2022.990405
text_rights_status: unverified_not_redistributed
title:
3,4-Methylenedioxy methamphetamine, synthetic cathinones and psychedelics: From recreational to novel psychotherapeutic drugs.

authors:
López-Arnau R, Camarasa J, Carbó ML, Nadal-Gratacós N, Puigseslloses P, Espinosa-Velasco M, Urquizu E, Escubedo E, Pubill D.

topic_tags:
Depression,PTSD,Mechanism of Action,Consciousness,Review Article,Treatment-Resistant Depression,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36262632","source_url":"https://doi.org/10.3389/fpsyt.2022.990405","doi":"10.3389/fpsyt.2022.990405","pmid":"36262632","publication_date":"2022-10-02","importer_version":"2.1.3","text_redistributed":false}


journal: Nature Communications
publication_date: 2022-10-02
doi: 10.1038/s41467-022-33578-1
pubmed_id: 36192411
source_url: https://doi.org/10.1038/s41467-022-33578-1
source_record_id: PMID:36192411
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Aging
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41467-022-33578-1
text_rights_status: unverified_not_redistributed
title:
Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.

authors:
Singleton SP, Luppi AI, Carhart-Harris RL, Cruzat J, Roseman L, Nutt DJ, Deco G, Kringelbach ML, Stamatakis EA, Kuceyeski A.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36192411","source_url":"https://doi.org/10.1038/s41467-022-33578-1","doi":"10.1038/s41467-022-33578-1","pmid":"36192411","publication_date":"2022-10-02","importer_version":"2.1.3","text_redistributed":false}


title: Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.
journal: Network Neuroscience
publication_date: 2022-09-30
doi: 10.1162/netn_a_00250
pubmed_id: 38800462
source_url: https://doi.org/10.1162/netn_a_00250
source_record_id: PMID:38800462
substance_tags: psilocybin
topic_tags: Mechanism of Action,Default Mode Network
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1162/netn_a_00250
text_rights_status: unverified_not_redistributed
authors:
Cruzat J, Perl YS, Escrichs A, Vohryzek J, Timmermann C, Roseman L, Luppi AI, Ibañez A, Nutt D, Carhart-Harris R, Tagliazucchi E, Deco G, Kringelbach ML.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:38800462","source_url":"https://doi.org/10.1162/netn_a_00250","doi":"10.1162/netn_a_00250","pmid":"38800462","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


title: Microdosing with classical psychedelics: Research trajectories and practical considerations.
authors: Wong A, Raz A.
publication_date: 2022-10-30
doi: 10.1177/13634615221129115
pubmed_id: 36317302
source_url: https://doi.org/10.1177/13634615221129115
source_record_id: PMID:36317302
substance_tags: psilocybin
topic_tags: Consciousness,Microdosing,Creativity,Healthcare Workers
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/13634615221129115
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36317302","source_url":"https://doi.org/10.1177/13634615221129115","doi":"10.1177/13634615221129115","pmid":"36317302","publication_date":"2022-10-30","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice.
authors: Gobbi G, Inserra A, Greenway KT, Lifshitz M, Kirmayer LJ
journal: Transcultural psychiatry
publication_date: 2022-09-30
doi: 10.1177/13634615221119388
pubmed_id: 36263521
source_url: https://pubmed.ncbi.nlm.nih.gov/36263521/
source_record_id: PMID:36263521
substance_tags: psilocybin
topic_tags: Mechanism of Action,Consciousness,Spirituality,Adverse Events
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36263521/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36263521","source_url":"https://pubmed.ncbi.nlm.nih.gov/36263521/","doi":"10.1177/13634615221119388","pmid":"36263521","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Dupuis D, Veissière S.
publication_date: 2022-10-18
doi: 10.1177/13634615221131465
pubmed_id: 36263513
source_url: https://doi.org/10.1177/13634615221131465
source_record_id: PMID:36263513
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Mechanism of Action,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/13634615221131465
text_rights_status: unverified_not_redistributed
title:
Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36263513","source_url":"https://doi.org/10.1177/13634615221131465","doi":"10.1177/13634615221131465","pmid":"36263513","publication_date":"2022-10-18","importer_version":"2.1.3","text_redistributed":false}


title: Animal Behavior in Psychedelic Research.
authors: Odland AU, Kristensen JL, Andreasen JT.
publication_date: 2022-09-30
doi: 10.1124/pharmrev.122.000590
pubmed_id: 36180111
source_url: https://doi.org/10.1124/pharmrev.122.000590
source_record_id: PMID:36180111
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1124/pharmrev.122.000590
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Receptor Pharmacology,Consciousness,Emotional Processing,Review Article,Drug Interactions

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36180111","source_url":"https://doi.org/10.1124/pharmrev.122.000590","doi":"10.1124/pharmrev.122.000590","pmid":"36180111","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


title: The Emerging Field of Psychedelic Psychotherapy.
authors: Barber GS, Aaronson ST.
publication_date: 2022-09-20
doi: 10.1007/s11920-022-01363-y
pubmed_id: 36129571
source_url: https://doi.org/10.1007/s11920-022-01363-y
source_record_id: PMID:36129571
substance_tags: psilocybin
topic_tags: Depression,PTSD,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s11920-022-01363-y
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36129571","source_url":"https://doi.org/10.1007/s11920-022-01363-y","doi":"10.1007/s11920-022-01363-y","pmid":"36129571","publication_date":"2022-09-20","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-09-11
doi: 10.1007/s40263-022-00944-y
pubmed_id: 36097251
source_url: https://doi.org/10.1007/s40263-022-00944-y
source_record_id: PMID:36097251
substance_tags: psilocybin
topic_tags: Randomized Controlled Trial,Systematic Review,Review Article
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s40263-022-00944-y
text_rights_status: unverified_not_redistributed
title:
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.

authors:
Pouyan N, Halvaei Khankahdani Z, Younesi Sisi F, Lee Y, Rosenblat JD, Teopiz KM, Lui LMW, Subramaniapillai M, Lin K, Nasri F, Rodrigues N, Gill H, Lipsitz O, Cao B, Ho R, Castle D, McIntyre RS.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36097251","source_url":"https://doi.org/10.1007/s40263-022-00944-y","doi":"10.1007/s40263-022-00944-y","pmid":"36097251","publication_date":"2022-09-11","importer_version":"2.1.3","text_redistributed":false}


title: Why Otolaryngologists Should Be Interested in Psychedelic Medicine.
authors: Asher BF
journal: Otolaryngologic clinics of North America
publication_date: 2022-09-30
doi: 10.1016/j.otc.2022.06.002
pubmed_id: 36088153
source_url: https://pubmed.ncbi.nlm.nih.gov/36088153/
source_record_id: PMID:36088153
substance_tags: psilocybin
topic_tags: Contraindications
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36088153/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36088153","source_url":"https://pubmed.ncbi.nlm.nih.gov/36088153/","doi":"10.1016/j.otc.2022.06.002","pmid":"36088153","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


title: Expectancy in placebo-controlled trials of psychedelics: if so, so what?
authors: Butler M, Jelen L, Rucker J
journal: Psychopharmacology
publication_date: 2022-09-30
doi: 10.1007/s00213-022-06221-6
pubmed_id: 36063208
source_url: https://pubmed.ncbi.nlm.nih.gov/36063208/
source_record_id: PMID:36063208
substance_tags: psilocybin
topic_tags: Clinical Trial,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36063208/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36063208","source_url":"https://pubmed.ncbi.nlm.nih.gov/36063208/","doi":"10.1007/s00213-022-06221-6","pmid":"36063208","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Erkizia-Santamaría I, Alles-Pascual R, Horrillo I, Meana JJ, Ortega JE.
journal: Biomedicine & Pharmacotherapy
publication_date: 2022-08-29
doi: 10.1016/j.biopha.2022.113612
pubmed_id: 36049313
source_url: https://doi.org/10.1016/j.biopha.2022.113612
source_record_id: PMID:36049313
substance_tags: psilocybin,psilocin
topic_tags: Mechanism of Action,Receptor Pharmacology,Animal Study,In Vitro Study,Adverse Events
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.biopha.2022.113612
text_rights_status: unverified_not_redistributed
title:
Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36049313","source_url":"https://doi.org/10.1016/j.biopha.2022.113612","doi":"10.1016/j.biopha.2022.113612","pmid":"36049313","publication_date":"2022-08-29","importer_version":"2.1.3","text_redistributed":false}


title: Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.
authors: Kaypak AC, Raz A.
publication_date: 2022-08-28
doi: 10.1177/13634615221119386
pubmed_id: 36031848
source_url: https://doi.org/10.1177/13634615221119386
source_record_id: PMID:36031848
substance_tags: psilocybin
topic_tags: Microdosing,Creativity,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/13634615221119386
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36031848","source_url":"https://doi.org/10.1177/13634615221119386","doi":"10.1177/13634615221119386","pmid":"36031848","publication_date":"2022-08-28","importer_version":"2.1.3","text_redistributed":false}


authors: Breeksema JJ, Kuin BW, Kamphuis J, van den Brink W, Vermetten E, Schoevers RA.
publication_date: 2022-08-25
doi: 10.1177/02698811221116926
pubmed_id: 36017784
source_url: https://doi.org/10.1177/02698811221116926
source_record_id: PMID:36017784
substance_tags: psilocybin
topic_tags: Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Adverse Events
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811221116926
text_rights_status: unverified_not_redistributed
title:
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36017784","source_url":"https://doi.org/10.1177/02698811221116926","doi":"10.1177/02698811221116926","pmid":"36017784","publication_date":"2022-08-25","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-09-30
doi: 10.1001/jamapsychiatry.2022.2096
pubmed_id: 36001306
source_url: https://doi.org/10.1001/jamapsychiatry.2022.2096
source_record_id: PMID:36001306
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Adverse Events
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1001/jamapsychiatry.2022.2096
text_rights_status: unverified_not_redistributed
title:
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.

authors:
Bogenschutz MP, Ross S, Bhatt S, Baron T, Forcehimes AA, Laska E, Mennenga SE, O'Donnell K, Owens LT, Podrebarac S, Rotrosen J, Tonigan JS, Worth L.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36001306","source_url":"https://doi.org/10.1001/jamapsychiatry.2022.2096","doi":"10.1001/jamapsychiatry.2022.2096","pmid":"36001306","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


title: Prevalence and associations of classic psychedelic-related seizures in a population-based sample.
authors: Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS
journal: Drug and alcohol dependence
publication_date: 2022-09-30
doi: 10.1016/j.drugalcdep.2022.109586
pubmed_id: 35981469
source_url: https://pubmed.ncbi.nlm.nih.gov/35981469/
source_record_id: PMID:35981469
substance_tags: psilocybin
topic_tags: Addiction,Safety
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35981469/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35981469","source_url":"https://pubmed.ncbi.nlm.nih.gov/35981469/","doi":"10.1016/j.drugalcdep.2022.109586","pmid":"35981469","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


title: New investigational agents for the treatment of major depressive disorder.
authors: Pochwat B, Krupa AJ, Siwek M, Szewczyk B
journal: Expert opinion on investigational drugs
publication_date: 2022-09-30
doi: 10.1080/13543784.2022.2113376
pubmed_id: 35975761
source_url: https://pubmed.ncbi.nlm.nih.gov/35975761/
source_record_id: PMID:35975761
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Receptor Pharmacology,Review Article
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35975761/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35975761","source_url":"https://pubmed.ncbi.nlm.nih.gov/35975761/","doi":"10.1080/13543784.2022.2113376","pmid":"35975761","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Barnett BS, Ziegler K, Doblin R, Carlo AD
journal: Journal of psychopharmacology (Oxford, England)
publication_date: 2022-09-30
doi: 10.1177/02698811221117536
pubmed_id: 35971893
source_url: https://pubmed.ncbi.nlm.nih.gov/35971893/
source_record_id: PMID:35971893
substance_tags: psilocybin
topic_tags: Case Report,Observational Study,In Vitro Study
study_type: Case Report
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35971893/
text_rights_status: unverified_not_redistributed
title:
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35971893","source_url":"https://pubmed.ncbi.nlm.nih.gov/35971893/","doi":"10.1177/02698811221117536","pmid":"35971893","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Levin A, Nagib PB, Deiparine S, Gao T, Mitchell J, Davis AK.
publication_date: 2022-08-10
doi: 10.1016/j.drugpo.2022.103816
pubmed_id: 35964449
source_url: https://doi.org/10.1016/j.drugpo.2022.103816
source_record_id: PMID:35964449
substance_tags: psilocybin
topic_tags: Aging,Observational Study,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.drugpo.2022.103816
text_rights_status: unverified_not_redistributed
title:
Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35964449","source_url":"https://doi.org/10.1016/j.drugpo.2022.103816","doi":"10.1016/j.drugpo.2022.103816","pmid":"35964449","publication_date":"2022-08-10","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review.
authors: Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J.
publication_date: 2022-08-11
doi: 10.1007/s11920-022-01361-0
pubmed_id: 35953638
source_url: https://doi.org/10.1007/s11920-022-01361-0
source_record_id: PMID:35953638
substance_tags: psilocybin
topic_tags: Depression,End-of-Life Distress,Mechanism of Action,Clinical Trial,Review Article,Adverse Events
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s11920-022-01361-0
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35953638","source_url":"https://doi.org/10.1007/s11920-022-01361-0","doi":"10.1007/s11920-022-01361-0","pmid":"35953638","publication_date":"2022-08-11","importer_version":"2.1.3","text_redistributed":false}


authors: Pilc A, Machaczka A, Kawalec P, Smith JL, Witkin JM.
journal: Expert Opinion on Drug Discovery
publication_date: 2022-08-21
doi: 10.1080/17460441.2022.2111415
pubmed_id: 35934973
source_url: https://doi.org/10.1080/17460441.2022.2111415
source_record_id: PMID:35934973
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/17460441.2022.2111415
text_rights_status: unverified_not_redistributed
title:
Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35934973","source_url":"https://doi.org/10.1080/17460441.2022.2111415","doi":"10.1080/17460441.2022.2111415","pmid":"35934973","publication_date":"2022-08-21","importer_version":"2.1.3","text_redistributed":false}


authors: Meyer TD, Meir P, Lex C, Soares JC.
journal: Psychiatry Research
publication_date: 2022-07-15
doi: 10.1016/j.psychres.2022.114727
pubmed_id: 35878481
source_url: https://doi.org/10.1016/j.psychres.2022.114727
source_record_id: PMID:35878481
substance_tags: psilocybin
topic_tags: Depression,Emotional Processing,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.psychres.2022.114727
text_rights_status: unverified_not_redistributed
title:
Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35878481","source_url":"https://doi.org/10.1016/j.psychres.2022.114727","doi":"10.1016/j.psychres.2022.114727","pmid":"35878481","publication_date":"2022-07-15","importer_version":"2.1.3","text_redistributed":false}


authors: Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC
journal: The journal of pain
publication_date: 2022-09-30
doi: 10.1016/j.jpain.2022.05.003
pubmed_id: 35643270
source_url: https://pubmed.ncbi.nlm.nih.gov/35643270/
source_record_id: PMID:35643270
substance_tags: psilocybin
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35643270/
text_rights_status: unverified_not_redistributed
title:
If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.

topic_tags:
Chronic Pain,Headache / Migraine,Mechanism of Action,Consciousness,Spirituality,Mystical Experience,Clinical Trial,Safety

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35643270","source_url":"https://pubmed.ncbi.nlm.nih.gov/35643270/","doi":"10.1016/j.jpain.2022.05.003","pmid":"35643270","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Timmermann C, Watts R, Dupuis D
journal: Transcultural psychiatry
publication_date: 2022-09-30
doi: 10.1177/13634615221082796
pubmed_id: 35313754
source_url: https://pubmed.ncbi.nlm.nih.gov/35313754/
source_record_id: PMID:35313754
substance_tags: psilocybin
topic_tags: Safety
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35313754/
text_rights_status: unverified_not_redistributed
title:
Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35313754","source_url":"https://pubmed.ncbi.nlm.nih.gov/35313754/","doi":"10.1177/13634615221082796","pmid":"35313754","publication_date":"2022-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Psiuk D, Nowak EM, Dycha N, Łopuszańska U, Kurzepa J, Samardakiewicz M.
publication_date: 2022-09-27
doi: 10.3390/ijms231911450
pubmed_id: 36232748
source_url: https://doi.org/10.3390/ijms231911450
source_record_id: PMID:36232748
substance_tags: psilocybin
topic_tags: Depression,Systematic Review,Review Article
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ijms231911450
text_rights_status: unverified_not_redistributed
title:
Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36232748","source_url":"https://doi.org/10.3390/ijms231911450","doi":"10.3390/ijms231911450","pmid":"36232748","publication_date":"2022-09-27","importer_version":"2.1.3","text_redistributed":false}


title: Differences across sexes on head-twitch behavior and 5-HT2A receptor signaling in C57BL/6J mice.
authors: Jaster AM, Younkin J, Cuddy T, de la Fuente Revenga M, Poklis JL, Dozmorov MG, González-Maeso J.
publication_date: 2022-08-09
doi: 10.1016/j.neulet.2022.136836
pubmed_id: 35963476
source_url: https://doi.org/10.1016/j.neulet.2022.136836
source_record_id: PMID:35963476
substance_tags: psilocybin
topic_tags: Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neulet.2022.136836
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35963476","source_url":"https://doi.org/10.1016/j.neulet.2022.136836","doi":"10.1016/j.neulet.2022.136836","pmid":"35963476","publication_date":"2022-08-09","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic drugs for psychiatric disorders.
authors: da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M.
publication_date: 2022-07-04
doi: 10.1016/j.jns.2022.120332
pubmed_id: 35841696
source_url: https://doi.org/10.1016/j.jns.2022.120332
source_record_id: PMID:35841696
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jns.2022.120332
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,End-of-Life Distress,Consciousness,Aging,Spirituality,Clinical Trial,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35841696","source_url":"https://doi.org/10.1016/j.jns.2022.120332","doi":"10.1016/j.jns.2022.120332","pmid":"35841696","publication_date":"2022-07-04","importer_version":"2.1.3","text_redistributed":false}


journal: Cureus
publication_date: 2022-08-31
doi: 10.7759/cureus.29167
pubmed_id: 36259015
source_url: https://pubmed.ncbi.nlm.nih.gov/36259015/
source_record_id: PMID:36259015
substance_tags: psilocybin
topic_tags: Depression,PTSD,Addiction,Receptor Pharmacology,Clinical Trial
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36259015/
text_rights_status: unverified_not_redistributed
title:
The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.

authors:
Kurtz JS, Patel NA, Gendreau JL, Yang C, Brown N, Bui N, Picton B, Harris M, Hatter M, Beyer R, Sahyouni R, Diaz-Aguilar LD, Castellanos J, Schuster N, Abraham ME

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36259015","source_url":"https://pubmed.ncbi.nlm.nih.gov/36259015/","doi":"10.7759/cureus.29167","pmid":"36259015","publication_date":"2022-08-31","importer_version":"2.1.3","text_redistributed":false}


title: Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.
authors: Mellner C, Dahlen M, Simonsson O
journal: International journal of environmental research and public health
publication_date: 2022-09-08
doi: 10.3390/ijerph191811353
pubmed_id: 36141631
source_url: https://pubmed.ncbi.nlm.nih.gov/36141631/
source_record_id: PMID:36141631
substance_tags: psilocybin
topic_tags: Mechanism of Action,Observational Study,Safety
study_type: Observational Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/36141631/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:36141631","source_url":"https://pubmed.ncbi.nlm.nih.gov/36141631/","doi":"10.3390/ijerph191811353","pmid":"36141631","publication_date":"2022-09-08","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin therapy reduces heavy drinking.
authors: O'Leary K.
journal: Nature Medicine
publication_date: 2022-09-07
doi: 10.1038/d41591-022-00093-1
pubmed_id: 36076081
source_url: https://doi.org/10.1038/d41591-022-00093-1
source_record_id: PMID:36076081
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36076081","source_url":"https://doi.org/10.1038/d41591-022-00093-1","doi":"10.1038/d41591-022-00093-1","pmid":"36076081","publication_date":"2022-09-07","importer_version":"2.1.3","text_redistributed":false}


title: Skepticism about Recent Evidence That Psilocybin "Liberates" Depressed Minds.
authors: Doss MK, Barrett FS, Corlett PR.
journal: ACS Chemical Neuroscience
publication_date: 2022-08-23
doi: 10.1021/acschemneuro.2c00461
pubmed_id: 36001741
source_url: https://doi.org/10.1021/acschemneuro.2c00461
source_record_id: PMID:36001741
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Receptor Pharmacology,Aging,Drug Interactions
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1021/acschemneuro.2c00461
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36001741","source_url":"https://doi.org/10.1021/acschemneuro.2c00461","doi":"10.1021/acschemneuro.2c00461","pmid":"36001741","publication_date":"2022-08-23","importer_version":"2.1.3","text_redistributed":false}


title: Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.
authors: Barba T, Buehler S, Kettner H, Radu C, Cunha BG, Nutt DJ, Erritzoe D, Roseman L, Carhart-Harris R.
journal: BJPsych Open
publication_date: 2022-09-05
doi: 10.1192/bjo.2022.565
pubmed_id: 36065128
source_url: https://doi.org/10.1192/bjo.2022.565
source_record_id: PMID:36065128
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Drug Interactions
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1192/bjo.2022.565
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36065128","source_url":"https://doi.org/10.1192/bjo.2022.565","doi":"10.1192/bjo.2022.565","pmid":"36065128","publication_date":"2022-09-05","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics for Alzheimer's Disease Palliative Care.
authors: McManus KR, Patrick R, Striepe MI, Drury MJ, Ozonsi R, Forester BP, Weinberg MS
journal: Advances in psychiatry and behavioral health
publication_date: 2022-08-31
doi: 10.1016/j.ypsc.2022.06.001
pubmed_id: 37786540
source_url: https://pubmed.ncbi.nlm.nih.gov/37786540/
source_record_id: PMID:37786540
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Aging
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:37786540","source_url":"https://pubmed.ncbi.nlm.nih.gov/37786540/","doi":"10.1016/j.ypsc.2022.06.001","pmid":"37786540","publication_date":"2022-08-31","importer_version":"2.1.3","text_redistributed":false}


authors: Clifton JM, Belcher AM, Greenblatt AD, Welsh CM, Cole TO, Davis AK.
journal: Journal of Psychedelic Studies
publication_date: 2022-08-04
doi: 10.1556/2054.2022.00214
pubmed_id: 36686617
source_url: https://doi.org/10.1556/2054.2022.00214
source_record_id: PMID:36686617
substance_tags: psilocybin
topic_tags: Addiction,Observational Study,Safety
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1556/2054.2022.00214
text_rights_status: unverified_not_redistributed
title:
Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36686617","source_url":"https://doi.org/10.1556/2054.2022.00214","doi":"10.1556/2054.2022.00214","pmid":"36686617","publication_date":"2022-08-04","importer_version":"2.1.3","text_redistributed":false}


title: Use of psychedelics in the Czech Republic: results of recent population surveys.
authors: Chomynová P, Kočárová R, Kňažek F, Plevková M, Bláhová B, Valeš K, Mravčík V.
journal: Central European Journal of Public Health
publication_date: 2022-08-31
doi: 10.21101/cejph.a7079
pubmed_id: 36239361
source_url: https://doi.org/10.21101/cejph.a7079
source_record_id: PMID:36239361
substance_tags: psilocybin
topic_tags: Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.21101/cejph.a7079
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36239361","source_url":"https://doi.org/10.21101/cejph.a7079","doi":"10.21101/cejph.a7079","pmid":"36239361","publication_date":"2022-08-31","importer_version":"2.1.3","text_redistributed":false}


title: [The use of psilocybin for treatment-resistant depression].
authors: Johannesdottir A, Sigurdsson E.
publication_date: 2022-08-31
doi: 10.17992/lbl.2022.09.706
pubmed_id: 36040772
source_url: https://doi.org/10.17992/lbl.2022.09.706
source_record_id: PMID:36040772
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:01
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.17992/lbl.2022.09.706
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Headache / Migraine,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36040772","source_url":"https://doi.org/10.17992/lbl.2022.09.706","doi":"10.17992/lbl.2022.09.706","pmid":"36040772","publication_date":"2022-08-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics as preventive treatment in headache and chronic pain disorders.
authors: Schindler EAD.
publication_date: 2022-06-15
doi: 10.1016/j.neuropharm.2022.109166
pubmed_id: 35718005
source_url: https://doi.org/10.1016/j.neuropharm.2022.109166
source_record_id: PMID:35718005
substance_tags: psilocybin
topic_tags: Chronic Pain,Headache / Migraine,Mechanism of Action,Review Article,Safety
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neuropharm.2022.109166
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35718005","source_url":"https://doi.org/10.1016/j.neuropharm.2022.109166","doi":"10.1016/j.neuropharm.2022.109166","pmid":"35718005","publication_date":"2022-06-15","importer_version":"2.1.3","text_redistributed":false}


title: Natural language signatures of psilocybin microdosing.
journal: Psychopharmacology
publication_date: 2022-06-08
doi: 10.1007/s00213-022-06170-0
pubmed_id: 35676541
source_url: https://doi.org/10.1007/s00213-022-06170-0
source_record_id: PMID:35676541
substance_tags: psilocybin
topic_tags: Microdosing,Wellbeing,Creativity
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-022-06170-0
text_rights_status: unverified_not_redistributed
authors:
Sanz C, Cavanna F, Muller S, de la Fuente L, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Carrillo F, García AM, Pallavicini C, Tagliazucchi E.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35676541","source_url":"https://doi.org/10.1007/s00213-022-06170-0","doi":"10.1007/s00213-022-06170-0","pmid":"35676541","publication_date":"2022-06-08","importer_version":"2.1.3","text_redistributed":false}


title: Magic mushroom extracts in lipid membranes.
authors: Nguyen TQT, Lund FW, Zanjani AAH, Khandelia H.
journal: Biochimica et Biophysica Acta (BBA) - Biomembranes
publication_date: 2022-05-09
doi: 10.1016/j.bbamem.2022.183957
pubmed_id: 35561790
source_url: https://doi.org/10.1016/j.bbamem.2022.183957
source_record_id: PMID:35561790
substance_tags: psilocybin,psilocin
topic_tags: Depression,Addiction,Receptor Pharmacology,Treatment-Resistant Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.bbamem.2022.183957
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35561790","source_url":"https://doi.org/10.1016/j.bbamem.2022.183957","doi":"10.1016/j.bbamem.2022.183957","pmid":"35561790","publication_date":"2022-05-09","importer_version":"2.1.3","text_redistributed":false}


authors: Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J.
publication_date: 2022-01-26
doi: 10.1080/02791072.2021.1983673
pubmed_id: 35083957
source_url: https://doi.org/10.1080/02791072.2021.1983673
source_record_id: PMID:35083957
substance_tags: psilocybin
topic_tags: OCD,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
text_rights_status: not_applicable_no_text
title:
Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35083957","source_url":"https://doi.org/10.1080/02791072.2021.1983673","doi":"10.1080/02791072.2021.1983673","pmid":"35083957","publication_date":"2022-01-26","importer_version":"2.1.3","text_redistributed":false}


authors: Lehto RH, Miller M, Sender J.
journal: Journal of Holistic Nursing
publication_date: 2021-09-05
doi: 10.1177/08980101211039086
pubmed_id: 34482761
source_url: https://doi.org/10.1177/08980101211039086
source_record_id: PMID:34482761
substance_tags: psilocybin
topic_tags: Anxiety,Consciousness,Aging,Spirituality,Review Article,Healthcare Workers
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/08980101211039086
text_rights_status: unverified_not_redistributed
title:
The Role of Psilocybin-Assisted Psychotherapy to Support Patients With Cancer: A Critical Scoping Review of the Research.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34482761","source_url":"https://doi.org/10.1177/08980101211039086","doi":"10.1177/08980101211039086","pmid":"34482761","publication_date":"2021-09-05","importer_version":"2.1.3","text_redistributed":false}


authors: Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J
journal: Journal of psychoactive drugs
publication_date: 2021-12-31
doi: 10.1080/02791072.2021.1971343
pubmed_id: 34468293
source_url: https://pubmed.ncbi.nlm.nih.gov/34468293/
source_record_id: PMID:34468293
substance_tags: psilocybin
topic_tags: Observational Study,Safety
study_type: Observational Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34468293/
text_rights_status: unverified_not_redistributed
title:
Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34468293","source_url":"https://pubmed.ncbi.nlm.nih.gov/34468293/","doi":"10.1080/02791072.2021.1971343","pmid":"34468293","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Yan YY, Zhang YZ, Vauras J, Zhao LN, Fan YG, Li HJ, Xu F.
journal: MycoKeys
publication_date: 2022-08-29
doi: 10.3897/mycokeys.92.86277
pubmed_id: 36761319
source_url: https://doi.org/10.3897/mycokeys.92.86277
source_record_id: PMID:36761319
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3897/mycokeys.92.86277
text_rights_status: unverified_not_redistributed
title:
﻿ Pseudospermaarenarium (Inocybaceae), a new poisonous species from Eurasia, based on morphological, ecological, molecular and biochemical evidence.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36761319","source_url":"https://doi.org/10.3897/mycokeys.92.86277","doi":"10.3897/mycokeys.92.86277","pmid":"36761319","publication_date":"2022-08-29","importer_version":"2.1.3","text_redistributed":false}


authors: Sweeney MM, Nayak S, Hurwitz ES, Mitchell LN, Swift TC, Griffiths RR.
journal: PLoS ONE
publication_date: 2022-08-23
doi: 10.1371/journal.pone.0271926
pubmed_id: 36001643
source_url: https://doi.org/10.1371/journal.pone.0271926
source_record_id: PMID:36001643
substance_tags: psilocybin
topic_tags: Spirituality,Mystical Experience,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1371/journal.pone.0271926
text_rights_status: unverified_not_redistributed
title:
Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36001643","source_url":"https://doi.org/10.1371/journal.pone.0271926","doi":"10.1371/journal.pone.0271926","pmid":"36001643","publication_date":"2022-08-23","importer_version":"2.1.3","text_redistributed":false}


authors: Yao S, Wei C, Lin H, Zhang P, Liu Y, Deng Y, Huang Q, Xie B.
journal: Journal of Fungi
publication_date: 2022-08-17
doi: 10.3390/jof8080870
pubmed_id: 36012858
source_url: https://doi.org/10.3390/jof8080870
source_record_id: PMID:36012858
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Mechanism of Action,Transcriptomics
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/jof8080870
text_rights_status: unverified_not_redistributed
title:
Cystathionine Gamma-Lyase Regulate Psilocybin Biosynthesis in Gymnopilus dilepis Mushroom via Amino Acid Metabolism Pathways.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36012858","source_url":"https://doi.org/10.3390/jof8080870","doi":"10.3390/jof8080870","pmid":"36012858","publication_date":"2022-08-17","importer_version":"2.1.3","text_redistributed":false}


authors: Gumpper RH, Fay JF, Roth BL.
publication_date: 2022-07-31
doi: 10.1016/j.celrep.2022.111211
pubmed_id: 35977511
source_url: https://doi.org/10.1016/j.celrep.2022.111211
source_record_id: PMID:35977511
substance_tags: psilocin
topic_tags: Mechanism of Action,Receptor Pharmacology
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.celrep.2022.111211
text_rights_status: unverified_not_redistributed
title:
Molecular insights into the regulation of constitutive activity by RNA editing of 5HT2C serotonin receptors.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35977511","source_url":"https://doi.org/10.1016/j.celrep.2022.111211","doi":"10.1016/j.celrep.2022.111211","pmid":"35977511","publication_date":"2022-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Review of potential psychedelic treatments for PTSD.
authors: Henner RL, Keshavan MS, Hill KP.
publication_date: 2022-05-29
doi: 10.1016/j.jns.2022.120302
pubmed_id: 35700643
source_url: https://doi.org/10.1016/j.jns.2022.120302
source_record_id: PMID:35700643
substance_tags: psilocybin
topic_tags: PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jns.2022.120302
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35700643","source_url":"https://doi.org/10.1016/j.jns.2022.120302","doi":"10.1016/j.jns.2022.120302","pmid":"35700643","publication_date":"2022-05-29","importer_version":"2.1.3","text_redistributed":false}


authors: Ortiz CE, Dourron HM, Sweat NW, Garcia-Romeu A, MacCarthy S, Anderson BT, Hendricks PS.
publication_date: 2022-05-12
doi: 10.1016/j.neuropharm.2022.109127
pubmed_id: 35577136
source_url: https://doi.org/10.1016/j.neuropharm.2022.109127
source_record_id: PMID:35577136
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neuropharm.2022.109127
text_rights_status: unverified_not_redistributed
title:
Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35577136","source_url":"https://doi.org/10.1016/j.neuropharm.2022.109127","doi":"10.1016/j.neuropharm.2022.109127","pmid":"35577136","publication_date":"2022-05-12","importer_version":"2.1.3","text_redistributed":false}


title: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.
authors: Fadahunsi N, Lund J, Breum AW, Mathiesen CV, Larsen IB, Knudsen GM, Klein AB, Clemmensen C.
journal: Translational Psychiatry
publication_date: 2022-08-10
doi: 10.1038/s41398-022-02103-9
pubmed_id: 35953488
source_url: https://doi.org/10.1038/s41398-022-02103-9
source_record_id: PMID:35953488
substance_tags: psilocybin
topic_tags: Addiction,Neuroplasticity,Pharmacology,Consciousness,Microdosing,Animal Study,Transcriptomics
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41398-022-02103-9
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35953488","source_url":"https://doi.org/10.1038/s41398-022-02103-9","doi":"10.1038/s41398-022-02103-9","pmid":"35953488","publication_date":"2022-08-10","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2021-12-31
doi: 10.1177/24705470221115342
pubmed_id: 35936944
source_url: https://doi.org/10.1177/24705470221115342
source_record_id: PMID:35936944
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Mechanism of Action,Aging,Systematic Review,Review Article
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/24705470221115342
text_rights_status: unverified_not_redistributed
title:
Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review.

authors:
Kuburi S, Di Passa AM, Tassone VK, Mahmood R, Lalovic A, Ladha KS, Dunlop K, Rizvi S, Demchenko I, Bhat V.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35936944","source_url":"https://doi.org/10.1177/24705470221115342","doi":"10.1177/24705470221115342","pmid":"35936944","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study.
journal: Translational Psychiatry
publication_date: 2022-08-01
doi: 10.1038/s41398-022-02039-0
pubmed_id: 35918311
source_url: https://doi.org/10.1038/s41398-022-02039-0
source_record_id: PMID:35918311
substance_tags: psilocybin
topic_tags: Brain Imaging,Microdosing,Wellbeing,Creativity
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41398-022-02039-0
text_rights_status: unverified_not_redistributed
authors:
Cavanna F, Muller S, de la Fuente LA, Zamberlan F, Palmucci M, Janeckova L, Kuchar M, Pallavicini C, Tagliazucchi E.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35918311","source_url":"https://doi.org/10.1038/s41398-022-02039-0","doi":"10.1038/s41398-022-02039-0","pmid":"35918311","publication_date":"2022-08-01","importer_version":"2.1.3","text_redistributed":false}


authors: Makin S.
publication_date: 2022-07-31
doi: 10.1038/scientificamerican0822-12
pubmed_id: 39016786
source_url: https://doi.org/10.1038/scientificamerican0822-12
source_record_id: PMID:39016786
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
text_rights_status: not_applicable_no_text
title:
Mushrooms' Legal Trip: As psilocybin research ramps up, the drug's status under the law is shifting.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:39016786","source_url":"https://doi.org/10.1038/scientificamerican0822-12","doi":"10.1038/scientificamerican0822-12","pmid":"39016786","publication_date":"2022-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.
journal: Journal of psychopharmacology (Oxford, England)
publication_date: 2022-07-31
doi: 10.1177/02698811221101061
pubmed_id: 35924888
source_url: https://pubmed.ncbi.nlm.nih.gov/35924888/
source_record_id: PMID:35924888
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Emotional Processing,Mystical Experience,Observational Study
study_type: Observational Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35924888/
text_rights_status: unverified_not_redistributed
authors:
Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35924888","source_url":"https://pubmed.ncbi.nlm.nih.gov/35924888/","doi":"10.1177/02698811221101061","pmid":"35924888","publication_date":"2022-07-31","importer_version":"2.1.3","text_redistributed":false}


title: From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.
authors: Suleiman M, Basu A, Belal S, Jacob T.
journal: The Journal of Nervous and Mental Disease
publication_date: 2022-07-31
doi: 10.1097/nmd.0000000000001489
pubmed_id: 35900779
source_url: https://doi.org/10.1097/nmd.0000000000001489
source_record_id: PMID:35900779
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Microdosing
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1097/nmd.0000000000001489
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35900779","source_url":"https://doi.org/10.1097/nmd.0000000000001489","doi":"10.1097/nmd.0000000000001489","pmid":"35900779","publication_date":"2022-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.
authors: Rusanen SS, De S, Schindler EAD, Artto VA, Storvik M.
publication_date: 2022-06-26
doi: 10.1007/s11916-022-01063-5
pubmed_id: 35759175
source_url: https://doi.org/10.1007/s11916-022-01063-5
source_record_id: PMID:35759175
substance_tags: psilocybin
topic_tags: Headache / Migraine,Systematic Review,Review Article,Observational Study
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s11916-022-01063-5
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35759175","source_url":"https://doi.org/10.1007/s11916-022-01063-5","doi":"10.1007/s11916-022-01063-5","pmid":"35759175","publication_date":"2022-06-26","importer_version":"2.1.3","text_redistributed":false}


authors: Felsch CL, Kuypers KPC.
publication_date: 2022-06-05
doi: 10.1016/j.neubiorev.2022.104724
pubmed_id: 35679988
source_url: https://doi.org/10.1016/j.neubiorev.2022.104724
source_record_id: PMID:35679988
substance_tags: psilocybin
topic_tags: Anxiety,Mechanism of Action,Systematic Review,Review Article
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neubiorev.2022.104724
text_rights_status: unverified_not_redistributed
title:
Don't be afraid, try to meditate- potential effects on neural activity and connectivity of psilocybin-assisted mindfulness-based intervention for social anxiety disorder: A systematic review.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35679988","source_url":"https://doi.org/10.1016/j.neubiorev.2022.104724","doi":"10.1016/j.neubiorev.2022.104724","pmid":"35679988","publication_date":"2022-06-05","importer_version":"2.1.3","text_redistributed":false}


title: Phosphate moiety in FDA-approved pharmaceutical salts and prodrugs.
authors: Fulmali A, Bharate SS.
publication_date: 2022-06-01
doi: 10.1002/ddr.21953
pubmed_id: 35656613
source_url: https://doi.org/10.1002/ddr.21953
source_record_id: PMID:35656613
substance_tags: psilocybin
topic_tags: Pharmacology,Review Article,Toxicity
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/ddr.21953
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35656613","source_url":"https://doi.org/10.1002/ddr.21953","doi":"10.1002/ddr.21953","pmid":"35656613","publication_date":"2022-06-01","importer_version":"2.1.3","text_redistributed":false}


title: Postpartum depression: A role for psychedelics?
authors: Jairaj C, Rucker JJ.
publication_date: 2022-05-29
doi: 10.1177/02698811221093793
pubmed_id: 35638179
source_url: https://doi.org/10.1177/02698811221093793
source_record_id: PMID:35638179
substance_tags: psilocybin
topic_tags: Depression,Aging,Review Article,Safety
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811221093793
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35638179","source_url":"https://doi.org/10.1177/02698811221093793","doi":"10.1177/02698811221093793","pmid":"35638179","publication_date":"2022-05-29","importer_version":"2.1.3","text_redistributed":false}


authors: Polito V, Liknaitzky P
journal: Neuroscience and biobehavioral reviews
publication_date: 2022-07-31
doi: 10.1016/j.neubiorev.2022.104706
pubmed_id: 35609684
source_url: https://pubmed.ncbi.nlm.nih.gov/35609684/
source_record_id: PMID:35609684
substance_tags: psilocybin
study_type: Systematic Review
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35609684/
text_rights_status: unverified_not_redistributed
title:
The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.

topic_tags:
Chronic Pain,Consciousness,Microdosing,Wellbeing,Personality Change,Creativity,Systematic Review,Review Article,Safety

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35609684","source_url":"https://pubmed.ncbi.nlm.nih.gov/35609684/","doi":"10.1016/j.neubiorev.2022.104706","pmid":"35609684","publication_date":"2022-07-31","importer_version":"2.1.3","text_redistributed":false}


title: Analytical profile, in vitro metabolism and behavioral properties of the lysergamide 1P-AL-LAD.
journal: Drug Testing and Analysis
publication_date: 2022-05-28
doi: 10.1002/dta.3281
pubmed_id: 35524430
source_url: https://doi.org/10.1002/dta.3281
source_record_id: PMID:35524430
substance_tags: psilocybin
topic_tags: Pharmacology,Receptor Pharmacology,Animal Study,In Vitro Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/dta.3281
text_rights_status: unverified_not_redistributed
authors:
Brandt SD, Kavanagh PV, Westphal F, Pulver B, Schwelm HM, Whitelock K, Stratford A, Auwärter V, Halberstadt AL.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35524430","source_url":"https://doi.org/10.1002/dta.3281","doi":"10.1002/dta.3281","pmid":"35524430","publication_date":"2022-05-28","importer_version":"2.1.3","text_redistributed":false}


authors: Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R.
journal: NeuroImage
publication_date: 2022-04-24
doi: 10.1016/j.neuroimage.2022.119220
pubmed_id: 35483649
source_url: https://doi.org/10.1016/j.neuroimage.2022.119220
source_record_id: PMID:35483649
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Aging
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neuroimage.2022.119220
text_rights_status: unverified_not_redistributed
title:
Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35483649","source_url":"https://doi.org/10.1016/j.neuroimage.2022.119220","doi":"10.1016/j.neuroimage.2022.119220","pmid":"35483649","publication_date":"2022-04-24","importer_version":"2.1.3","text_redistributed":false}


authors: Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ.
journal: Journal of Psychopharmacology
publication_date: 2022-04-06
doi: 10.1177/02698811221084063
pubmed_id: 35388724
source_url: https://doi.org/10.1177/02698811221084063
source_record_id: PMID:35388724
substance_tags: psilocybin
topic_tags: Anxiety,Spirituality,Observational Study,Safety
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811221084063
text_rights_status: unverified_not_redistributed
title:
Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35388724","source_url":"https://doi.org/10.1177/02698811221084063","doi":"10.1177/02698811221084063","pmid":"35388724","publication_date":"2022-04-06","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of palliative medicine
publication_date: 2022-07-31
doi: 10.1089/jpm.2022.0036
pubmed_id: 35285721
source_url: https://pubmed.ncbi.nlm.nih.gov/35285721/
source_record_id: PMID:35285721
substance_tags: psilocybin
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35285721/
text_rights_status: unverified_not_redistributed
title:
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.

authors:
Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y

topic_tags:
Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Treatment-Resistant Depression,Healthcare Workers,Safety

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35285721","source_url":"https://pubmed.ncbi.nlm.nih.gov/35285721/","doi":"10.1089/jpm.2022.0036","pmid":"35285721","publication_date":"2022-07-31","importer_version":"2.1.3","text_redistributed":false}


authors: Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z.
publication_date: 2022-07-27
doi: 10.1038/s41598-022-17428-0
pubmed_id: 35902723
source_url: https://doi.org/10.1038/s41598-022-17428-0
source_record_id: PMID:35902723
substance_tags: psilocybin
topic_tags: Microdosing
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
text_rights_status: not_applicable_no_text
title:
Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35902723","source_url":"https://doi.org/10.1038/s41598-022-17428-0","doi":"10.1038/s41598-022-17428-0","pmid":"35902723","publication_date":"2022-07-27","importer_version":"2.1.3","text_redistributed":false}


authors: Golden CT, Chadderton P.
journal: Scientific Reports
publication_date: 2022-07-25
doi: 10.1038/s41598-022-16325-w
pubmed_id: 35882885
source_url: https://doi.org/10.1038/s41598-022-16325-w
source_record_id: PMID:35882885
substance_tags: psilocybin
topic_tags: Depression,PTSD,Mechanism of Action,Default Mode Network,Animal Study
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41598-022-16325-w
text_rights_status: unverified_not_redistributed
title:
Psilocybin reduces low frequency oscillatory power and neuronal phase-locking in the anterior cingulate cortex of awake rodents.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35882885","source_url":"https://doi.org/10.1038/s41598-022-16325-w","doi":"10.1038/s41598-022-16325-w","pmid":"35882885","publication_date":"2022-07-25","importer_version":"2.1.3","text_redistributed":false}


title: Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.
authors: Roseman L, Preller KH, Fotiou E, Winkelman MJ
journal: Frontiers in pharmacology
publication_date: 2021-12-31
doi: 10.3389/fphar.2022.979764
pubmed_id: 35935854
source_url: https://pubmed.ncbi.nlm.nih.gov/35935854/
source_record_id: PMID:35935854
substance_tags: psilocybin
topic_tags: Pharmacology,Receptor Pharmacology
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35935854","source_url":"https://pubmed.ncbi.nlm.nih.gov/35935854/","doi":"10.3389/fphar.2022.979764","pmid":"35935854","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Glatfelter GC, Pham DNK, Walther D, Golen JA, Chadeayne AR, Baumann MH, Manke DR.
journal: ACS Omega
publication_date: 2022-07-04
doi: 10.1021/acsomega.2c03476
pubmed_id: 35874244
source_url: https://doi.org/10.1021/acsomega.2c03476
source_record_id: PMID:35874244
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Animal Study,In Vitro Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1021/acsomega.2c03476
text_rights_status: unverified_not_redistributed
title:
Synthesis, Structural Characterization, and Pharmacological Activity of Novel Quaternary Salts of 4-Substituted Tryptamines.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35874244","source_url":"https://doi.org/10.1021/acsomega.2c03476","doi":"10.1021/acsomega.2c03476","pmid":"35874244","publication_date":"2022-07-04","importer_version":"2.1.3","text_redistributed":false}


title: Genetic Survey of Psilocybe Natural Products.
journal: ChemBioChem
publication_date: 2022-06-08
doi: 10.1002/cbic.202200249
pubmed_id: 35583969
source_url: https://doi.org/10.1002/cbic.202200249
source_record_id: PMID:35583969
substance_tags: psilocybin,psilocin
topic_tags: Observational Study,Genomics,Metabolomics
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/cbic.202200249
text_rights_status: unverified_not_redistributed
authors:
Dörner S, Rogge K, Fricke J, Schäfer T, Wurlitzer JM, Gressler M, Pham DNK, Manke DR, Chadeayne AR, Hoffmeister D.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35583969","source_url":"https://doi.org/10.1002/cbic.202200249","doi":"10.1002/cbic.202200249","pmid":"35583969","publication_date":"2022-06-08","importer_version":"2.1.3","text_redistributed":false}


title: A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.
authors: Farley M, Tran H, Towler S, Gevorkyan J, Pearring S, Rodda LN.
publication_date: 2022-06-30
doi: 10.1093/jat/bkab075
pubmed_id: 34159389
source_url: https://doi.org/10.1093/jat/bkab075
source_record_id: PMID:34159389
substance_tags: psilocin
topic_tags: Addiction,Safety,Toxicity
study_type: Qualitative Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1093/jat/bkab075
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34159389","source_url":"https://doi.org/10.1093/jat/bkab075","doi":"10.1093/jat/bkab075","pmid":"34159389","publication_date":"2022-06-30","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics, Mystical Experience, and Therapeutic Efficacy: A Systematic Review.
authors: Ko K, Knight G, Rucker JJ, Cleare AJ.
publication_date: 2022-07-11
doi: 10.3389/fpsyt.2022.917199
pubmed_id: 35923458
source_url: https://doi.org/10.3389/fpsyt.2022.917199
source_record_id: PMID:35923458
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Mystical Experience,Systematic Review,Review Article,Cancer Patients
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2022.917199
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35923458","source_url":"https://doi.org/10.3389/fpsyt.2022.917199","doi":"10.3389/fpsyt.2022.917199","pmid":"35923458","publication_date":"2022-07-11","importer_version":"2.1.3","text_redistributed":false}


authors: Kiraga MK, Kuypers KPC, Uthaug MV, Ramaekers JG, Mason NL.
journal: Frontiers in Psychiatry
publication_date: 2022-07-06
doi: 10.3389/fpsyt.2022.883869
pubmed_id: 35873251
source_url: https://doi.org/10.3389/fpsyt.2022.883869
source_record_id: PMID:35873251
substance_tags: psilocybin,psilocin
topic_tags: Anxiety,Mechanism of Action,Personality Change,Observational Study,Healthy Volunteers
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2022.883869
text_rights_status: unverified_not_redistributed
title:
Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35873251","source_url":"https://doi.org/10.3389/fpsyt.2022.883869","doi":"10.3389/fpsyt.2022.883869","pmid":"35873251","publication_date":"2022-07-06","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics in the treatment of unipolar and bipolar depression.
authors: Bosch OG, Halm S, Seifritz E.
publication_date: 2022-07-04
doi: 10.1186/s40345-022-00265-5
pubmed_id: 35788817
source_url: https://doi.org/10.1186/s40345-022-00265-5
source_record_id: PMID:35788817
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1186/s40345-022-00265-5
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35788817","source_url":"https://doi.org/10.1186/s40345-022-00265-5","doi":"10.1186/s40345-022-00265-5","pmid":"35788817","publication_date":"2022-07-04","importer_version":"2.1.3","text_redistributed":false}


title: Assessment of Bioactivity-Modulating Pseudo-Ring Formation in Psilocin and Related Tryptamines.
authors: Lenz C, Dörner S, Trottmann F, Hertweck C, Sherwood A, Hoffmeister D.
journal: ChemBioChem
publication_date: 2022-05-17
doi: 10.1002/cbic.202200183
pubmed_id: 35483009
source_url: https://doi.org/10.1002/cbic.202200183
source_record_id: PMID:35483009
substance_tags: psilocybin,psilocin
topic_tags: Depression,Pharmacology,Consciousness,Drug Interactions
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/cbic.202200183
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35483009","source_url":"https://doi.org/10.1002/cbic.202200183","doi":"10.1002/cbic.202200183","pmid":"35483009","publication_date":"2022-05-17","importer_version":"2.1.3","text_redistributed":false}


title: Self-administration of Psilocybin in the Setting of Treatment-resistant Depression.
authors: Lyons A.
journal: PubMed
publication_date: 2022-06-30
pubmed_id: 36204170
source_url: https://europepmc.org/article/MED/36204170
source_record_id: PMID:36204170
substance_tags: psilocybin
topic_tags: Depression,Microdosing,Randomized Controlled Trial,Treatment-Resistant Depression,Adverse Events
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/MED/36204170
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36204170","source_url":"https://europepmc.org/article/MED/36204170","doi":"","pmid":"36204170","publication_date":"2022-06-30","importer_version":"2.1.3","text_redistributed":false}


title: Classic Psychedelics and Human-Animal Relations.
authors: Pöllänen E, Osika W, Stenfors CUD, Simonsson O
journal: International journal of environmental research and public health
publication_date: 2022-06-30
doi: 10.3390/ijerph19138114
pubmed_id: 35805769
source_url: https://pubmed.ncbi.nlm.nih.gov/35805769/
source_record_id: PMID:35805769
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35805769/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35805769","source_url":"https://pubmed.ncbi.nlm.nih.gov/35805769/","doi":"10.3390/ijerph19138114","pmid":"35805769","publication_date":"2022-06-30","importer_version":"2.1.3","text_redistributed":false}


authors: Smausz R, Neill J, Gigg J.
publication_date: 2022-05-29
doi: 10.1177/02698811221092508
pubmed_id: 35638159
source_url: https://doi.org/10.1177/02698811221092508
source_record_id: PMID:35638159
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811221092508
text_rights_status: unverified_not_redistributed
title:
Neural mechanisms underlying psilocybin's therapeutic potential - the need for preclinical in vivo electrophysiology.

topic_tags:
Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Review Article,Animal Study

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35638159","source_url":"https://doi.org/10.1177/02698811221092508","doi":"10.1177/02698811221092508","pmid":"35638159","publication_date":"2022-05-29","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2021-06-09
source_url: https://osf.io/preprints/psyarxiv/64kyg_v1
source_record_id: https://osf.io/preprints/psyarxiv/64kyg_v1
substance_tags: psilocybin
topic_tags: Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Review Article
study_type: Clinical Trial
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/64kyg_v1
text_rights_status: unverified_not_redistributed
title:
Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analyses

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/64kyg_v1","source_url":"https://osf.io/preprints/psyarxiv/64kyg_v1","doi":"","pmid":"","publication_date":"2021-06-09","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-04-25
doi: 10.1016/j.psychres.2022.114577
pubmed_id: 35580433
source_url: https://doi.org/10.1016/j.psychres.2022.114577
source_record_id: PMID:35580433
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Aging,Review Article,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.psychres.2022.114577
text_rights_status: unverified_not_redistributed
title:
The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.

authors:
Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35580433","source_url":"https://doi.org/10.1016/j.psychres.2022.114577","doi":"10.1016/j.psychres.2022.114577","pmid":"35580433","publication_date":"2022-04-25","importer_version":"2.1.3","text_redistributed":false}


authors: Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y, Dang Y.
journal: Drug Testing and Analysis
publication_date: 2022-03-28
doi: 10.1002/dta.3255
pubmed_id: 35312166
source_url: https://doi.org/10.1002/dta.3255
source_record_id: PMID:35312166
substance_tags: psilocybin,psilocin
topic_tags: Pharmacology,Biomarkers,Epigenetics,Clinical Trial,In Vitro Study
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/dta.3255
text_rights_status: unverified_not_redistributed
title:
Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35312166","source_url":"https://doi.org/10.1002/dta.3255","doi":"10.1002/dta.3255","pmid":"35312166","publication_date":"2022-03-28","importer_version":"2.1.3","text_redistributed":false}


authors: Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H.
publication_date: 2022-01-18
doi: 10.1055/a-1714-9097
pubmed_id: 35045580
source_url: https://doi.org/10.1055/a-1714-9097
source_record_id: PMID:35045580
substance_tags: psilocybin
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1055/a-1714-9097
text_rights_status: unverified_not_redistributed
title:
Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.

topic_tags:
Depression,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35045580","source_url":"https://doi.org/10.1055/a-1714-9097","doi":"10.1055/a-1714-9097","pmid":"35045580","publication_date":"2022-01-18","importer_version":"2.1.3","text_redistributed":false}


title: A systematic literature review of clinical trials and therapeutic applications of ibogaine.
authors: Köck P, Froelich K, Walter M, Lang U, Dürsteler KM.
publication_date: 2021-12-29
doi: 10.1016/j.jsat.2021.108717
pubmed_id: 35012793
source_url: https://doi.org/10.1016/j.jsat.2021.108717
source_record_id: PMID:35012793
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jsat.2021.108717
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35012793","source_url":"https://doi.org/10.1016/j.jsat.2021.108717","doi":"10.1016/j.jsat.2021.108717","pmid":"35012793","publication_date":"2021-12-29","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic-inspired approaches for treating neurodegenerative disorders.
authors: Saeger HN, Olson DE
journal: Journal of neurochemistry
publication_date: 2022-06-30
doi: 10.1111/jnc.15544
pubmed_id: 34816433
source_url: https://pubmed.ncbi.nlm.nih.gov/34816433/
source_record_id: PMID:34816433
substance_tags: psilocybin
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34816433/
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Inflammation,Immune Function

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34816433","source_url":"https://pubmed.ncbi.nlm.nih.gov/34816433/","doi":"10.1111/jnc.15544","pmid":"34816433","publication_date":"2022-06-30","importer_version":"2.1.3","text_redistributed":false}


title: Molecular insights into psychedelic drug action.
authors: Slocum ST, DiBerto JF, Roth BL.
publication_date: 2021-11-30
doi: 10.1111/jnc.15540
pubmed_id: 34797943
source_url: https://doi.org/10.1111/jnc.15540
source_record_id: PMID:34797943
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Review Article,Treatment-Resistant Depression
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1111/jnc.15540
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34797943","source_url":"https://doi.org/10.1111/jnc.15540","doi":"10.1111/jnc.15540","pmid":"34797943","publication_date":"2021-11-30","importer_version":"2.1.3","text_redistributed":false}


authors: Kozlowska U, Nichols C, Wiatr K, Figiel M.
publication_date: 2021-10-21
doi: 10.1111/jnc.15509
pubmed_id: 34519052
source_url: https://doi.org/10.1111/jnc.15509
source_record_id: PMID:34519052
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1111/jnc.15509
text_rights_status: unverified_not_redistributed
title:
From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.

topic_tags:
Depression,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Review Article,Animal Study,Drug Interactions,Inflammation

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34519052","source_url":"https://doi.org/10.1111/jnc.15509","doi":"10.1111/jnc.15509","pmid":"34519052","publication_date":"2021-10-21","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin: A brief overview for psychiatric mental health nurse practitioners.
authors: Fradkin D.
journal: Perspectives In Psychiatric Care
publication_date: 2021-06-07
doi: 10.1111/ppc.12888
pubmed_id: 34101846
source_url: https://doi.org/10.1111/ppc.12888
source_record_id: PMID:34101846
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1111/ppc.12888
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34101846","source_url":"https://doi.org/10.1111/ppc.12888","doi":"10.1111/ppc.12888","pmid":"34101846","publication_date":"2021-06-07","importer_version":"2.1.3","text_redistributed":false}


authors: Rootman JM, Kiraga M, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Walsh Z.
journal: Scientific Reports
publication_date: 2022-06-29
doi: 10.1038/s41598-022-14512-3
pubmed_id: 35773270
source_url: https://doi.org/10.1038/s41598-022-14512-3
source_record_id: PMID:35773270
substance_tags: psilocybin
topic_tags: Aging,Microdosing,Observational Study,Older Adults
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41598-022-14512-3
text_rights_status: unverified_not_redistributed
title:
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35773270","source_url":"https://doi.org/10.1038/s41598-022-14512-3","doi":"10.1038/s41598-022-14512-3","pmid":"35773270","publication_date":"2022-06-29","importer_version":"2.1.3","text_redistributed":false}


title: 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.
authors: Inouye A, Wolfgang A.
publication_date: 2022-06-27
doi: 10.7759/cureus.26402
pubmed_id: 35915689
source_url: https://doi.org/10.7759/cureus.26402
source_record_id: PMID:35915689
substance_tags: psilocybin
topic_tags: Depression,PTSD,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.7759/cureus.26402
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35915689","source_url":"https://doi.org/10.7759/cureus.26402","doi":"10.7759/cureus.26402","pmid":"35915689","publication_date":"2022-06-27","importer_version":"2.1.3","text_redistributed":false}


authors: Vorobyeva N, Kozlova AA.
publication_date: 2022-06-27
doi: 10.3389/fphar.2022.927984
pubmed_id: 35837277
source_url: https://doi.org/10.3389/fphar.2022.927984
source_record_id: PMID:35837277
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fphar.2022.927984
text_rights_status: unverified_not_redistributed
title:
Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35837277","source_url":"https://doi.org/10.3389/fphar.2022.927984","doi":"10.3389/fphar.2022.927984","pmid":"35837277","publication_date":"2022-06-27","importer_version":"2.1.3","text_redistributed":false}


authors: Wang Q, Ren Y, Cui Y, Gao B, Zhang H, Jiang Q, Loor JJ, Deng Z, Xu C.
journal: Frontiers in Veterinary Science
publication_date: 2022-06-26
doi: 10.3389/fvets.2022.852321
pubmed_id: 35832333
source_url: https://doi.org/10.3389/fvets.2022.852321
source_record_id: PMID:35832333
substance_tags: psilocybin
topic_tags: Pharmacology,Mechanism of Action
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fvets.2022.852321
text_rights_status: unverified_not_redistributed
title:
Bacillus subtilis Produces Amino Acids to Stimulate Protein Synthesis in Ruminal Tissue Explants via the Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta-Serine/Threonine Kinase-Mammalian Target of Rapamycin Complex 1 Pathway.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35832333","source_url":"https://doi.org/10.3389/fvets.2022.852321","doi":"10.3389/fvets.2022.852321","pmid":"35832333","publication_date":"2022-06-26","importer_version":"2.1.3","text_redistributed":false}


authors: Jones G, Lipson J, Nock MK.
journal: Scientific Reports
publication_date: 2022-06-21
doi: 10.1038/s41598-022-14809-3
pubmed_id: 35732796
source_url: https://doi.org/10.1038/s41598-022-14809-3
source_record_id: PMID:35732796
substance_tags: psilocybin
topic_tags: Addiction,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41598-022-14809-3
text_rights_status: unverified_not_redistributed
title:
Associations between classic psychedelics and nicotine dependence in a nationally representative sample.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35732796","source_url":"https://doi.org/10.1038/s41598-022-14809-3","doi":"10.1038/s41598-022-14809-3","pmid":"35732796","publication_date":"2022-06-21","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Personalized Medicine
publication_date: 2022-06-18
doi: 10.3390/jpm12061004
pubmed_id: 35743788
source_url: https://doi.org/10.3390/jpm12061004
source_record_id: PMID:35743788
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Emotional Processing,Healthy Volunteers
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/jpm12061004
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience.

authors:
Viktorin V, Griškova-Bulanova I, Voicikas A, Dojčánová D, Zach P, Bravermanová A, Andrashko V, Tylš F, Korčák J, Viktorinová M, Koudelka V, Hájková K, Kuchař M, Horáček J, Brunovský M, Páleníček T.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35743788","source_url":"https://doi.org/10.3390/jpm12061004","doi":"10.3390/jpm12061004","pmid":"35743788","publication_date":"2022-06-18","importer_version":"2.1.3","text_redistributed":false}


journal: International Journal of Molecular Sciences
publication_date: 2022-06-15
doi: 10.3390/ijms23126713
pubmed_id: 35743159
source_url: https://doi.org/10.3390/ijms23126713
source_record_id: PMID:35743159
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Receptor Pharmacology,Animal Study,Toxicity
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ijms23126713
text_rights_status: unverified_not_redistributed
title:
Effect of Psilocybin and Ketamine on Brain Neurotransmitters, Glutamate Receptors, DNA and Rat Behavior.

authors:
Wojtas A, Bysiek A, Wawrzczak-Bargiela A, Szych Z, Majcher-Maślanka I, Herian M, Maćkowiak M, Gołembiowska K.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35743159","source_url":"https://doi.org/10.3390/ijms23126713","doi":"10.3390/ijms23126713","pmid":"35743159","publication_date":"2022-06-15","importer_version":"2.1.3","text_redistributed":false}


authors: Hibicke M, Nichols CD.
journal: Scientific Reports
publication_date: 2022-06-14
doi: 10.1038/s41598-022-14165-2
pubmed_id: 35705666
source_url: https://doi.org/10.1038/s41598-022-14165-2
source_record_id: PMID:35705666
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41598-022-14165-2
text_rights_status: unverified_not_redistributed
title:
Validation of the forced swim test in Drosophila, and its use to demonstrate psilocybin has long-lasting antidepressant-like effects in flies.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35705666","source_url":"https://doi.org/10.1038/s41598-022-14165-2","doi":"10.1038/s41598-022-14165-2","pmid":"35705666","publication_date":"2022-06-14","importer_version":"2.1.3","text_redistributed":false}


authors: Polo-Castellano C, Álvarez JÁ, Palma M, Barbero GF, Ayuso J, Ferreiro-González M.
journal: Journal of Fungi
publication_date: 2022-06-01
doi: 10.3390/jof8060598
pubmed_id: 35736081
source_url: https://doi.org/10.3390/jof8060598
source_record_id: PMID:35736081
substance_tags: psilocybin,psilocin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/jof8060598
text_rights_status: unverified_not_redistributed
title:
Optimization through a Box-Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (Psylocibe cubensis).

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35736081","source_url":"https://doi.org/10.3390/jof8060598","doi":"10.3390/jof8060598","pmid":"35736081","publication_date":"2022-06-01","importer_version":"2.1.3","text_redistributed":false}


authors: Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG.
journal: Expert Opinion on Drug Safety
publication_date: 2022-04-26
doi: 10.1080/14740338.2022.2066650
pubmed_id: 35426754
source_url: https://doi.org/10.1080/14740338.2022.2066650
source_record_id: PMID:35426754
substance_tags: psilocybin
topic_tags: Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/14740338.2022.2066650
text_rights_status: unverified_not_redistributed
title:
Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35426754","source_url":"https://doi.org/10.1080/14740338.2022.2066650","doi":"10.1080/14740338.2022.2066650","pmid":"35426754","publication_date":"2022-04-26","importer_version":"2.1.3","text_redistributed":false}


authors: Husain MI, Umer M, Mulsant BH
journal: Expert opinion on drug safety
publication_date: 2022-05-31
doi: 10.1080/14740338.2022.2063274
pubmed_id: 35387542
source_url: https://pubmed.ncbi.nlm.nih.gov/35387542/
source_record_id: PMID:35387542
substance_tags: psilocybin
topic_tags: Depression,PTSD,Addiction,Safety
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
text_rights_status: not_applicable_no_text
title:
Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35387542","source_url":"https://pubmed.ncbi.nlm.nih.gov/35387542/","doi":"10.1080/14740338.2022.2063274","pmid":"35387542","publication_date":"2022-05-31","importer_version":"2.1.3","text_redistributed":false}


authors: van den Berg M, Magaraggia I, Schreiber R, Hillhouse TM, Porter JH
journal: Psychopharmacology
publication_date: 2022-05-31
doi: 10.1007/s00213-022-06106-8
pubmed_id: 35348806
source_url: https://pubmed.ncbi.nlm.nih.gov/35348806/
source_record_id: PMID:35348806
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Mystical Experience,Treatment-Resistant Depression
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35348806/
text_rights_status: unverified_not_redistributed
title:
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35348806","source_url":"https://pubmed.ncbi.nlm.nih.gov/35348806/","doi":"10.1007/s00213-022-06106-8","pmid":"35348806","publication_date":"2022-05-31","importer_version":"2.1.3","text_redistributed":false}


journal: Metabolic Engineering Communications
publication_date: 2022-03-11
doi: 10.1016/j.mec.2022.e00196
pubmed_id: 35310468
source_url: https://doi.org/10.1016/j.mec.2022.e00196
source_record_id: PMID:35310468
substance_tags: psilocybin
topic_tags: Mechanism of Action,Receptor Pharmacology,Animal Study,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.mec.2022.e00196
text_rights_status: unverified_not_redistributed
title:
Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.

authors:
Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35310468","source_url":"https://doi.org/10.1016/j.mec.2022.e00196","doi":"10.1016/j.mec.2022.e00196","pmid":"35310468","publication_date":"2022-03-11","importer_version":"2.1.3","text_redistributed":false}


title: The promises and perils of psychedelic pharmacology for psychiatry.
authors: McClure-Begley TD, Roth BL.
publication_date: 2022-03-16
doi: 10.1038/s41573-022-00421-7
pubmed_id: 35301459
source_url: https://doi.org/10.1038/s41573-022-00421-7
source_record_id: PMID:35301459
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41573-022-00421-7
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35301459","source_url":"https://doi.org/10.1038/s41573-022-00421-7","doi":"10.1038/s41573-022-00421-7","pmid":"35301459","publication_date":"2022-03-16","importer_version":"2.1.3","text_redistributed":false}


title: Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.
authors: Sarparast A, Thomas K, Malcolm B, Stauffer CS.
publication_date: 2022-03-06
doi: 10.1007/s00213-022-06083-y
pubmed_id: 35253070
source_url: https://doi.org/10.1007/s00213-022-06083-y
source_record_id: PMID:35253070
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-022-06083-y
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,PTSD,Pharmacology,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Drug Interactions

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35253070","source_url":"https://doi.org/10.1007/s00213-022-06083-y","doi":"10.1007/s00213-022-06083-y","pmid":"35253070","publication_date":"2022-03-06","importer_version":"2.1.3","text_redistributed":false}


authors: Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J.
journal: Psychopharmacology
publication_date: 2022-03-01
doi: 10.1007/s00213-021-06020-5
pubmed_id: 35234983
source_url: https://doi.org/10.1007/s00213-021-06020-5
source_record_id: PMID:35234983
substance_tags: psilocybin,psilocin
topic_tags: Depression,Receptor Pharmacology
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-021-06020-5
text_rights_status: unverified_not_redistributed
title:
Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35234983","source_url":"https://doi.org/10.1007/s00213-021-06020-5","doi":"10.1007/s00213-021-06020-5","pmid":"35234983","publication_date":"2022-03-01","importer_version":"2.1.3","text_redistributed":false}


authors: Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J.
publication_date: 2022-03-01
doi: 10.1007/s00213-022-06092-x
pubmed_id: 35233648
source_url: https://doi.org/10.1007/s00213-022-06092-x
source_record_id: PMID:35233648
substance_tags: psilocybin
topic_tags: Depression,Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Safety
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-022-06092-x
text_rights_status: unverified_not_redistributed
title:
Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35233648","source_url":"https://doi.org/10.1007/s00213-022-06092-x","doi":"10.1007/s00213-022-06092-x","pmid":"35233648","publication_date":"2022-03-01","importer_version":"2.1.3","text_redistributed":false}


title: The therapeutic potential of psilocybin: a systematic review.
authors: van Amsterdam J, van den Brink W.
publication_date: 2022-03-01
doi: 10.1080/14740338.2022.2047929
pubmed_id: 35225143
source_url: https://doi.org/10.1080/14740338.2022.2047929
source_record_id: PMID:35225143
substance_tags: psilocybin
topic_tags: Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/14740338.2022.2047929
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35225143","source_url":"https://doi.org/10.1080/14740338.2022.2047929","doi":"10.1080/14740338.2022.2047929","pmid":"35225143","publication_date":"2022-03-01","importer_version":"2.1.3","text_redistributed":false}


authors: Maia LO, Beaussant Y, Garcia ACM.
publication_date: 2022-02-10
doi: 10.1016/j.jpainsymman.2022.01.024
pubmed_id: 35157985
source_url: https://doi.org/10.1016/j.jpainsymman.2022.01.024
source_record_id: PMID:35157985
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jpainsymman.2022.01.024
text_rights_status: unverified_not_redistributed
title:
The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.

topic_tags:
Anxiety,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35157985","source_url":"https://doi.org/10.1016/j.jpainsymman.2022.01.024","doi":"10.1016/j.jpainsymman.2022.01.024","pmid":"35157985","publication_date":"2022-02-10","importer_version":"2.1.3","text_redistributed":false}


authors: Müller F, Kraus E, Holze F, Becker A, Ley L, Schmid Y, Vizeli P, Liechti ME, Borgwardt S.
journal: Psychopharmacology
publication_date: 2022-01-24
doi: 10.1007/s00213-022-06066-z
pubmed_id: 35076721
source_url: https://doi.org/10.1007/s00213-022-06066-z
source_record_id: PMID:35076721
substance_tags: psilocybin
topic_tags: Clinical Trial,Healthy Volunteers
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-022-06066-z
text_rights_status: unverified_not_redistributed
title:
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35076721","source_url":"https://doi.org/10.1007/s00213-022-06066-z","doi":"10.1007/s00213-022-06066-z","pmid":"35076721","publication_date":"2022-01-24","importer_version":"2.1.3","text_redistributed":false}


authors: Miceli McMillan R, Jordens C.
publication_date: 2022-01-21
doi: 10.1007/s11019-022-10070-7
pubmed_id: 35064398
source_url: https://doi.org/10.1007/s11019-022-10070-7
source_record_id: PMID:35064398
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s11019-022-10070-7
text_rights_status: unverified_not_redistributed
title:
Psychedelic-assisted psychotherapy for the treatment of major depression: a synthesis of phenomenological explanations.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35064398","source_url":"https://doi.org/10.1007/s11019-022-10070-7","doi":"10.1007/s11019-022-10070-7","pmid":"35064398","publication_date":"2022-01-21","importer_version":"2.1.3","text_redistributed":false}


authors: Bender D, Hellerstein DJ.
publication_date: 2022-01-12
doi: 10.1007/s00213-021-06049-6
pubmed_id: 35022823
source_url: https://doi.org/10.1007/s00213-021-06049-6
source_record_id: PMID:35022823
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-021-06049-6
text_rights_status: unverified_not_redistributed
title:
Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.

topic_tags:
Brain Imaging,Aging,Clinical Trial,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35022823","source_url":"https://doi.org/10.1007/s00213-021-06049-6","doi":"10.1007/s00213-021-06049-6","pmid":"35022823","publication_date":"2022-01-12","importer_version":"2.1.3","text_redistributed":false}


authors: Murray CH, Tare I, Perry CM, Malina M, Lee R, de Wit H.
publication_date: 2021-10-05
doi: 10.1007/s00213-021-05991-9
pubmed_id: 34613430
source_url: https://doi.org/10.1007/s00213-021-05991-9
source_record_id: PMID:34613430
substance_tags: psilocybin
topic_tags: Anxiety,Brain Imaging,Default Mode Network,Consciousness,Microdosing,Adolescents
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-021-05991-9
text_rights_status: unverified_not_redistributed
title:
Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34613430","source_url":"https://doi.org/10.1007/s00213-021-05991-9","doi":"10.1007/s00213-021-05991-9","pmid":"34613430","publication_date":"2021-10-05","importer_version":"2.1.3","text_redistributed":false}


title: Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice.
journal: Psychopharmacology
publication_date: 2022-05-31
doi: 10.1007/s00213-021-05913-9
pubmed_id: 34345931
source_url: https://pubmed.ncbi.nlm.nih.gov/34345931/
source_record_id: PMID:34345931
substance_tags: psilocybin
topic_tags: Pharmacology,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34345931/
text_rights_status: unverified_not_redistributed
authors:
Vohra HZ, Saunders JM, Jaster AM, de la Fuente Revenga M, Jimenez J, Fernández-Teruel A, Wolstenholme JT, Beardsley PM, González-Maeso J

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34345931","source_url":"https://pubmed.ncbi.nlm.nih.gov/34345931/","doi":"10.1007/s00213-021-05913-9","pmid":"34345931","publication_date":"2022-05-31","importer_version":"2.1.3","text_redistributed":false}


title: Serotonin toxicity of serotonergic psychedelics.
authors: Malcolm B, Thomas K
journal: Psychopharmacology
publication_date: 2022-05-31
doi: 10.1007/s00213-021-05876-x
pubmed_id: 34251464
source_url: https://pubmed.ncbi.nlm.nih.gov/34251464/
source_record_id: PMID:34251464
substance_tags: psilocybin
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34251464/
text_rights_status: unverified_not_redistributed
topic_tags:
Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Safety,Toxicity,Drug Interactions

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34251464","source_url":"https://pubmed.ncbi.nlm.nih.gov/34251464/","doi":"10.1007/s00213-021-05876-x","pmid":"34251464","publication_date":"2022-05-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic perceptions: mental health service user attitudes to psilocybin therapy.
journal: Irish Journal of Medical Science (1971 -)
publication_date: 2021-06-14
doi: 10.1007/s11845-021-02668-2
pubmed_id: 34131812
source_url: https://doi.org/10.1007/s11845-021-02668-2
source_record_id: PMID:34131812
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s11845-021-02668-2
text_rights_status: unverified_not_redistributed
authors:
Corrigan K, Haran M, McCandliss C, McManus R, Cleary S, Trant R, Kelly Y, Ledden K, Rush G, O'Keane V, Kelly JR.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34131812","source_url":"https://doi.org/10.1007/s11845-021-02668-2","doi":"10.1007/s11845-021-02668-2","pmid":"34131812","publication_date":"2021-06-14","importer_version":"2.1.3","text_redistributed":false}


authors: van Elk M, Fejer G, Lempe P, Prochazckova L, Kuchar M, Hajkova K, Marschall J.
journal: Psychopharmacology
publication_date: 2021-04-29
doi: 10.1007/s00213-021-05857-0
pubmed_id: 33928421
source_url: https://doi.org/10.1007/s00213-021-05857-0
source_record_id: PMID:33928421
substance_tags: psilocybin
topic_tags: Chronic Pain,Microdosing,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-021-05857-0
text_rights_status: unverified_not_redistributed
title:
Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:33928421","source_url":"https://doi.org/10.1007/s00213-021-05857-0","doi":"10.1007/s00213-021-05857-0","pmid":"33928421","publication_date":"2021-04-29","importer_version":"2.1.3","text_redistributed":false}


authors: Al-Imam A, Motyka MA, Witulska Z, Younus M, Michalak M.
journal: International Journal of Environmental Research and Public Health
publication_date: 2022-05-28
doi: 10.3390/ijerph19116619
pubmed_id: 35682204
source_url: https://doi.org/10.3390/ijerph19116619
source_record_id: PMID:35682204
substance_tags: psilocybin
topic_tags: Addiction,Receptor Pharmacology,Consciousness,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ijerph19116619
text_rights_status: unverified_not_redistributed
title:
Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35682204","source_url":"https://doi.org/10.3390/ijerph19116619","doi":"10.3390/ijerph19116619","pmid":"35682204","publication_date":"2022-05-28","importer_version":"2.1.3","text_redistributed":false}


title: Unraveling the Mysteries of Mental Illness With Psilocybin.
authors: Sotille R, Singh H, Weisman A, Vida T.
publication_date: 2022-05-26
doi: 10.7759/cureus.25414
pubmed_id: 35769681
source_url: https://doi.org/10.7759/cureus.25414
source_record_id: PMID:35769681
substance_tags: psilocybin,psilocin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:01
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.7759/cureus.25414
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35769681","source_url":"https://doi.org/10.7759/cureus.25414","doi":"10.7759/cureus.25414","pmid":"35769681","publication_date":"2022-05-26","importer_version":"2.1.3","text_redistributed":false}


title: Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.
publication_date: 2022-05-22
doi: 10.7759/cureus.25235
pubmed_id: 35747039
source_url: https://doi.org/10.7759/cureus.25235
source_record_id: PMID:35747039
substance_tags: psilocybin
topic_tags: Anxiety,PTSD,End-of-Life Distress,Pharmacology,Mechanism of Action
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.7759/cureus.25235
text_rights_status: unverified_not_redistributed
authors:
Elsouri KN, Kalhori S, Colunge D, Grabarczyk G, Hanna G, Carrasco C, Aleman Espino A, Francisco A, Borosky B, Bekheit B, Ighanifard M, Astudillo AA, Demory Beckler M.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35747039","source_url":"https://doi.org/10.7759/cureus.25235","doi":"10.7759/cureus.25235","pmid":"35747039","publication_date":"2022-05-22","importer_version":"2.1.3","text_redistributed":false}


authors: Frymann T, Whitney S, Yaden DB, Lipson J
journal: Frontiers in psychology
publication_date: 2021-12-31
doi: 10.3389/fpsyg.2022.863247
pubmed_id: 35677137
source_url: https://pubmed.ncbi.nlm.nih.gov/35677137/
source_record_id: PMID:35677137
substance_tags: psilocybin
topic_tags: Observational Study,Healthcare Workers
study_type: Observational Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35677137/
text_rights_status: unverified_not_redistributed
title:
The Psychedelic Integration Scales: Tools for Measuring Psychedelic Integration Behaviors and Experiences.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35677137","source_url":"https://pubmed.ncbi.nlm.nih.gov/35677137/","doi":"10.3389/fpsyg.2022.863247","pmid":"35677137","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.
authors: Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW
journal: Frontiers in psychology
publication_date: 2021-12-31
doi: 10.3389/fpsyg.2022.873279
pubmed_id: 35677124
source_url: https://pubmed.ncbi.nlm.nih.gov/35677124/
source_record_id: PMID:35677124
substance_tags: psilocybin
topic_tags: Spirituality,Safety
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35677124/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35677124","source_url":"https://pubmed.ncbi.nlm.nih.gov/35677124/","doi":"10.3389/fpsyg.2022.873279","pmid":"35677124","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: New Paradigms of Old Psychedelics in Schizophrenia.
authors: Mahmood D, Alenezi SK, Anwar MJ, Azam F, Qureshi KA, Jaremko M.
publication_date: 2022-05-22
doi: 10.3390/ph15050640
pubmed_id: 35631466
source_url: https://doi.org/10.3390/ph15050640
source_record_id: PMID:35631466
substance_tags: psilocybin
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ph15050640
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Microdosing,Drug Interactions

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35631466","source_url":"https://doi.org/10.3390/ph15050640","doi":"10.3390/ph15050640","pmid":"35631466","publication_date":"2022-05-22","importer_version":"2.1.3","text_redistributed":false}


title: Chronic Treatment With Psilocybin Decreases Changes in Body Weight in a Rodent Model of Obesity.
authors: Huang J, Pham M, Panenka WJ, Honer WG, Barr AM.
journal: Frontiers in Psychiatry
publication_date: 2022-05-17
doi: 10.3389/fpsyt.2022.891512
pubmed_id: 35664477
source_url: https://doi.org/10.3389/fpsyt.2022.891512
source_record_id: PMID:35664477
substance_tags: psilocybin,psilocin
topic_tags: Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2022.891512
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35664477","source_url":"https://doi.org/10.3389/fpsyt.2022.891512","doi":"10.3389/fpsyt.2022.891512","pmid":"35664477","publication_date":"2022-05-17","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-05-17
doi: 10.3390/neurolint14020035
pubmed_id: 35645354
source_url: https://doi.org/10.3390/neurolint14020035
source_record_id: PMID:35645354
substance_tags: psilocybin
topic_tags: Addiction,Chronic Pain,Headache / Migraine,Receptor Pharmacology,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/neurolint14020035
text_rights_status: unverified_not_redistributed
title:
Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.

authors:
Edinoff AN, Fort JM, Singh C, Wagner SE, Rodriguez JR, Johnson CA, Cornett EM, Murnane KS, Kaye AM, Kaye AD.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35645354","source_url":"https://doi.org/10.3390/neurolint14020035","doi":"10.3390/neurolint14020035","pmid":"35645354","publication_date":"2022-05-17","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-induced takotsubo cardiomyopathy.
authors: Kotts WJ, Gamble DT, Dawson DK, Connor D.
journal: BMJ Case Reports
publication_date: 2022-05-16
doi: 10.1136/bcr-2021-245863
pubmed_id: 35580942
source_url: https://doi.org/10.1136/bcr-2021-245863
source_record_id: PMID:35580942
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1136/bcr-2021-245863
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35580942","source_url":"https://doi.org/10.1136/bcr-2021-245863","doi":"10.1136/bcr-2021-245863","pmid":"35580942","publication_date":"2022-05-16","importer_version":"2.1.3","text_redistributed":false}


title: Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.
authors: Mocanu V, Mackay L, Christie D, Argento E.
journal: Substance Abuse Treatment Prevention and Policy
publication_date: 2022-05-13
doi: 10.1186/s13011-022-00468-0
pubmed_id: 35568884
source_url: https://doi.org/10.1186/s13011-022-00468-0
source_record_id: PMID:35568884
substance_tags: psilocybin
topic_tags: Aging,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1186/s13011-022-00468-0
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35568884","source_url":"https://doi.org/10.1186/s13011-022-00468-0","doi":"10.1186/s13011-022-00468-0","pmid":"35568884","publication_date":"2022-05-13","importer_version":"2.1.3","text_redistributed":false}


authors: Johansen L, Liknaitzky P, Nedeljkovic M, Mastin-Purcell L, Murray G
journal: Systematic reviews
publication_date: 2022-05-04
doi: 10.1186/s13643-022-01930-7
pubmed_id: 35513876
source_url: https://pubmed.ncbi.nlm.nih.gov/35513876/
source_record_id: PMID:35513876
substance_tags: psilocybin
topic_tags: Depression,Systematic Review,Review Article
study_type: Systematic Review
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35513876/
text_rights_status: unverified_not_redistributed
title:
The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35513876","source_url":"https://pubmed.ncbi.nlm.nih.gov/35513876/","doi":"10.1186/s13643-022-01930-7","pmid":"35513876","publication_date":"2022-05-04","importer_version":"2.1.3","text_redistributed":false}


title: The Pharmacology and Clinical Applications of Psychedelic Medicines Within Midwifery Practice.
authors: Stein CA, Penn A, Van Hope S, Dorsen CG, Mangini M
journal: Journal of midwifery & women's health
publication_date: 2022-04-30
doi: 10.1111/jmwh.13371
pubmed_id: 35522087
source_url: https://pubmed.ncbi.nlm.nih.gov/35522087/
source_record_id: PMID:35522087
substance_tags: psilocybin
topic_tags: Depression,PTSD,Pharmacology,Review Article
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35522087/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35522087","source_url":"https://pubmed.ncbi.nlm.nih.gov/35522087/","doi":"10.1111/jmwh.13371","pmid":"35522087","publication_date":"2022-04-30","importer_version":"2.1.3","text_redistributed":false}


journal: Neuropsychopharmacology
publication_date: 2022-02-24
doi: 10.1038/s41386-022-01297-2
pubmed_id: 35217796
source_url: https://doi.org/10.1038/s41386-022-01297-2
source_record_id: PMID:35217796
substance_tags: psilocybin
topic_tags: Anxiety,Pharmacology,Healthy Volunteers
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41386-022-01297-2
text_rights_status: unverified_not_redistributed
title:
Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.

authors:
Holze F, Ley L, Müller F, Becker AM, Straumann I, Vizeli P, Kuehne SS, Roder MA, Duthaler U, Kolaczynska KE, Varghese N, Eckert A, Liechti ME.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35217796","source_url":"https://doi.org/10.1038/s41386-022-01297-2","doi":"10.1038/s41386-022-01297-2","pmid":"35217796","publication_date":"2022-02-24","importer_version":"2.1.3","text_redistributed":false}


title: Will psilocybin lose its magic in the clinical setting?
authors: Hayes C, Wahba M, Watson S.
publication_date: 2022-04-21
doi: 10.1177/20451253221090822
pubmed_id: 35480296
source_url: https://doi.org/10.1177/20451253221090822
source_record_id: PMID:35480296
substance_tags: psilocybin
topic_tags: Depression,Review Article,Healthcare Workers
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/20451253221090822
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35480296","source_url":"https://doi.org/10.1177/20451253221090822","doi":"10.1177/20451253221090822","pmid":"35480296","publication_date":"2022-04-21","importer_version":"2.1.3","text_redistributed":false}


authors: Hackl B, Todt H, Kubista H, Kubista H, Hilber K, Koenig X.
journal: The International Journal of Neuropsychopharmacology
publication_date: 2022-03-31
doi: 10.1093/ijnp/pyab085
pubmed_id: 34871422
source_url: https://doi.org/10.1093/ijnp/pyab085
source_record_id: PMID:34871422
substance_tags: psilocybin,psilocin
topic_tags: Aging,Clinical Trial,Safety,Toxicity
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1093/ijnp/pyab085
text_rights_status: unverified_not_redistributed
title:
Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34871422","source_url":"https://doi.org/10.1093/ijnp/pyab085","doi":"10.1093/ijnp/pyab085","pmid":"34871422","publication_date":"2022-03-31","importer_version":"2.1.3","text_redistributed":false}


title: Models of psychedelic drug action: modulation of cortical-subcortical circuits.
authors: Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN, Barrett FS.
journal: Brain
publication_date: 2022-03-31
doi: 10.1093/brain/awab406
pubmed_id: 34897383
source_url: https://doi.org/10.1093/brain/awab406
source_record_id: PMID:34897383
substance_tags: psilocybin
topic_tags: Receptor Pharmacology
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1093/brain/awab406
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34897383","source_url":"https://doi.org/10.1093/brain/awab406","doi":"10.1093/brain/awab406","pmid":"34897383","publication_date":"2022-03-31","importer_version":"2.1.3","text_redistributed":false}


authors: Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L, Ngwa W.
publication_date: 2022-04-13
doi: 10.3390/molecules27082520
pubmed_id: 35458717
source_url: https://doi.org/10.3390/molecules27082520
source_record_id: PMID:35458717
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Spirituality,Review Article,Cancer Patients,Adverse Events,Toxicity
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/molecules27082520
text_rights_status: unverified_not_redistributed
title:
Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35458717","source_url":"https://doi.org/10.3390/molecules27082520","doi":"10.3390/molecules27082520","pmid":"35458717","publication_date":"2022-04-13","importer_version":"2.1.3","text_redistributed":false}


authors: Jones G, Ricard JA, Lipson J, Nock MK.
journal: Scientific Reports
publication_date: 2022-04-06
doi: 10.1038/s41598-022-08085-4
pubmed_id: 35393455
source_url: https://doi.org/10.1038/s41598-022-08085-4
source_record_id: PMID:35393455
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Observational Study
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41598-022-08085-4
text_rights_status: unverified_not_redistributed
title:
Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35393455","source_url":"https://doi.org/10.1038/s41598-022-08085-4","doi":"10.1038/s41598-022-08085-4","pmid":"35393455","publication_date":"2022-04-06","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin increases brain network integration in patients with depression.
journal: Nature Medicine
publication_date: 2022-03-31
doi: 10.1038/s41591-022-01769-4
pubmed_id: 35411079
source_url: https://doi.org/10.1038/s41591-022-01769-4
source_record_id: PMID:35411079
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35411079","source_url":"https://doi.org/10.1038/s41591-022-01769-4","doi":"10.1038/s41591-022-01769-4","pmid":"35411079","publication_date":"2022-03-31","importer_version":"2.1.3","text_redistributed":false}


title: Increased global integration in the brain after psilocybin therapy for depression.
journal: Nature Medicine
publication_date: 2022-04-10
doi: 10.1038/s41591-022-01744-z
pubmed_id: 35411074
source_url: https://doi.org/10.1038/s41591-022-01744-z
source_record_id: PMID:35411074
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41591-022-01744-z
text_rights_status: unverified_not_redistributed
authors:
Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D, Roseman L, Nutt D, Carhart-Harris R.

topic_tags:
Depression,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35411074","source_url":"https://doi.org/10.1038/s41591-022-01744-z","doi":"10.1038/s41591-022-01744-z","pmid":"35411074","publication_date":"2022-04-10","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-02-10
doi: 10.1016/j.funbio.2022.01.003
pubmed_id: 35314062
source_url: https://doi.org/10.1016/j.funbio.2022.01.003
source_record_id: PMID:35314062
substance_tags: psilocybin
topic_tags: Mechanism of Action,Review Article,Safety
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.funbio.2022.01.003
text_rights_status: unverified_not_redistributed
title:
Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.

authors:
Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35314062","source_url":"https://doi.org/10.1016/j.funbio.2022.01.003","doi":"10.1016/j.funbio.2022.01.003","pmid":"35314062","publication_date":"2022-02-10","importer_version":"2.1.3","text_redistributed":false}


journal: Clinical Pharmacology & Therapeutics
publication_date: 2021-11-21
doi: 10.1002/cpt.2487
pubmed_id: 34743319
source_url: https://doi.org/10.1002/cpt.2487
source_record_id: PMID:34743319
substance_tags: psilocybin,psilocin
topic_tags: Depression,Anxiety,Pharmacology,Healthy Volunteers,Drug Interactions
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/cpt.2487
text_rights_status: unverified_not_redistributed
title:
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.

authors:
Becker AM, Holze F, Grandinetti T, Klaiber A, Toedtli VE, Kolaczynska KE, Duthaler U, Varghese N, Eckert A, Grünblatt E, Liechti ME.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34743319","source_url":"https://doi.org/10.1002/cpt.2487","doi":"10.1002/cpt.2487","pmid":"34743319","publication_date":"2021-11-21","importer_version":"2.1.3","text_redistributed":false}


authors: Cox DJ, Johnson MW.
publication_date: 2021-07-21
doi: 10.1037/pha0000404
pubmed_id: 34291991
source_url: https://doi.org/10.1037/pha0000404
source_record_id: PMID:34291991
substance_tags: psilocybin
topic_tags: Addiction,Pharmacology,Healthcare Workers
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1037/pha0000404
text_rights_status: unverified_not_redistributed
title:
Verbal behavior related to drug reinforcement in polysubstance cannabis users: Comparison across drugs.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34291991","source_url":"https://doi.org/10.1037/pha0000404","doi":"10.1037/pha0000404","pmid":"34291991","publication_date":"2021-07-21","importer_version":"2.1.3","text_redistributed":false}


title: Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.
journal: Frontiers in Pharmacology
publication_date: 2022-03-30
doi: 10.3389/fphar.2021.788155
pubmed_id: 35431912
source_url: https://doi.org/10.3389/fphar.2021.788155
source_record_id: PMID:35431912
substance_tags: psilocybin
topic_tags: Depression,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fphar.2021.788155
text_rights_status: unverified_not_redistributed
authors:
Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J, Read T, Murphy-Beiner A, Baker-Jones M, Nutt D, Erritzoe D, Watts R, Carhart-Harris R.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35431912","source_url":"https://doi.org/10.3389/fphar.2021.788155","doi":"10.3389/fphar.2021.788155","pmid":"35431912","publication_date":"2022-03-30","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin-Assisted Compassion Focused Therapy for Depression.
authors: Pots W, Chakhssi F.
journal: Frontiers in Psychology
publication_date: 2022-03-24
doi: 10.3389/fpsyg.2022.812930
pubmed_id: 35401294
source_url: https://doi.org/10.3389/fpsyg.2022.812930
source_record_id: PMID:35401294
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyg.2022.812930
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35401294","source_url":"https://doi.org/10.3389/fpsyg.2022.812930","doi":"10.3389/fpsyg.2022.812930","pmid":"35401294","publication_date":"2022-03-24","importer_version":"2.1.3","text_redistributed":false}


authors: Davis AK, Arterberry BJ, Xin Y, Agin-Liebes G, Schwarting C, Williams MT.
journal: Frontiers in Epidemiology
publication_date: 2022-03-22
doi: 10.3389/fepid.2022.876706
pubmed_id: 38455323
source_url: https://doi.org/10.3389/fepid.2022.876706
source_record_id: PMID:38455323
substance_tags: psilocybin
topic_tags: Observational Study,Safety
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fepid.2022.876706
text_rights_status: unverified_not_redistributed
title:
Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:38455323","source_url":"https://doi.org/10.3389/fepid.2022.876706","doi":"10.3389/fepid.2022.876706","pmid":"38455323","publication_date":"2022-03-22","importer_version":"2.1.3","text_redistributed":false}


authors: Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L
journal: Frontiers in psychiatry
publication_date: 2021-12-31
doi: 10.3389/fpsyt.2022.877390
pubmed_id: 35401265
source_url: https://pubmed.ncbi.nlm.nih.gov/35401265/
source_record_id: PMID:35401265
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Observational Study
study_type: Observational Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35401265/
text_rights_status: unverified_not_redistributed
title:
Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35401265","source_url":"https://pubmed.ncbi.nlm.nih.gov/35401265/","doi":"10.3389/fpsyt.2022.877390","pmid":"35401265","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Dworatzyk K, Jansen T, Schmidt TT.
journal: PLoS ONE
publication_date: 2022-03-15
doi: 10.1371/journal.pone.0264927
pubmed_id: 35294453
source_url: https://doi.org/10.1371/journal.pone.0264927
source_record_id: PMID:35294453
substance_tags: psilocybin
topic_tags: Anxiety,Consciousness,Mystical Experience,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1371/journal.pone.0264927
text_rights_status: unverified_not_redistributed
title:
Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI).

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35294453","source_url":"https://doi.org/10.1371/journal.pone.0264927","doi":"10.1371/journal.pone.0264927","pmid":"35294453","publication_date":"2022-03-15","importer_version":"2.1.3","text_redistributed":false}


authors: Raison CL, Jain R, Penn AD, Cole SP, Jain S
journal: Frontiers in psychiatry
publication_date: 2021-12-31
doi: 10.3389/fpsyt.2022.831092
pubmed_id: 35370864
source_url: https://pubmed.ncbi.nlm.nih.gov/35370864/
source_record_id: PMID:35370864
substance_tags: psilocybin
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35370864/
text_rights_status: unverified_not_redistributed
title:
Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.

topic_tags:
Depression,Anxiety,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Safety

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35370864","source_url":"https://pubmed.ncbi.nlm.nih.gov/35370864/","doi":"10.3389/fpsyt.2022.831092","pmid":"35370864","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Pearson C, Siegel J, Gold JA.
publication_date: 2021-12-15
doi: 10.1016/j.jns.2021.120096
pubmed_id: 34942586
source_url: https://doi.org/10.1016/j.jns.2021.120096
source_record_id: PMID:34942586
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jns.2021.120096
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34942586","source_url":"https://doi.org/10.1016/j.jns.2021.120096","doi":"10.1016/j.jns.2021.120096","pmid":"34942586","publication_date":"2021-12-15","importer_version":"2.1.3","text_redistributed":false}


authors: Meade E, Hehir S, Rowan N, Garvey M.
publication_date: 2022-03-10
doi: 10.3390/jof8030290
pubmed_id: 35330292
source_url: https://doi.org/10.3390/jof8030290
source_record_id: PMID:35330292
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Chronic Pain,Review Article,Safety,Inflammation,Immune Function
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/jof8030290
text_rights_status: unverified_not_redistributed
title:
Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35330292","source_url":"https://doi.org/10.3390/jof8030290","doi":"10.3390/jof8030290","pmid":"35330292","publication_date":"2022-03-10","importer_version":"2.1.3","text_redistributed":false}


journal: Frontiers in Pharmacology
publication_date: 2022-03-08
doi: 10.3389/fphar.2022.841648
pubmed_id: 35355714
source_url: https://doi.org/10.3389/fphar.2022.841648
source_record_id: PMID:35355714
substance_tags: psilocybin
topic_tags: Mystical Experience,Healthy Volunteers
study_type: Qualitative Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fphar.2022.841648
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Induced Mystical-Type Experiences are Related to Persisting Positive Effects: A Quantitative and Qualitative Report.

authors:
McCulloch DE, Grzywacz MZ, Madsen MK, Jensen PS, Ozenne B, Armand S, Knudsen GM, Fisher PM, Stenbæk DS.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35355714","source_url":"https://doi.org/10.3389/fphar.2022.841648","doi":"10.3389/fphar.2022.841648","pmid":"35355714","publication_date":"2022-03-08","importer_version":"2.1.3","text_redistributed":false}


journal: Neuroscience Applied
publication_date: 2022-03-06
doi: 10.1016/j.nsa.2022.100104
pubmed_id: 40656230
source_url: https://doi.org/10.1016/j.nsa.2022.100104
source_record_id: PMID:40656230
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.nsa.2022.100104
text_rights_status: unverified_not_redistributed
title:
Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.

authors:
Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:40656230","source_url":"https://doi.org/10.1016/j.nsa.2022.100104","doi":"10.1016/j.nsa.2022.100104","pmid":"40656230","publication_date":"2022-03-06","importer_version":"2.1.3","text_redistributed":false}


title: Virtual Reality as a Moderator of Psychedelic-Assisted Psychotherapy.
authors: Sekula AD, Downey L, Puspanathan P.
publication_date: 2022-03-03
doi: 10.3389/fpsyg.2022.813746
pubmed_id: 35310225
source_url: https://doi.org/10.3389/fpsyg.2022.813746
source_record_id: PMID:35310225
substance_tags: psilocybin
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyg.2022.813746
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,Consciousness,Spirituality,Mystical Experience,Treatment-Resistant Depression,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35310225","source_url":"https://doi.org/10.3389/fpsyg.2022.813746","doi":"10.3389/fpsyg.2022.813746","pmid":"35310225","publication_date":"2022-03-03","importer_version":"2.1.3","text_redistributed":false}


authors: Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF.
publication_date: 2022-03-06
doi: 10.1007/s11864-022-00954-4
pubmed_id: 35254595
source_url: https://doi.org/10.1007/s11864-022-00954-4
source_record_id: PMID:35254595
substance_tags: psilocybin
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s11864-022-00954-4
text_rights_status: unverified_not_redistributed
title:
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.

topic_tags:
Depression,Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Aging,Cancer Patients,Healthcare Workers,Safety

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35254595","source_url":"https://doi.org/10.1007/s11864-022-00954-4","doi":"10.1007/s11864-022-00954-4","pmid":"35254595","publication_date":"2022-03-06","importer_version":"2.1.3","text_redistributed":false}


authors: Wolff M, Mertens LJ, Walter M, Enge S, Evens R.
journal: Journal of Psychopharmacology
publication_date: 2022-02-28
doi: 10.1177/02698811211073758
pubmed_id: 35253518
source_url: https://doi.org/10.1177/02698811211073758
source_record_id: PMID:35253518
substance_tags: psilocybin
topic_tags: Mechanism of Action,Psychological Flexibility,Observational Study,Drug Interactions
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211073758
text_rights_status: unverified_not_redistributed
title:
The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs' effects on psychological flexibility.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35253518","source_url":"https://doi.org/10.1177/02698811211073758","doi":"10.1177/02698811211073758","pmid":"35253518","publication_date":"2022-02-28","importer_version":"2.1.3","text_redistributed":false}


title: Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.
authors: Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ
journal: Journal of psychopharmacology (Oxford, England)
publication_date: 2022-02-28
doi: 10.1177/02698811211069100
pubmed_id: 35107059
source_url: https://pubmed.ncbi.nlm.nih.gov/35107059/
source_record_id: PMID:35107059
substance_tags: psilocybin
topic_tags: Review Article,Healthcare Workers,Safety,Toxicity,Abuse Liability
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35107059/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35107059","source_url":"https://pubmed.ncbi.nlm.nih.gov/35107059/","doi":"10.1177/02698811211069100","pmid":"35107059","publication_date":"2022-02-28","importer_version":"2.1.3","text_redistributed":false}


title: [Are psychedelics fast acting antidepressant agents?]
authors: Gründer G, Brand M, Kärtner L, Scharf D, Schmitz C, Spangemacher M, Mertens LJ.
publication_date: 2022-01-31
doi: 10.1007/s00115-021-01255-1
pubmed_id: 35103814
source_url: https://doi.org/10.1007/s00115-021-01255-1
source_record_id: PMID:35103814
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:04
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00115-021-01255-1
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35103814","source_url":"https://doi.org/10.1007/s00115-021-01255-1","doi":"10.1007/s00115-021-01255-1","pmid":"35103814","publication_date":"2022-01-31","importer_version":"2.1.3","text_redistributed":false}


title: Beating pain with psychedelics: Matter over mind?
authors: Elman I, Pustilnik A, Borsook D.
publication_date: 2021-12-15
doi: 10.1016/j.neubiorev.2021.12.005
pubmed_id: 34922987
source_url: https://doi.org/10.1016/j.neubiorev.2021.12.005
source_record_id: PMID:34922987
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.neubiorev.2021.12.005
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Emotional Processing,Review Article,Safety,Inflammation

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34922987","source_url":"https://doi.org/10.1016/j.neubiorev.2021.12.005","doi":"10.1016/j.neubiorev.2021.12.005","pmid":"34922987","publication_date":"2021-12-15","importer_version":"2.1.3","text_redistributed":false}


title: [Rapid-acting antidepressants-neurobiological mechanisms of action].
authors: Gass P, Vasilescu AN, Inta D.
publication_date: 2021-11-10
doi: 10.1007/s00115-021-01225-7
pubmed_id: 34766186
source_url: https://doi.org/10.1007/s00115-021-01225-7
source_record_id: PMID:34766186
substance_tags: psilocybin
topic_tags: Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00115-021-01225-7
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34766186","source_url":"https://doi.org/10.1007/s00115-021-01225-7","doi":"10.1007/s00115-021-01225-7","pmid":"34766186","publication_date":"2021-11-10","importer_version":"2.1.3","text_redistributed":false}


title: Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.
authors: Thomas CW, Blanco-Duque C, Bréant BJ, Goodwin GM, Sharp T, Bannerman DM, Vyazovskiy VV.
journal: Translational Psychiatry
publication_date: 2022-02-22
doi: 10.1038/s41398-022-01846-9
pubmed_id: 35197453
source_url: https://doi.org/10.1038/s41398-022-01846-9
source_record_id: PMID:35197453
substance_tags: psilocybin,psilocin
topic_tags: Depression,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Wellbeing,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41398-022-01846-9
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35197453","source_url":"https://doi.org/10.1038/s41398-022-01846-9","doi":"10.1038/s41398-022-01846-9","pmid":"35197453","publication_date":"2022-02-22","importer_version":"2.1.3","text_redistributed":false}


authors: Jones GM, Nock MK.
journal: Scientific Reports
publication_date: 2022-02-15
doi: 10.1038/s41598-022-06580-2
pubmed_id: 35173246
source_url: https://doi.org/10.1038/s41598-022-06580-2
source_record_id: PMID:35173246
substance_tags: psilocybin
topic_tags: Addiction,Personality Change,Observational Study,Adolescents
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41598-022-06580-2
text_rights_status: unverified_not_redistributed
title:
Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35173246","source_url":"https://doi.org/10.1038/s41598-022-06580-2","doi":"10.1038/s41598-022-06580-2","pmid":"35173246","publication_date":"2022-02-15","importer_version":"2.1.3","text_redistributed":false}


authors: Kargbo RB, Sherwood AM, Meisenheimer P, Lenoch K, Abebe S.
journal: ACS Omega
publication_date: 2022-02-06
doi: 10.1021/acsomega.1c06708
pubmed_id: 35187358
source_url: https://doi.org/10.1021/acsomega.1c06708
source_record_id: PMID:35187358
substance_tags: psilocybin,psilocin
topic_tags: Depression,Clinical Trial,Treatment-Resistant Depression,Drug Interactions
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1021/acsomega.1c06708
text_rights_status: unverified_not_redistributed
title:
Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35187358","source_url":"https://doi.org/10.1021/acsomega.1c06708","doi":"10.1021/acsomega.1c06708","pmid":"35187358","publication_date":"2022-02-06","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2022-02-10
doi: 10.3390/jcm11040938
pubmed_id: 35207210
source_url: https://doi.org/10.3390/jcm11040938
source_record_id: PMID:35207210
substance_tags: psilocybin
topic_tags: Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/jcm11040938
text_rights_status: unverified_not_redistributed
title:
Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.

authors:
Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35207210","source_url":"https://doi.org/10.3390/jcm11040938","doi":"10.3390/jcm11040938","pmid":"35207210","publication_date":"2022-02-10","importer_version":"2.1.3","text_redistributed":false}


authors: Coppola M, Bevione F, Mondola R.
publication_date: 2022-02-06
doi: 10.3390/jox12010004
pubmed_id: 35225956
source_url: https://doi.org/10.3390/jox12010004
source_record_id: PMID:35225956
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Spirituality
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/jox12010004
text_rights_status: unverified_not_redistributed
title:
Psilocybin for Treating Psychiatric Disorders: A Psychonaut Legend or a Promising Therapeutic Perspective?

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35225956","source_url":"https://doi.org/10.3390/jox12010004","doi":"10.3390/jox12010004","pmid":"35225956","publication_date":"2022-02-06","importer_version":"2.1.3","text_redistributed":false}


authors: Yang Y, Meng G, Ni S, Zhang H, Dong C.
journal: Journal of Fungi
publication_date: 2022-02-05
doi: 10.3390/jof8020162
pubmed_id: 35205916
source_url: https://doi.org/10.3390/jof8020162
source_record_id: PMID:35205916
substance_tags: psilocybin
topic_tags: Pharmacology,Genomics
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/jof8020162
text_rights_status: unverified_not_redistributed
title:
Genomic Analysis of Stropharia rugosoannulata Reveals Its Nutritional Strategy and Application Potential in Bioremediation.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35205916","source_url":"https://doi.org/10.3390/jof8020162","doi":"10.3390/jof8020162","pmid":"35205916","publication_date":"2022-02-05","importer_version":"2.1.3","text_redistributed":false}


title: Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.
authors: Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR.
publication_date: 2022-02-04
doi: 10.7759/cureus.21944
pubmed_id: 35273885
source_url: https://doi.org/10.7759/cureus.21944
source_record_id: PMID:35273885
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.7759/cureus.21944
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35273885","source_url":"https://doi.org/10.7759/cureus.21944","doi":"10.7759/cureus.21944","pmid":"35273885","publication_date":"2022-02-04","importer_version":"2.1.3","text_redistributed":false}


authors: Averill LA, Abdallah CG
journal: Expert opinion on investigational drugs
publication_date: 2022-01-31
doi: 10.1080/13543784.2022.2035358
pubmed_id: 35188023
source_url: https://pubmed.ncbi.nlm.nih.gov/35188023/
source_record_id: PMID:35188023
substance_tags: psilocybin
topic_tags: PTSD,Neuroplasticity
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
text_rights_status: not_applicable_no_text
title:
Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35188023","source_url":"https://pubmed.ncbi.nlm.nih.gov/35188023/","doi":"10.1080/13543784.2022.2035358","pmid":"35188023","publication_date":"2022-01-31","importer_version":"2.1.3","text_redistributed":false}


authors: Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR.
journal: Journal of Psychopharmacology
publication_date: 2022-01-31
doi: 10.1177/02698811211073759
pubmed_id: 35166158
source_url: https://doi.org/10.1177/02698811211073759
source_record_id: PMID:35166158
substance_tags: psilocybin
topic_tags: Depression,Wellbeing,Spirituality,Mystical Experience,Safety,Adverse Events
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211073759
text_rights_status: unverified_not_redistributed
title:
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35166158","source_url":"https://doi.org/10.1177/02698811211073759","doi":"10.1177/02698811211073759","pmid":"35166158","publication_date":"2022-01-31","importer_version":"2.1.3","text_redistributed":false}


title: Crystallographic hallucinations.
authors: Toby BH
journal: Acta crystallographica. Section C, Structural chemistry
publication_date: 2022-01-31
doi: 10.1107/s2053229622000511
pubmed_id: 35119383
source_url: https://pubmed.ncbi.nlm.nih.gov/35119383/
source_record_id: PMID:35119383
substance_tags: psilocybin
topic_tags: General
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35119383/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35119383","source_url":"https://pubmed.ncbi.nlm.nih.gov/35119383/","doi":"10.1107/s2053229622000511","pmid":"35119383","publication_date":"2022-01-31","importer_version":"2.1.3","text_redistributed":false}


title: Analysis of recreational psychedelic substance use experiences classified by substance.
authors: Hase A, Erdmann M, Limbach V, Hasler G.
journal: Psychopharmacology
publication_date: 2022-01-14
doi: 10.1007/s00213-022-06062-3
pubmed_id: 35031816
source_url: https://doi.org/10.1007/s00213-022-06062-3
source_record_id: PMID:35031816
substance_tags: psilocybin
topic_tags: Addiction,Biomarkers,Emotional Processing,Mystical Experience,Clinical Trial
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-022-06062-3
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35031816","source_url":"https://doi.org/10.1007/s00213-022-06062-3","doi":"10.1007/s00213-022-06062-3","pmid":"35031816","publication_date":"2022-01-14","importer_version":"2.1.3","text_redistributed":false}


title: Hallucinogen Use and Misuse in Older Adults.
authors: Redden WM, Paracha SU, Sheheryar Q.
publication_date: 2022-01-31
doi: 10.1016/j.cger.2021.07.007
pubmed_id: 34794703
source_url: https://doi.org/10.1016/j.cger.2021.07.007
source_record_id: PMID:34794703
substance_tags: psilocybin
topic_tags: Aging,Older Adults
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.cger.2021.07.007
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34794703","source_url":"https://doi.org/10.1016/j.cger.2021.07.007","doi":"10.1016/j.cger.2021.07.007","pmid":"34794703","publication_date":"2022-01-31","importer_version":"2.1.3","text_redistributed":false}


title: Structure-based discovery of nonhallucinogenic psychedelic analogs.
authors: Cao D, Yu J, Wang H, Luo Z, Liu X, He L, Qi J, Fan L, Tang L, Chen Z, Li J, Cheng J, Wang S.
journal: Science
publication_date: 2022-01-26
doi: 10.1126/science.abl8615
pubmed_id: 35084960
source_url: https://doi.org/10.1126/science.abl8615
source_record_id: PMID:35084960
substance_tags: psilocybin,psilocin
topic_tags: Depression,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1126/science.abl8615
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35084960","source_url":"https://doi.org/10.1126/science.abl8615","doi":"10.1126/science.abl8615","pmid":"35084960","publication_date":"2022-01-26","importer_version":"2.1.3","text_redistributed":false}


title: Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.
authors: Markopoulos A, Inserra A, De Gregorio D, Gobbi G.
publication_date: 2022-01-26
doi: 10.3389/fphar.2021.749068
pubmed_id: 35177979
source_url: https://doi.org/10.3389/fphar.2021.749068
source_record_id: PMID:35177979
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fphar.2021.749068
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35177979","source_url":"https://doi.org/10.3389/fphar.2021.749068","doi":"10.3389/fphar.2021.749068","pmid":"35177979","publication_date":"2022-01-26","importer_version":"2.1.3","text_redistributed":false}


authors: Barrett FS, Zhou Y, Carbonaro TM, Roberts JM, Smith GS, Griffiths RR, Wong DF.
journal: Frontiers in Neuroergonomics
publication_date: 2022-01-19
doi: 10.3389/fnrgo.2021.784576
pubmed_id: 38235248
source_url: https://doi.org/10.3389/fnrgo.2021.784576
source_record_id: PMID:38235248
substance_tags: psilocybin
topic_tags: Addiction,Brain Imaging,Receptor Pharmacology,Default Mode Network,Healthy Volunteers
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fnrgo.2021.784576
text_rights_status: unverified_not_redistributed
title:
Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:38235248","source_url":"https://doi.org/10.3389/fnrgo.2021.784576","doi":"10.3389/fnrgo.2021.784576","pmid":"38235248","publication_date":"2022-01-19","importer_version":"2.1.3","text_redistributed":false}


title: [Psilocybin compared with escitalopram for depression].
authors: Strous JFM.
journal: PubMed
publication_date: 2022-01-16
pubmed_id: 35138714
source_url: https://europepmc.org/article/MED/35138714
source_record_id: PMID:35138714
substance_tags: psilocybin
topic_tags: Depression,Clinical Trial,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://europepmc.org/article/MED/35138714
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35138714","source_url":"https://europepmc.org/article/MED/35138714","doi":"","pmid":"35138714","publication_date":"2022-01-16","importer_version":"2.1.3","text_redistributed":false}


authors: Khan FI, Hassan F, Lai D.
journal: Frontiers in Immunology
publication_date: 2022-01-13
doi: 10.3389/fimmu.2021.794780
pubmed_id: 35095870
source_url: https://doi.org/10.3389/fimmu.2021.794780
source_record_id: PMID:35095870
substance_tags: psilocybin,psilocin
topic_tags: Receptor Pharmacology
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fimmu.2021.794780
text_rights_status: unverified_not_redistributed
title:
In Silico Studies on Psilocybin Drug Derivatives Against SARS-CoV-2 and Cytokine Storm of Human Interleukin-6 Receptor.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35095870","source_url":"https://doi.org/10.3389/fimmu.2021.794780","doi":"10.3389/fimmu.2021.794780","pmid":"35095870","publication_date":"2022-01-13","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health Outcomes.
authors: Matzopoulos R, Morlock R, Morlock A, Lerer B, Lerer L
journal: Frontiers in psychiatry
publication_date: 2020-12-31
doi: 10.3389/fpsyt.2021.780696
pubmed_id: 35046855
source_url: https://pubmed.ncbi.nlm.nih.gov/35046855/
source_record_id: PMID:35046855
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Wellbeing,Observational Study
study_type: Observational Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35046855/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35046855","source_url":"https://pubmed.ncbi.nlm.nih.gov/35046855/","doi":"10.3389/fpsyt.2021.780696","pmid":"35046855","publication_date":"2020-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Identity Shift: A Critical Approach to Set And Setting
journal: Kennedy Institute of Ethics journal
publication_date: 2022-11-30
doi: 10.1353/ken.2022.0022
pubmed_id: 38588216
source_url: https://doi.org/10.1353/ken.2022.0022
source_record_id: PMID:38588216
substance_tags: psilocybin
topic_tags: Addiction,Mechanism of Action
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1353/ken.2022.0022
text_rights_status: unverified_not_redistributed
authors:
Neşe Devenot, Aidan Seale-Feldman, Elyse Smith, Tehseen Noorani, Albert Garcia-Romeu, Matthew W. Johnson

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:38588216","source_url":"https://doi.org/10.1353/ken.2022.0022","doi":"10.1353/ken.2022.0022","pmid":"38588216","publication_date":"2022-11-30","importer_version":"2.1.3","text_redistributed":false}


title: Multi-locus identification of Psilocybe cubensis by high-resolution melting (HRM).
authors: Zhang X, Yu H, Wang Z, Yang Q, Xia R, Qu Y, Tao R, Shi Y, Xiang P, Zhang S, Li C.
journal: Forensic Sciences Research
publication_date: 2021-04-12
doi: 10.1080/20961790.2021.1875580
pubmed_id: 36353314
source_url: https://doi.org/10.1080/20961790.2021.1875580
source_record_id: PMID:36353314
substance_tags: psilocybin,psilocin
topic_tags: Biomarkers,Toxicity
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/20961790.2021.1875580
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36353314","source_url":"https://doi.org/10.1080/20961790.2021.1875580","doi":"10.1080/20961790.2021.1875580","pmid":"36353314","publication_date":"2021-04-12","importer_version":"2.1.3","text_redistributed":false}


authors: Kiguchi Y.
journal: YAKUGAKU ZASSHI
publication_date: 2021-12-31
doi: 10.1248/yakushi.22-00141
pubmed_id: 36328444
source_url: https://doi.org/10.1248/yakushi.22-00141
source_record_id: PMID:36328444
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:37
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1248/yakushi.22-00141
text_rights_status: unverified_not_redistributed
title:
[A Novel System for Discovering High-affinity Antibody Mutants That Enables Immunoassays with Higher Sensitivities -Development and Application of Clonal Array Profiling (CAP)].

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:36328444","source_url":"https://doi.org/10.1248/yakushi.22-00141","doi":"10.1248/yakushi.22-00141","pmid":"36328444","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Trauma-Related Disorders.
authors: Khan AJ, Bradley E, O'Donovan A, Woolley J.
publication_date: 2021-12-31
doi: 10.1007/7854_2022_366
pubmed_id: 35711024
source_url: https://doi.org/10.1007/7854_2022_366
source_record_id: PMID:35711024
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Mechanism of Action,Emotional Processing,Veterans,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/7854_2022_366
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35711024","source_url":"https://doi.org/10.1007/7854_2022_366","doi":"10.1007/7854_2022_366","pmid":"35711024","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
authors: Johnson MW.
publication_date: 2021-12-31
doi: 10.1007/7854_2022_327
pubmed_id: 35704271
source_url: https://doi.org/10.1007/7854_2022_327
source_record_id: PMID:35704271
substance_tags: psilocybin
topic_tags: Addiction,Receptor Pharmacology,Review Article,Safety
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:03
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/7854_2022_327
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35704271","source_url":"https://doi.org/10.1007/7854_2022_327","doi":"10.1007/7854_2022_327","pmid":"35704271","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Anti-inflammatory Activity in Animal Models.
authors: Flanagan TW, Nichols CD
journal: Current topics in behavioral neurosciences
publication_date: 2021-12-31
doi: 10.1007/7854_2022_367
pubmed_id: 35546383
source_url: https://pubmed.ncbi.nlm.nih.gov/35546383/
source_record_id: PMID:35546383
substance_tags: psilocybin
topic_tags: Receptor Pharmacology,Review Article,Animal Study,Inflammation,Immune Function
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35546383/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35546383","source_url":"https://pubmed.ncbi.nlm.nih.gov/35546383/","doi":"10.1007/7854_2022_367","pmid":"35546383","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics in the Treatment of Headache and Chronic Pain Disorders.
authors: Schindler EAD.
publication_date: 2021-12-31
doi: 10.1007/7854_2022_365
pubmed_id: 35546382
source_url: https://doi.org/10.1007/7854_2022_365
source_record_id: PMID:35546382
substance_tags: psilocybin
topic_tags: Chronic Pain,Headache / Migraine,Review Article,Safety
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/7854_2022_365
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35546382","source_url":"https://doi.org/10.1007/7854_2022_365","doi":"10.1007/7854_2022_365","pmid":"35546382","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin Conspectus: Status, Production Methods, and Considerations.
authors: Plotnik L, Gibbs G, Graham T.
journal: International journal of medicinal mushrooms
publication_date: 2021-12-31
doi: 10.1615/intjmedmushrooms.2021041921
pubmed_id: 35442591
source_url: https://doi.org/10.1615/intjmedmushrooms.2021041921
source_record_id: PMID:35442591
substance_tags: psilocybin
topic_tags: Clinical Trial,Review Article
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1615/intjmedmushrooms.2021041921
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35442591","source_url":"https://doi.org/10.1615/intjmedmushrooms.2021041921","doi":"10.1615/intjmedmushrooms.2021041921","pmid":"35442591","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Human behavioral pharmacology of psychedelics.
authors: Strickland JC, Johnson MW.
publication_date: 2021-11-10
doi: 10.1016/bs.apha.2021.10.003
pubmed_id: 35341564
source_url: https://doi.org/10.1016/bs.apha.2021.10.003
source_record_id: PMID:35341564
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/bs.apha.2021.10.003
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Addiction,Pharmacology,Mechanism of Action,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Abuse Liability

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35341564","source_url":"https://doi.org/10.1016/bs.apha.2021.10.003","doi":"10.1016/bs.apha.2021.10.003","pmid":"35341564","publication_date":"2021-11-10","importer_version":"2.1.3","text_redistributed":false}


authors: Jones GM, Nock MK.
journal: Journal of Psychopharmacology
publication_date: 2021-12-31
doi: 10.1177/02698811211058933
pubmed_id: 35090364
source_url: https://doi.org/10.1177/02698811211058933
source_record_id: PMID:35090364
substance_tags: psilocybin
topic_tags: Addiction,Personality Change,Observational Study,Adolescents
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211058933
text_rights_status: unverified_not_redistributed
title:
Psilocybin use is associated with lowered odds of crime arrests in US adults: A replication and extension.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35090364","source_url":"https://doi.org/10.1177/02698811211058933","doi":"10.1177/02698811211058933","pmid":"35090364","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Psychopharmacology
publication_date: 2022-01-03
doi: 10.1177/02698811211064720
pubmed_id: 35090363
source_url: https://doi.org/10.1177/02698811211064720
source_record_id: PMID:35090363
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211064720
text_rights_status: unverified_not_redistributed
title:
The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.

authors:
Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH.

topic_tags:
Depression,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35090363","source_url":"https://doi.org/10.1177/02698811211064720","doi":"10.1177/02698811211064720","pmid":"35090363","publication_date":"2022-01-03","importer_version":"2.1.3","text_redistributed":false}


authors: Jones GM, Nock MK.
journal: Journal of Psychopharmacology
publication_date: 2022-01-04
doi: 10.1177/02698811211066714
pubmed_id: 34983261
source_url: https://doi.org/10.1177/02698811211066714
source_record_id: PMID:34983261
substance_tags: psilocybin
topic_tags: Depression,Addiction,Chronic Pain,Observational Study,Adolescents
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211066714
text_rights_status: unverified_not_redistributed
title:
Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34983261","source_url":"https://doi.org/10.1177/02698811211066714","doi":"10.1177/02698811211066714","pmid":"34983261","publication_date":"2022-01-04","importer_version":"2.1.3","text_redistributed":false}


authors: Jones GM, Nock MK.
journal: Journal of Psychopharmacology
publication_date: 2022-01-04
doi: 10.1177/02698811211058923
pubmed_id: 34983249
source_url: https://doi.org/10.1177/02698811211058923
source_record_id: PMID:34983249
substance_tags: psilocybin
topic_tags: Observational Study,Adolescents,Safety
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211058923
text_rights_status: unverified_not_redistributed
title:
MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34983249","source_url":"https://doi.org/10.1177/02698811211058923","doi":"10.1177/02698811211058923","pmid":"34983249","publication_date":"2022-01-04","importer_version":"2.1.3","text_redistributed":false}


authors: Sherwood AM, Kargbo RB, Kaylo KW, Cozzi NV, Meisenheimer P, Kaduk JA.
journal: Acta Crystallographica Section C Structural Chemistry
publication_date: 2021-12-31
doi: 10.1107/s2053229621013164
pubmed_id: 34982048
source_url: https://doi.org/10.1107/s2053229621013164
source_record_id: PMID:34982048
substance_tags: psilocybin
topic_tags: Clinical Trial
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1107/s2053229621013164
text_rights_status: unverified_not_redistributed
title:
Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34982048","source_url":"https://doi.org/10.1107/s2053229621013164","doi":"10.1107/s2053229621013164","pmid":"34982048","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: The Potential of Psychedelics for End of Life and Palliative Care.
authors: Yaden DB, Nayak SM, Gukasyan N, Anderson BT, Griffiths RR
journal: Current topics in behavioral neurosciences
publication_date: 2021-12-31
doi: 10.1007/7854_2021_278
pubmed_id: 34958455
source_url: https://pubmed.ncbi.nlm.nih.gov/34958455/
source_record_id: PMID:34958455
substance_tags: psilocybin
topic_tags: Depression,End-of-Life Distress,Wellbeing,Review Article,Healthcare Workers
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34958455/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34958455","source_url":"https://pubmed.ncbi.nlm.nih.gov/34958455/","doi":"10.1007/7854_2021_278","pmid":"34958455","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Marschall J, Fejer G, Lempe P, Prochazkova L, Kuchar M, Hajkova K, van Elk M.
journal: Journal of Psychopharmacology
publication_date: 2021-12-16
doi: 10.1177/02698811211050556
pubmed_id: 34915762
source_url: https://doi.org/10.1177/02698811211050556
source_record_id: PMID:34915762
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Mechanism of Action,Microdosing,Emotional Processing,Observational Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211050556
text_rights_status: unverified_not_redistributed
title:
Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34915762","source_url":"https://doi.org/10.1177/02698811211050556","doi":"10.1177/02698811211050556","pmid":"34915762","publication_date":"2021-12-16","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.
authors: Rieser NM, Herdener M, Preller KH
journal: Current topics in behavioral neurosciences
publication_date: 2021-12-31
doi: 10.1007/7854_2021_284
pubmed_id: 34910289
source_url: https://pubmed.ncbi.nlm.nih.gov/34910289/
source_record_id: PMID:34910289
substance_tags: psilocybin
topic_tags: Addiction,Neuroplasticity,Mechanism of Action,Emotional Processing,Mystical Experience
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34910289/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34910289","source_url":"https://pubmed.ncbi.nlm.nih.gov/34910289/","doi":"10.1007/7854_2021_284","pmid":"34910289","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic medicines for mood disorders: current evidence and clinical considerations.
authors: Sarris J, Pinzon Rubiano D, Day K, Galvão-Coelho NL, Perkins D.
journal: PubMed
publication_date: 2021-12-31
doi: 10.1097/yco.0000000000000759
pubmed_id: 34855694
source_url: https://doi.org/10.1097/yco.0000000000000759
source_record_id: PMID:34855694
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1097/yco.0000000000000759
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,PTSD,Neuroplasticity,Neurogenesis,Mechanism of Action,Aging,Microdosing,Clinical Trial,Review Article,Animal Study,Treatment-Resistant Depression,Genomics,Microbiome,Inflammation

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34855694","source_url":"https://doi.org/10.1097/yco.0000000000000759","doi":"10.1097/yco.0000000000000759","pmid":"34855694","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
authors: Sousa TR, Rema J, Machado S, Novais F.
journal: Current Topics in Medicinal Chemistry
publication_date: 2021-12-31
doi: 10.2174/1568026621666211201145800
pubmed_id: 34852736
source_url: https://doi.org/10.2174/1568026621666211201145800
source_record_id: PMID:34852736
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.2174/1568026621666211201145800
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,Addiction,OCD,Mechanism of Action,Default Mode Network,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34852736","source_url":"https://doi.org/10.2174/1568026621666211201145800","doi":"10.2174/1568026621666211201145800","pmid":"34852736","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA.
publication_date: 2021-11-22
doi: 10.1007/s00213-021-06027-y
pubmed_id: 34812901
source_url: https://doi.org/10.1007/s00213-021-06027-y
source_record_id: PMID:34812901
substance_tags: psilocybin
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s00213-021-06027-y
text_rights_status: unverified_not_redistributed
title:
Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

topic_tags:
Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Systematic Review,Review Article,Safety

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34812901","source_url":"https://doi.org/10.1007/s00213-021-06027-y","doi":"10.1007/s00213-021-06027-y","pmid":"34812901","publication_date":"2021-11-22","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.
authors: Agin-Liebes G, Davis AK.
journal: Current topics in behavioral neurosciences
publication_date: 2021-12-31
doi: 10.1007/7854_2021_282
pubmed_id: 34811715
source_url: https://doi.org/10.1007/7854_2021_282
source_record_id: PMID:34811715
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/7854_2021_282
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34811715","source_url":"https://doi.org/10.1007/7854_2021_282","doi":"10.1007/7854_2021_282","pmid":"34811715","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.
publication_date: 2021-11-16
doi: 10.1007/s40263-021-00877-y
pubmed_id: 34791625
source_url: https://doi.org/10.1007/s40263-021-00877-y
source_record_id: PMID:34791625
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/s40263-021-00877-y
text_rights_status: unverified_not_redistributed
authors:
Ling S, Ceban F, Lui LMW, Lee Y, Teopiz KM, Rodrigues NB, Lipsitz O, Gill H, Subramaniapillai M, Mansur RB, Lin K, Ho R, Rosenblat JD, Castle D, McIntyre RS.

topic_tags:
Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Review Article,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34791625","source_url":"https://doi.org/10.1007/s40263-021-00877-y","doi":"10.1007/s40263-021-00877-y","pmid":"34791625","publication_date":"2021-11-16","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for the Treatment of Obsessive-Compulsive Disorders.
authors: Ehrmann K, Allen JJB, Moreno FA.
publication_date: 2021-12-31
doi: 10.1007/7854_2021_279
pubmed_id: 34784024
source_url: https://doi.org/10.1007/7854_2021_279
source_record_id: PMID:34784024
substance_tags: psilocybin
topic_tags: OCD,Mechanism of Action,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/7854_2021_279
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34784024","source_url":"https://doi.org/10.1007/7854_2021_279","doi":"10.1007/7854_2021_279","pmid":"34784024","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Dosing Psychedelics and MDMA.
authors: Liechti ME, Holze F.
publication_date: 2021-12-31
doi: 10.1007/7854_2021_270
pubmed_id: 34734392
source_url: https://doi.org/10.1007/7854_2021_270
source_record_id: PMID:34734392
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Headache / Migraine,Microdosing
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1007/7854_2021_270
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34734392","source_url":"https://doi.org/10.1007/7854_2021_270","doi":"10.1007/7854_2021_270","pmid":"34734392","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.
authors: Garcia-Romeu A, Darcy S, Jackson H, White T, Rosenberg P
journal: Current topics in behavioral neurosciences
publication_date: 2021-12-31
doi: 10.1007/7854_2021_267
pubmed_id: 34734390
source_url: https://pubmed.ncbi.nlm.nih.gov/34734390/
source_record_id: PMID:34734390
substance_tags: psilocybin
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34734390/
text_rights_status: unverified_not_redistributed
topic_tags:
Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Inflammation

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34734390","source_url":"https://pubmed.ncbi.nlm.nih.gov/34734390/","doi":"10.1007/7854_2021_267","pmid":"34734390","publication_date":"2021-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Barnett BS, Parker SE, Weleff J.
publication_date: 2021-10-05
doi: 10.1016/j.drugpo.2021.103473
pubmed_id: 34624734
source_url: https://doi.org/10.1016/j.drugpo.2021.103473
source_record_id: PMID:34624734
substance_tags: psilocybin
topic_tags: Addiction,Clinical Trial,Review Article,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.drugpo.2021.103473
text_rights_status: unverified_not_redistributed
title:
United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34624734","source_url":"https://doi.org/10.1016/j.drugpo.2021.103473","doi":"10.1016/j.drugpo.2021.103473","pmid":"34624734","publication_date":"2021-10-05","importer_version":"2.1.3","text_redistributed":false}


authors: Li NX, Hu YR, Chen WN, Zhang B.
publication_date: 2021-09-16
doi: 10.1016/j.jad.2021.09.041
pubmed_id: 34587546
source_url: https://doi.org/10.1016/j.jad.2021.09.041
source_record_id: PMID:34587546
substance_tags: psilocybin
topic_tags: Depression,Meta-Analysis,Systematic Review,Review Article,Cancer Patients
study_type: Meta-Analysis
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.jad.2021.09.041
text_rights_status: unverified_not_redistributed
title:
Dose effect of psilocybin on primary and secondary depression: a preliminary systematic review and meta-analysis.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34587546","source_url":"https://doi.org/10.1016/j.jad.2021.09.041","doi":"10.1016/j.jad.2021.09.041","pmid":"34587546","publication_date":"2021-09-16","importer_version":"2.1.3","text_redistributed":false}


authors: Leger RF, Unterwald EM.
publication_date: 2021-09-13
doi: 10.1177/02698811211044688
pubmed_id: 34519567
source_url: https://doi.org/10.1177/02698811211044688
source_record_id: PMID:34519567
substance_tags: psilocybin
study_type: Meta-Analysis
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211044688
text_rights_status: unverified_not_redistributed
title:
Assessing the effects of methodological differences on outcomes in the use of psychedelics in the treatment of anxiety and depressive disorders: A systematic review and meta-analysis.

topic_tags:
Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34519567","source_url":"https://doi.org/10.1177/02698811211044688","doi":"10.1177/02698811211044688","pmid":"34519567","publication_date":"2021-09-13","importer_version":"2.1.3","text_redistributed":false}


authors: Mayer CE, LeBaron VT, Acquaviva KD.
journal: Journal of Psychoactive Drugs
publication_date: 2021-07-15
doi: 10.1080/02791072.2021.1916659
pubmed_id: 34266372
source_url: https://doi.org/10.1080/02791072.2021.1916659
source_record_id: PMID:34266372
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Safety
study_type: Qualitative Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/02791072.2021.1916659
text_rights_status: unverified_not_redistributed
title:
Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34266372","source_url":"https://doi.org/10.1080/02791072.2021.1916659","doi":"10.1080/02791072.2021.1916659","pmid":"34266372","publication_date":"2021-07-15","importer_version":"2.1.3","text_redistributed":false}


authors: McCulloch DE, Madsen MK, Stenbæk DS, Kristiansen S, Ozenne B, Jensen PS, Knudsen GM, Fisher PM.
journal: Journal of Psychopharmacology
publication_date: 2021-06-29
doi: 10.1177/02698811211026454
pubmed_id: 34189985
source_url: https://doi.org/10.1177/02698811211026454
source_record_id: PMID:34189985
substance_tags: psilocybin
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211026454
text_rights_status: unverified_not_redistributed
title:
Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals.

topic_tags:
Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Wellbeing,Personality Change,Observational Study

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34189985","source_url":"https://doi.org/10.1177/02698811211026454","doi":"10.1177/02698811211026454","pmid":"34189985","publication_date":"2021-06-29","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and health behaviour change.
publication_date: 2021-05-28
doi: 10.1177/02698811211008554
pubmed_id: 34053342
source_url: https://doi.org/10.1177/02698811211008554
source_record_id: PMID:34053342
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Eating Disorders,Mechanism of Action,Wellbeing,Safety,Toxicity
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/02698811211008554
text_rights_status: unverified_not_redistributed
authors:
Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34053342","source_url":"https://doi.org/10.1177/02698811211008554","doi":"10.1177/02698811211008554","pmid":"34053342","publication_date":"2021-05-28","importer_version":"2.1.3","text_redistributed":false}


authors: Rotem Petranker, Thomas Anderson, Larissa J. Maier, Monica J. Barratt, Jason Ferris, Adam Winstock
journal: Journal of Psychopharmacology
publication_date: 2020-10-07
doi: 10.1177/0269881120953994
pubmed_id: 33591231
source_url: https://doi.org/10.1177/0269881120953994
source_record_id: PMID:33591231
substance_tags: psilocybin
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:39
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1177/0269881120953994
text_rights_status: unverified_not_redistributed
title:
Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention

topic_tags:
Pharmacology,Receptor Pharmacology,Microdosing,Creativity,Observational Study,Adverse Events,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"PMID:33591231","source_url":"https://doi.org/10.1177/0269881120953994","doi":"10.1177/0269881120953994","pmid":"33591231","publication_date":"2020-10-07","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic philanthropy: The nonprofit sector and Timothy Leary's 1960s psychedelic movement.
authors: Elcock C.
journal: Journal of the History of the Behavioral Sciences
publication_date: 2021-01-31
doi: 10.1002/jhbs.22083
pubmed_id: 33524159
source_url: https://doi.org/10.1002/jhbs.22083
source_record_id: PMID:33524159
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/jhbs.22083
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:33524159","source_url":"https://doi.org/10.1002/jhbs.22083","doi":"10.1002/jhbs.22083","pmid":"33524159","publication_date":"2021-01-31","importer_version":"2.1.3","text_redistributed":false}


authors: Frontiers Production Office
journal: Frontiers in psychiatry
publication_date: 2020-12-31
doi: 10.3389/fpsyt.2021.832766
pubmed_id: 35002818
source_url: https://pubmed.ncbi.nlm.nih.gov/35002818/
source_record_id: PMID:35002818
substance_tags: psilocybin
topic_tags: Psychological Flexibility
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/35002818/
text_rights_status: unverified_not_redistributed
title:
Erratum: A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:35002818","source_url":"https://pubmed.ncbi.nlm.nih.gov/35002818/","doi":"10.3389/fpsyt.2021.832766","pmid":"35002818","publication_date":"2020-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Niles H, Fogg C, Kelmendi B, Lazenby M
journal: BMC palliative care
publication_date: 2021-12-19
doi: 10.1186/s12904-021-00889-x
pubmed_id: 34930220
source_url: https://pubmed.ncbi.nlm.nih.gov/34930220/
source_record_id: PMID:34930220
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Spirituality,Clinical Trial,Healthcare Workers,Safety
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34930220/
text_rights_status: unverified_not_redistributed
title:
Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34930220","source_url":"https://pubmed.ncbi.nlm.nih.gov/34930220/","doi":"10.1186/s12904-021-00889-x","pmid":"34930220","publication_date":"2021-12-19","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective.
authors: Kelly JR, Gillan CM, Prenderville J, Kelly C, Harkin A, Clarke G, O'Keane V
journal: Frontiers in psychiatry
publication_date: 2020-12-31
doi: 10.3389/fpsyt.2021.800072
pubmed_id: 34975593
source_url: https://pubmed.ncbi.nlm.nih.gov/34975593/
source_record_id: PMID:34975593
substance_tags: psilocybin
study_type: Review Article
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34975593/
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Pharmacology,Mechanism of Action,Emotional Processing,Review Article,Treatment-Resistant Depression

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34975593","source_url":"https://pubmed.ncbi.nlm.nih.gov/34975593/","doi":"10.3389/fpsyt.2021.800072","pmid":"34975593","publication_date":"2020-12-31","importer_version":"2.1.3","text_redistributed":false}


authors: Vilca-Melendez S, Uthaug MV, Griffin JL.
publication_date: 2021-12-12
doi: 10.3389/fpsyt.2021.742856
pubmed_id: 34966300
source_url: https://doi.org/10.3389/fpsyt.2021.742856
source_record_id: PMID:34966300
substance_tags: psilocin
topic_tags: Depression,Mechanism of Action,Systematic Review,Review Article,Metabolomics,Microbiome
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2021.742856
text_rights_status: unverified_not_redistributed
title:
1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34966300","source_url":"https://doi.org/10.3389/fpsyt.2021.742856","doi":"10.3389/fpsyt.2021.742856","pmid":"34966300","publication_date":"2021-12-12","importer_version":"2.1.3","text_redistributed":false}


authors: Whitfield HJ.
journal: Frontiers in Psychiatry
publication_date: 2021-12-06
doi: 10.3389/fpsyt.2021.727572
pubmed_id: 34950063
source_url: https://doi.org/10.3389/fpsyt.2021.727572
source_record_id: PMID:34950063
substance_tags: psilocybin
topic_tags: Depression,PTSD,Mechanism of Action,Psychological Flexibility,Review Article
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2021.727572
text_rights_status: unverified_not_redistributed
title:
A Spectrum of Selves Reinforced in Multilevel Coherence: A Contextual Behavioural Response to the Challenges of Psychedelic-Assisted Therapy Development.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34950063","source_url":"https://doi.org/10.3389/fpsyt.2021.727572","doi":"10.3389/fpsyt.2021.727572","pmid":"34950063","publication_date":"2021-12-06","importer_version":"2.1.3","text_redistributed":false}


authors: Rucker J, Jafari H, Mantingh T, Bird C, Modlin NL, Knight G, Reinholdt F, Day C, Carter B, Young A.
journal: BMJ Open
publication_date: 2021-11-30
doi: 10.1136/bmjopen-2021-056091
pubmed_id: 34853114
source_url: https://doi.org/10.1136/bmjopen-2021-056091
source_record_id: PMID:34853114
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Biomarkers,Aging,Randomized Controlled Trial,Review Article
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1136/bmjopen-2021-056091
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34853114","source_url":"https://doi.org/10.1136/bmjopen-2021-056091","doi":"10.1136/bmjopen-2021-056091","pmid":"34853114","publication_date":"2021-11-30","importer_version":"2.1.3","text_redistributed":false}


authors: Gibbons WJ, McKinney MG, O'Dell PJ, Bollinger BA, Jones JA.
journal: Bioengineered
publication_date: 2021-11-30
doi: 10.1080/21655979.2021.1987090
pubmed_id: 34607532
source_url: https://doi.org/10.1080/21655979.2021.1987090
source_record_id: PMID:34607532
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/21655979.2021.1987090
text_rights_status: unverified_not_redistributed
title:
Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34607532","source_url":"https://doi.org/10.1080/21655979.2021.1987090","doi":"10.1080/21655979.2021.1987090","pmid":"34607532","publication_date":"2021-11-30","importer_version":"2.1.3","text_redistributed":false}


title: Use of hallucinogens in Slovakia: Does it differ from global trends?
authors: Lukačovič M, Masaryk R.
publication_date: 2021-08-04
doi: 10.1016/j.drugpo.2021.103385
pubmed_id: 34364200
source_url: https://doi.org/10.1016/j.drugpo.2021.103385
source_record_id: PMID:34364200
substance_tags: psilocybin
topic_tags: Observational Study,Safety
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.drugpo.2021.103385
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34364200","source_url":"https://doi.org/10.1016/j.drugpo.2021.103385","doi":"10.1016/j.drugpo.2021.103385","pmid":"34364200","publication_date":"2021-08-04","importer_version":"2.1.3","text_redistributed":false}


authors: Yaden DB, Berghella AP, Regier PS, Garcia-Romeu A, Johnson MW, Hendricks PS.
publication_date: 2021-07-26
doi: 10.1016/j.drugpo.2021.103380
pubmed_id: 34329952
source_url: https://doi.org/10.1016/j.drugpo.2021.103380
source_record_id: PMID:34329952
substance_tags: psilocybin
topic_tags: Addiction,Aging,Clinical Trial,Review Article
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:05
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.drugpo.2021.103380
text_rights_status: unverified_not_redistributed
title:
Classic psychedelics in the treatment of substance use disorder: Potential synergies with twelve-step programs.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34329952","source_url":"https://doi.org/10.1016/j.drugpo.2021.103380","doi":"10.1016/j.drugpo.2021.103380","pmid":"34329952","publication_date":"2021-07-26","importer_version":"2.1.3","text_redistributed":false}


title: Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy.
authors: Horton DM, Morrison B, Schmidt J.
publication_date: 2021-07-22
doi: 10.1176/appi.psychotherapy.20200055
pubmed_id: 34293927
source_url: https://doi.org/10.1176/appi.psychotherapy.20200055
source_record_id: PMID:34293927
substance_tags: psilocybin
topic_tags: Clinical Trial,Review Article
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1176/appi.psychotherapy.20200055
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34293927","source_url":"https://doi.org/10.1176/appi.psychotherapy.20200055","doi":"10.1176/appi.psychotherapy.20200055","pmid":"34293927","publication_date":"2021-07-22","importer_version":"2.1.3","text_redistributed":false}


title: Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.
journal: Australian & New Zealand Journal of Psychiatry
publication_date: 2021-03-20
doi: 10.1177/0004867421998785
pubmed_id: 33745287
source_url: https://doi.org/10.1177/0004867421998785
source_record_id: PMID:33745287
substance_tags: psilocybin
topic_tags: Addiction,Mechanism of Action,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1177/0004867421998785
text_rights_status: unverified_not_redistributed
authors:
Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:33745287","source_url":"https://doi.org/10.1177/0004867421998785","doi":"10.1177/0004867421998785","pmid":"33745287","publication_date":"2021-03-20","importer_version":"2.1.3","text_redistributed":false}


authors: Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J
journal: International journal of molecular sciences
publication_date: 2021-11-29
doi: 10.3390/ijms222312995
pubmed_id: 34884800
source_url: https://pubmed.ncbi.nlm.nih.gov/34884800/
source_record_id: PMID:34884800
substance_tags: psilocybin
topic_tags: Addiction,Receptor Pharmacology,In Vitro Study,Drug Interactions
study_type: In Vitro Study
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34884800/
text_rights_status: unverified_not_redistributed
title:
Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34884800","source_url":"https://pubmed.ncbi.nlm.nih.gov/34884800/","doi":"10.3390/ijms222312995","pmid":"34884800","publication_date":"2021-11-29","importer_version":"2.1.3","text_redistributed":false}


authors: Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P.
publication_date: 2021-11-23
doi: 10.3390/ph14121213
pubmed_id: 34959614
source_url: https://doi.org/10.3390/ph14121213
source_record_id: PMID:34959614
substance_tags: psilocybin
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ph14121213
text_rights_status: unverified_not_redistributed
title:
Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.

topic_tags:
Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Spirituality,Review Article,Safety,Inflammation

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34959614","source_url":"https://doi.org/10.3390/ph14121213","doi":"10.3390/ph14121213","pmid":"34959614","publication_date":"2021-11-23","importer_version":"2.1.3","text_redistributed":false}


journal: Cerebral Cortex
publication_date: 2021-10-31
doi: 10.1093/cercor/bhab202
pubmed_id: 34255821
source_url: https://doi.org/10.1093/cercor/bhab202
source_record_id: PMID:34255821
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Consciousness,Aging
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1093/cercor/bhab202
text_rights_status: unverified_not_redistributed
title:
Psilocybin Induces Aberrant Prediction Error Processing of Tactile Mismatch Responses-A Simultaneous EEG-FMRI Study.

authors:
Duerler P, Brem S, Fraga-González G, Neef T, Allen M, Zeidman P, Stämpfli P, Vollenweider FX, Preller KH.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34255821","source_url":"https://doi.org/10.1093/cercor/bhab202","doi":"10.1093/cercor/bhab202","pmid":"34255821","publication_date":"2021-10-31","importer_version":"2.1.3","text_redistributed":false}


journal: Science Advances
publication_date: 2021-11-16
doi: 10.1126/sciadv.abh2399
pubmed_id: 34788104
source_url: https://doi.org/10.1126/sciadv.abh2399
source_record_id: PMID:34788104
substance_tags: psilocybin
topic_tags: Mechanism of Action,Biomarkers
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1126/sciadv.abh2399
text_rights_status: unverified_not_redistributed
title:
Psilocybin targets a common molecular mechanism for cognitive impairment and increased craving in alcoholism.

authors:
Meinhardt MW, Pfarr S, Fouquet G, Rohleder C, Meinhardt ML, Barroso-Flores J, Hoffmann R, Jeanblanc J, Paul E, Wagner K, Hansson AC, Köhr G, Meier N, von Bohlen Und Halbach O, Bell RL, Endepols H, Neumaier B, Schönig K, Bartsch D, Naassila M, Spanagel R, Sommer WH.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34788104","source_url":"https://doi.org/10.1126/sciadv.abh2399","doi":"10.1126/sciadv.abh2399","pmid":"34788104","publication_date":"2021-11-16","importer_version":"2.1.3","text_redistributed":false}


journal: Scientific Reports
publication_date: 2021-11-17
doi: 10.1038/s41598-021-01811-4
pubmed_id: 34795334
source_url: https://doi.org/10.1038/s41598-021-01811-4
source_record_id: PMID:34795334
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Microdosing,Wellbeing,Observational Study,Adolescents
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41598-021-01811-4
text_rights_status: unverified_not_redistributed
title:
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers.

authors:
Rootman JM, Kryskow P, Harvey K, Stamets P, Santos-Brault E, Kuypers KPC, Polito V, Bourzat F, Walsh Z.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34795334","source_url":"https://doi.org/10.1038/s41598-021-01811-4","doi":"10.1038/s41598-021-01811-4","pmid":"34795334","publication_date":"2021-11-17","importer_version":"2.1.3","text_redistributed":false}


title: Policy in focus: Is psilocybin the next cannabis?
authors: Basky G.
journal: Canadian Medical Association Journal
publication_date: 2021-10-31
doi: 10.1503/cmaj.1095974
pubmed_id: 34782381
source_url: https://doi.org/10.1503/cmaj.1095974
source_record_id: PMID:34782381
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34782381","source_url":"https://doi.org/10.1503/cmaj.1095974","doi":"10.1503/cmaj.1095974","pmid":"34782381","publication_date":"2021-10-31","importer_version":"2.1.3","text_redistributed":false}


title: Daily briefing: Largest trial shows psilocybin is effective to treat depression.
authors: Graham F.
journal: Nature
publication_date: 2021-11-09
doi: 10.1038/d41586-021-03413-6
pubmed_id: 34764467
source_url: https://doi.org/10.1038/d41586-021-03413-6
source_record_id: PMID:34764467
substance_tags: psilocybin
topic_tags: Depression
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34764467","source_url":"https://doi.org/10.1038/d41586-021-03413-6","doi":"10.1038/d41586-021-03413-6","pmid":"34764467","publication_date":"2021-11-09","importer_version":"2.1.3","text_redistributed":false}


journal: Translational Psychiatry
publication_date: 2021-11-07
doi: 10.1038/s41398-021-01706-y
pubmed_id: 34750350
source_url: https://doi.org/10.1038/s41398-021-01706-y
source_record_id: PMID:34750350
substance_tags: psilocybin
topic_tags: Depression,Brain Imaging,Mechanism of Action,Aging
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41398-021-01706-y
text_rights_status: unverified_not_redistributed
title:
Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.

authors:
Doss MK, Považan M, Rosenberg MD, Sepeda ND, Davis AK, Finan PH, Smith GS, Pekar JJ, Barker PB, Griffiths RR, Barrett FS.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34750350","source_url":"https://doi.org/10.1038/s41398-021-01706-y","doi":"10.1038/s41398-021-01706-y","pmid":"34750350","publication_date":"2021-11-07","importer_version":"2.1.3","text_redistributed":false}


journal: Frontiers in psychiatry
publication_date: 2020-12-31
doi: 10.3389/fpsyt.2021.737738
pubmed_id: 34803761
source_url: https://pubmed.ncbi.nlm.nih.gov/34803761/
source_record_id: PMID:34803761
substance_tags: psilocybin
topic_tags: Depression,Creativity,Clinical Trial,Healthcare Workers,Safety
study_type: Clinical Trial
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34803761/
text_rights_status: unverified_not_redistributed
title:
Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.

authors:
Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J

source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34803761","source_url":"https://pubmed.ncbi.nlm.nih.gov/34803761/","doi":"10.3389/fpsyt.2021.737738","pmid":"34803761","publication_date":"2020-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics.
authors: Aleksandrova LR, Phillips AG.
publication_date: 2021-09-23
doi: 10.1016/j.tips.2021.08.003
pubmed_id: 34565579
source_url: https://doi.org/10.1016/j.tips.2021.08.003
source_record_id: PMID:34565579
substance_tags: psilocybin
topic_tags: Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.tips.2021.08.003
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34565579","source_url":"https://doi.org/10.1016/j.tips.2021.08.003","doi":"10.1016/j.tips.2021.08.003","pmid":"34565579","publication_date":"2021-09-23","importer_version":"2.1.3","text_redistributed":false}


authors: Hendin HM, Penn AD.
journal: Bipolar Disorders
publication_date: 2021-05-17
doi: 10.1111/bdi.13095
pubmed_id: 33934465
source_url: https://doi.org/10.1111/bdi.13095
source_record_id: PMID:33934465
substance_tags: psilocybin
topic_tags: Case Report
study_type: Case Report
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
text_rights_status: not_applicable_no_text
title:
An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:33934465","source_url":"https://doi.org/10.1111/bdi.13095","doi":"10.1111/bdi.13095","pmid":"33934465","publication_date":"2021-05-17","importer_version":"2.1.3","text_redistributed":false}


title: A potential effect of psilocybin on anxiety in neurotic personality structures in adolescents.
authors: Bogadi M, Kaštelan S.
journal: Croatian Medical Journal
publication_date: 2021-09-30
doi: 10.3325/cmj.2021.62.528
pubmed_id: 34730895
source_url: https://europepmc.org/article/MED/34730895
source_record_id: PMID:34730895
substance_tags: psilocybin
topic_tags: Anxiety,Personality Change,Adolescents
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34730895","source_url":"https://europepmc.org/article/MED/34730895","doi":"10.3325/cmj.2021.62.528","pmid":"34730895","publication_date":"2021-09-30","importer_version":"2.1.3","text_redistributed":false}


title: Analysis of Five Mushroom Toxins in Blood by UPLC-HRMS.
authors: Liu WQ, Shi Y, Xiang P, Yu F, Xie B, Dong M, Ha J, Ma CL, Wen D.
publication_date: 2021-09-30
doi: 10.12116/j.issn.1004-5619.2020.301001
pubmed_id: 35187916
source_url: https://doi.org/10.12116/j.issn.1004-5619.2020.301001
source_record_id: PMID:35187916
substance_tags: psilocin
topic_tags: General
study_type: Qualitative Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.12116/j.issn.1004-5619.2020.301001
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:35187916","source_url":"https://doi.org/10.12116/j.issn.1004-5619.2020.301001","doi":"10.12116/j.issn.1004-5619.2020.301001","pmid":"35187916","publication_date":"2021-09-30","importer_version":"2.1.3","text_redistributed":false}


title: Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".
journal: Frontiers in Psychiatry
publication_date: 2021-10-19
doi: 10.3389/fpsyt.2021.735523
pubmed_id: 34744825
source_url: https://doi.org/10.3389/fpsyt.2021.735523
source_record_id: PMID:34744825
substance_tags: psilocybin
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2021.735523
text_rights_status: unverified_not_redistributed
authors:
Spriggs MJ, Douglass HM, Park RJ, Read T, Danby JL, de Magalhães FJC, Alderton KL, Williams TM, Blemings A, Lafrance A, Nicholls DE, Erritzoe D, Nutt DJ, Carhart-Harris RL.

topic_tags:
Eating Disorders,End-of-Life Distress,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34744825","source_url":"https://doi.org/10.3389/fpsyt.2021.735523","doi":"10.3389/fpsyt.2021.735523","pmid":"34744825","publication_date":"2021-10-19","importer_version":"2.1.3","text_redistributed":false}


title: Psilocin Derivatives as Serotonergic Psychedelic Agents for the Treatment of CNS Disorders.
authors: Kargbo RB.
publication_date: 2021-09-11
doi: 10.1021/acsmedchemlett.1c00467
pubmed_id: 34676027
source_url: https://doi.org/10.1021/acsmedchemlett.1c00467
source_record_id: PMID:34676027
substance_tags: psilocin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:05
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34676027","source_url":"https://doi.org/10.1021/acsmedchemlett.1c00467","doi":"10.1021/acsmedchemlett.1c00467","pmid":"34676027","publication_date":"2021-09-11","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics and Other Psychoplastogens for Treating Mental Illness.
authors: Vargas MV, Meyer R, Avanes AA, Rus M, Olson DE
journal: Frontiers in psychiatry
publication_date: 2020-12-31
doi: 10.3389/fpsyt.2021.727117
pubmed_id: 34671279
source_url: https://pubmed.ncbi.nlm.nih.gov/34671279/
source_record_id: PMID:34671279
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Addiction,Neuroplasticity
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34671279/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34671279","source_url":"https://pubmed.ncbi.nlm.nih.gov/34671279/","doi":"10.3389/fpsyt.2021.727117","pmid":"34671279","publication_date":"2020-12-31","importer_version":"2.1.3","text_redistributed":false}


title: Many Drugs of Abuse May Be Acutely Transformed to Dopamine, Norepinephrine and Epinephrine In Vivo.
authors: Fitzgerald PJ
journal: International journal of molecular sciences
publication_date: 2021-10-01
doi: 10.3390/ijms221910706
pubmed_id: 34639047
source_url: https://pubmed.ncbi.nlm.nih.gov/34639047/
source_record_id: PMID:34639047
substance_tags: psilocybin
topic_tags: Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Adverse Events
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:20:39
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34639047/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34639047","source_url":"https://pubmed.ncbi.nlm.nih.gov/34639047/","doi":"10.3390/ijms221910706","pmid":"34639047","publication_date":"2021-10-01","importer_version":"2.1.3","text_redistributed":false}


authors: Vejmola Č, Tylš F, Piorecká V, Koudelka V, Kadeřábek L, Novák T, Páleníček T.
journal: Translational Psychiatry
publication_date: 2021-10-01
doi: 10.1038/s41398-021-01603-4
pubmed_id: 34601495
source_url: https://doi.org/10.1038/s41398-021-01603-4
source_record_id: PMID:34601495
substance_tags: psilocybin,psilocin
topic_tags: Brain Imaging
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1038/s41398-021-01603-4
text_rights_status: unverified_not_redistributed
title:
Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34601495","source_url":"https://doi.org/10.1038/s41398-021-01603-4","doi":"10.1038/s41398-021-01603-4","pmid":"34601495","publication_date":"2021-10-01","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.
authors: Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS.
publication_date: 2021-10-07
doi: 10.30773/pi.2021.0209
pubmed_id: 34619818
source_url: https://doi.org/10.30773/pi.2021.0209
source_record_id: PMID:34619818
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.30773/pi.2021.0209
text_rights_status: unverified_not_redistributed
topic_tags:
Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34619818","source_url":"https://doi.org/10.30773/pi.2021.0209","doi":"10.30773/pi.2021.0209","pmid":"34619818","publication_date":"2021-10-07","importer_version":"2.1.3","text_redistributed":false}


title: Magic mushroom: all is not as it seems.
authors: Castro BN, Prata Saraiva R, Afonso João D, Dantas Costa S
journal: Acta chirurgica Belgica
publication_date: 2021-09-30
doi: 10.1080/00015458.2021.1972590
pubmed_id: 34427171
source_url: https://pubmed.ncbi.nlm.nih.gov/34427171/
source_record_id: PMID:34427171
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: PubMed
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 06:54:14
abstract_source: PubMed
abstract_source_url: https://pubmed.ncbi.nlm.nih.gov/34427171/
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"PubMed","source_record_id":"PMID:34427171","source_url":"https://pubmed.ncbi.nlm.nih.gov/34427171/","doi":"10.1080/00015458.2021.1972590","pmid":"34427171","publication_date":"2021-09-30","importer_version":"2.1.3","text_redistributed":false}


authors: Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT.
journal: Experimental and Clinical Psychopharmacology
publication_date: 2021-06-06
doi: 10.1037/pha0000490
pubmed_id: 34096755
source_url: https://doi.org/10.1037/pha0000490
source_record_id: PMID:34096755
substance_tags: psilocybin
topic_tags: Depression,Anxiety,PTSD,Addiction,Pharmacology,Clinical Trial,Safety
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1037/pha0000490
text_rights_status: unverified_not_redistributed
title:
Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34096755","source_url":"https://doi.org/10.1037/pha0000490","doi":"10.1037/pha0000490","pmid":"34096755","publication_date":"2021-06-06","importer_version":"2.1.3","text_redistributed":false}


title: Psychedelics, Sociality, and Human Evolution.
authors: Rodríguez Arce JM, Winkelman MJ.
journal: Frontiers in Psychology
publication_date: 2021-09-28
doi: 10.3389/fpsyg.2021.729425
pubmed_id: 34659037
source_url: https://doi.org/10.3389/fpsyg.2021.729425
source_record_id: PMID:34659037
substance_tags: psilocybin
topic_tags: Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Drug Interactions
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyg.2021.729425
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34659037","source_url":"https://doi.org/10.3389/fpsyg.2021.729425","doi":"10.3389/fpsyg.2021.729425","pmid":"34659037","publication_date":"2021-09-28","importer_version":"2.1.3","text_redistributed":false}


authors: Castelhano J, Lima G, Teixeira M, Soares C, Pais M, Castelo-Branco M.
publication_date: 2021-09-28
doi: 10.3389/fphar.2021.739053
pubmed_id: 34658876
source_url: https://doi.org/10.3389/fphar.2021.739053
source_record_id: PMID:34658876
substance_tags: psilocybin
topic_tags: Brain Imaging,Receptor Pharmacology,Aging,Meta-Analysis,Review Article
study_type: Meta-Analysis
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fphar.2021.739053
text_rights_status: unverified_not_redistributed
title:
The Effects of Tryptamine Psychedelics in the Brain: A meta-Analysis of Functional and Review of Molecular Imaging Studies.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34658876","source_url":"https://doi.org/10.3389/fphar.2021.739053","doi":"10.3389/fphar.2021.739053","pmid":"34658876","publication_date":"2021-09-28","importer_version":"2.1.3","text_redistributed":false}


title: Rediscovering Psilocybin as an Antidepressive Treatment Strategy.
authors: Zeiss R, Gahr M, Graf H.
publication_date: 2021-09-27
doi: 10.3390/ph14100985
pubmed_id: 34681209
source_url: https://doi.org/10.3390/ph14100985
source_record_id: PMID:34681209
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Mechanism of Action,Review Article,Safety,Adverse Events
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:02
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3390/ph14100985
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34681209","source_url":"https://doi.org/10.3390/ph14100985","doi":"10.3390/ph14100985","pmid":"34681209","publication_date":"2021-09-27","importer_version":"2.1.3","text_redistributed":false}


title: A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.
authors: Hagsäter SM, Pettersson R, Pettersson C, Atanasovski D, Näslund J, Eriksson E.
journal: The International Journal of Neuropsychopharmacology
publication_date: 2021-08-31
doi: 10.1093/ijnp/pyab040
pubmed_id: 34228806
source_url: https://doi.org/10.1093/ijnp/pyab040
source_record_id: PMID:34228806
substance_tags: psilocybin
topic_tags: Anxiety,Receptor Pharmacology
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1093/ijnp/pyab040
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34228806","source_url":"https://doi.org/10.1093/ijnp/pyab040","doi":"10.1093/ijnp/pyab040","pmid":"34228806","publication_date":"2021-08-31","importer_version":"2.1.3","text_redistributed":false}


authors: Basedow LA, Riemer TG, Reiche S, Kreutz R, Majić T.
publication_date: 2021-09-15
doi: 10.3389/fphar.2021.739966
pubmed_id: 34603053
source_url: https://doi.org/10.3389/fphar.2021.739966
source_record_id: PMID:34603053
substance_tags: psilocybin
topic_tags: Addiction,Receptor Pharmacology,Consciousness,Meta-Analysis,Systematic Review,Review Article
study_type: Meta-Analysis
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fphar.2021.739966
text_rights_status: unverified_not_redistributed
title:
Neuropsychological Functioning in Users of Serotonergic Psychedelics - A Systematic Review and Meta-Analysis.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34603053","source_url":"https://doi.org/10.3389/fphar.2021.739966","doi":"10.3389/fphar.2021.739966","pmid":"34603053","publication_date":"2021-09-15","importer_version":"2.1.3","text_redistributed":false}


publication_date: 2021-09-15
doi: 10.1039/d1ay01157j
pubmed_id: 34528944
source_url: https://doi.org/10.1039/d1ay01157j
source_record_id: PMID:34528944
substance_tags: psilocybin,psilocin
topic_tags: Animal Study
study_type: Animal Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1039/d1ay01157j
text_rights_status: unverified_not_redistributed
title:
Derivatization-assisted enzyme-linked immunosorbent assay for identifying hallucinogenic mushrooms with enhanced sensitivity.

authors:
Morita I, Kiguchi Y, Oyama H, Takeuchi A, Tode C, Tanaka R, Ogata J, Kikura-Hanajiri R, Kobayashi N.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34528944","source_url":"https://doi.org/10.1039/d1ay01157j","doi":"10.1039/d1ay01157j","pmid":"34528944","publication_date":"2021-09-15","importer_version":"2.1.3","text_redistributed":false}


authors: de Vos CMH, Mason NL, Kuypers KPC.
publication_date: 2021-09-09
doi: 10.3389/fpsyt.2021.724606
pubmed_id: 34566723
source_url: https://doi.org/10.3389/fpsyt.2021.724606
source_record_id: PMID:34566723
substance_tags: psilocybin
topic_tags: Neuroplasticity,Neurogenesis,Mechanism of Action,Systematic Review,Review Article,Animal Study
study_type: Systematic Review
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3389/fpsyt.2021.724606
text_rights_status: unverified_not_redistributed
title:
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34566723","source_url":"https://doi.org/10.3389/fpsyt.2021.724606","doi":"10.3389/fpsyt.2021.724606","pmid":"34566723","publication_date":"2021-09-09","importer_version":"2.1.3","text_redistributed":false}


authors: Argento E, Christie D, Mackay L, Callon C, Walsh Z.
journal: Frontiers in Psychiatry
publication_date: 2021-09-05
doi: 10.3389/fpsyt.2021.716593
pubmed_id: 34552518
source_url: https://doi.org/10.3389/fpsyt.2021.716593
source_record_id: PMID:34552518
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
text_rights_status: not_applicable_no_text
title:
Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34552518","source_url":"https://doi.org/10.3389/fpsyt.2021.716593","doi":"10.3389/fpsyt.2021.716593","pmid":"34552518","publication_date":"2021-09-05","importer_version":"2.1.3","text_redistributed":false}


title: Treatment-Resistant Depression: Approaches to Treatment.
authors: Kverno KS, Mangano E.
publication_date: 2021-08-31
doi: 10.3928/02793695-20210816-01
pubmed_id: 34459676
source_url: https://doi.org/10.3928/02793695-20210816-01
source_record_id: PMID:34459676
substance_tags: psilocybin
topic_tags: Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety
study_type: Review Article
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.3928/02793695-20210816-01
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34459676","source_url":"https://doi.org/10.3928/02793695-20210816-01","doi":"10.3928/02793695-20210816-01","pmid":"34459676","publication_date":"2021-08-31","importer_version":"2.1.3","text_redistributed":false}


authors: Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.
journal: Pharmacopsychiatry
publication_date: 2021-08-03
doi: 10.1055/a-1524-2794
pubmed_id: 34348413
source_url: https://doi.org/10.1055/a-1524-2794
source_record_id: PMID:34348413
substance_tags: psilocybin
topic_tags: Depression,Safety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1055/a-1524-2794
text_rights_status: unverified_not_redistributed
title:
Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34348413","source_url":"https://doi.org/10.1055/a-1524-2794","doi":"10.1055/a-1524-2794","pmid":"34348413","publication_date":"2021-08-03","importer_version":"2.1.3","text_redistributed":false}


journal: European Neuropsychopharmacology
publication_date: 2021-07-07
doi: 10.1016/j.euroneuro.2021.06.001
pubmed_id: 34246868
source_url: https://doi.org/10.1016/j.euroneuro.2021.06.001
source_record_id: PMID:34246868
substance_tags: psilocybin,psilocin
topic_tags: Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.euroneuro.2021.06.001
text_rights_status: unverified_not_redistributed
title:
Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experience.

authors:
Madsen MK, Stenbæk DS, Arvidsson A, Armand S, Marstrand-Joergensen MR, Johansen SS, Linnet K, Ozenne B, Knudsen GM, Fisher PM.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34246868","source_url":"https://doi.org/10.1016/j.euroneuro.2021.06.001","doi":"10.1016/j.euroneuro.2021.06.001","pmid":"34246868","publication_date":"2021-07-07","importer_version":"2.1.3","text_redistributed":false}


authors: Bambauer TP, Wagmann L, Weber AA, Meyer MR.
publication_date: 2021-06-09
doi: 10.1002/dta.3106
pubmed_id: 34080326
source_url: https://doi.org/10.1002/dta.3106
source_record_id: PMID:34080326
substance_tags: psilocin
topic_tags: Biomarkers,Drug Interactions
study_type: Clinical Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1002/dta.3106
text_rights_status: unverified_not_redistributed
title:
Further development of a liquid chromatography-high-resolution mass spectrometry/mass spectrometry-based strategy for analyzing eight biomarkers in human urine indicating toxic mushroom or Ricinus communis ingestions.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34080326","source_url":"https://doi.org/10.1002/dta.3106","doi":"10.1002/dta.3106","pmid":"34080326","publication_date":"2021-06-09","importer_version":"2.1.3","text_redistributed":false}


authors: Magaraggia I, Kuiperes Z, Schreiber R.
publication_date: 2021-05-25
doi: 10.1016/j.nlm.2021.107467
pubmed_id: 34048913
source_url: https://doi.org/10.1016/j.nlm.2021.107467
source_record_id: PMID:34048913
substance_tags: psilocybin
topic_tags: Depression,Neuroplasticity,Neurogenesis,Resilience,Emotional Processing
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.nlm.2021.107467
text_rights_status: unverified_not_redistributed
title:
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.

source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34048913","source_url":"https://doi.org/10.1016/j.nlm.2021.107467","doi":"10.1016/j.nlm.2021.107467","pmid":"34048913","publication_date":"2021-05-25","importer_version":"2.1.3","text_redistributed":false}


title: Blinding and expectancy confounds in psychedelic randomized controlled trials.
authors: Muthukumaraswamy SD, Forsyth A, Lumley T.
publication_date: 2021-08-25
doi: 10.1080/17512433.2021.1933434
pubmed_id: 34038314
source_url: https://doi.org/10.1080/17512433.2021.1933434
source_record_id: PMID:34038314
substance_tags: psilocybin
topic_tags: Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article
study_type: Randomized Controlled Trial
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/17512433.2021.1933434
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34038314","source_url":"https://doi.org/10.1080/17512433.2021.1933434","doi":"10.1080/17512433.2021.1933434","pmid":"34038314","publication_date":"2021-08-25","importer_version":"2.1.3","text_redistributed":false}


title: Trends in the Top-Cited Articles on Classic Psychedelics.
authors: Lawrence DW, Sharma B, Griffiths RR, Carhart-Harris R.
journal: Journal of Psychoactive Drugs
publication_date: 2021-02-02
doi: 10.1080/02791072.2021.1874573
pubmed_id: 33535907
source_url: https://doi.org/10.1080/02791072.2021.1874573
source_record_id: PMID:33535907
substance_tags: psilocybin
topic_tags: Addiction,Observational Study,Animal Study
study_type: Observational Study
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-04 07:00:38
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1080/02791072.2021.1874573
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:33535907","source_url":"https://doi.org/10.1080/02791072.2021.1874573","doi":"10.1080/02791072.2021.1874573","pmid":"33535907","publication_date":"2021-02-02","importer_version":"2.1.3","text_redistributed":false}


title: Sociological investigations of human enhancement drugs: The case of microdosing psychedelics.
authors: Liokaftos D.
publication_date: 2021-01-28
doi: 10.1016/j.drugpo.2020.103099
pubmed_id: 33518382
source_url: https://doi.org/10.1016/j.drugpo.2020.103099
source_record_id: PMID:33518382
substance_tags: psilocybin
topic_tags: Microdosing
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:05
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.drugpo.2020.103099
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:33518382","source_url":"https://doi.org/10.1016/j.drugpo.2020.103099","doi":"10.1016/j.drugpo.2020.103099","pmid":"33518382","publication_date":"2021-01-28","importer_version":"2.1.3","text_redistributed":false}


title: Rethinking enhancement substance use: A critical discourse studies approach.
authors: Askew R, Williams L.
publication_date: 2020-11-29
doi: 10.1016/j.drugpo.2020.102994
pubmed_id: 33272772
source_url: https://doi.org/10.1016/j.drugpo.2020.102994
source_record_id: PMID:33272772
substance_tags: psilocybin
topic_tags: Addiction
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:06
abstract_source: Europe PMC
abstract_source_url: https://doi.org/10.1016/j.drugpo.2020.102994
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:33272772","source_url":"https://doi.org/10.1016/j.drugpo.2020.102994","doi":"10.1016/j.drugpo.2020.102994","pmid":"33272772","publication_date":"2020-11-29","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin for Depression.
authors: Wiley JF, Bei B.
publication_date: 2021-07-31
doi: 10.1056/nejmc2108082
pubmed_id: 34437794
source_url: https://doi.org/10.1056/nejmc2108082
source_record_id: PMID:34437794
substance_tags: psilocybin
topic_tags: Depression,Anxiety
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:48:06
last_checked: 2026-07-01 11:22:04
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:34437794","source_url":"https://doi.org/10.1056/nejmc2108082","doi":"10.1056/nejmc2108082","pmid":"34437794","publication_date":"2021-07-31","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Affective Disorders Reports
publication_date: 2026-06-30
doi: 10.1016/j.jadr.2026.101098
source_url: https://doi.org/10.1016/j.jadr.2026.101098
source_record_id: DOI:10.1016/j.jadr.2026.101098
substance_tags: psilocybin
topic_tags: OCD,Systematic Review,Review Article,Animal Study
study_type: Systematic Review
source_name: Crossref
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-08 01:20:22
text_rights_status: not_applicable_no_text
title:
Revealing shortcomings in the assessment of psilocybin effects on OCD-related symptoms in preclinical and clinical studies: A systematic review

authors:
Jalalian-Javadpour Marzieh, Yekta Batool Ghorbani, Reyhani Niloufar, Hajizamani Shadi, Azizi Ali, Azad Najma Khoshrooz, Mohammadi Hamidreza, Vaseghi Salar

source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1016/j.jadr.2026.101098","source_url":"https://doi.org/10.1016/j.jadr.2026.101098","doi":"10.1016/j.jadr.2026.101098","pmid":"","publication_date":"2026-06-30","importer_version":"2.1.3","text_redistributed":false}


title: The relevance of the 5HT2A-mGlu2 heterodimer in explaining the clinical ambivalence of psilocybin
authors: Escobar-Cornejo Guillermo, Corredor-Gamba Julián, Rodriguez-Rojas Yoly, Cárdenas F. P.
journal: Revista de Neuro-Psiquiatría
publication_date: 2026-06-29
doi: 10.20453/rnp.v89i2.7539
source_url: https://doi.org/10.20453/rnp.v89i2.7539
source_record_id: DOI:10.20453/rnp.v89i2.7539
substance_tags: psilocybin
topic_tags: Receptor Pharmacology
study_type: Other
source_name: Crossref
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-07 01:20:41
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.20453/rnp.v89i2.7539","source_url":"https://doi.org/10.20453/rnp.v89i2.7539","doi":"10.20453/rnp.v89i2.7539","pmid":"","publication_date":"2026-06-29","importer_version":"2.1.3","text_redistributed":false}


title: Phase 1 trial suggests benefit of psilocybin in OCD treatment
journal: The Brown University Psychopharmacology Update
publication_date: 2026-07-31
doi: 10.1002/pu.31474
source_url: https://doi.org/10.1002/pu.31474
source_record_id: DOI:10.1002/pu.31474
substance_tags: psilocybin
topic_tags: OCD,Clinical Trial,Adverse Events
study_type: Clinical Trial
source_name: Crossref
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-05 01:20:21
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1002/pu.31474
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1002/pu.31474","source_url":"https://doi.org/10.1002/pu.31474","doi":"10.1002/pu.31474","pmid":"","publication_date":"2026-07-31","importer_version":"2.1.3","text_redistributed":false}


authors: Astrit Sabani, Adnan Khatak
journal: Annals of Medicine and Surgery
publication_date: 2026-06-17
doi: 10.1097/ms9.0000000000005244
source_url: https://doi.org/10.1097/ms9.0000000000005244
source_record_id: DOI:10.1097/ms9.0000000000005244
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1097/ms9.0000000000005244
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence

topic_tags:
Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1097/ms9.0000000000005244","source_url":"https://doi.org/10.1097/ms9.0000000000005244","doi":"10.1097/ms9.0000000000005244","pmid":"","publication_date":"2026-06-17","importer_version":"2.1.3","text_redistributed":false}


journal: Frontiers in Public Health
publication_date: 2026-06-16
doi: 10.3389/fpubh.2026.1845943
source_url: https://doi.org/10.3389/fpubh.2026.1845943
source_record_id: DOI:10.3389/fpubh.2026.1845943
substance_tags: psilocybin
topic_tags: PTSD,Chronic Pain,Aging,Clinical Trial,Veterans,Healthcare Workers,Safety,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3389/fpubh.2026.1845943
text_rights_status: unverified_not_redistributed
title:
Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico

authors:
Lawrence Leeman, Maya Armstrong, Dara Menashi, Hanifa Nayo-Washington, Elliot Marseille, Janus Herrera, Crystal Romero, Janet Page-Reeves

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3389/fpubh.2026.1845943","source_url":"https://doi.org/10.3389/fpubh.2026.1845943","doi":"10.3389/fpubh.2026.1845943","pmid":"","publication_date":"2026-06-16","importer_version":"2.1.3","text_redistributed":false}


journal: Psychiatry International
publication_date: 2026-06-14
doi: 10.3390/psychiatryint7030137
source_url: https://doi.org/10.3390/psychiatryint7030137
source_record_id: DOI:10.3390/psychiatryint7030137
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.3390/psychiatryint7030137
text_rights_status: unverified_not_redistributed
title:
Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis

authors:
Angel Labra-Lorenzana, Dania Nimbe Lima Sanchez, Christian Alejandro Delaflor-Wagner, Diana Martínez-Hernández, Christian Ramos-Jiménez, Christian Gabriel Toledo-Lozano

topic_tags:
Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.3390/psychiatryint7030137","source_url":"https://doi.org/10.3390/psychiatryint7030137","doi":"10.3390/psychiatryint7030137","pmid":"","publication_date":"2026-06-14","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA
authors: SAIMSARA
journal: SAIMSARA Journal
publication_date: 2026-06-14
doi: 10.62487/saimsara7a54f680
source_url: https://doi.org/10.62487/saimsara7a54f680
source_record_id: DOI:10.62487/saimsara7a54f680
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.62487/saimsara7a54f680
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.62487/saimsara7a54f680","source_url":"https://doi.org/10.62487/saimsara7a54f680","doi":"10.62487/saimsara7a54f680","pmid":"","publication_date":"2026-06-14","importer_version":"2.1.3","text_redistributed":false}


title: Unmixing the psychedelic connectome: Brain network traits of psilocybin
journal: Network Neuroscience
publication_date: 2026-07-01
doi: 10.1162/netn.a.594
source_url: https://doi.org/10.1162/netn.a.594
source_record_id: DOI:10.1162/netn.a.594
substance_tags: psilocybin,psilocin
topic_tags: Brain Imaging,Consciousness,Healthy Volunteers
study_type: Other
source_name: Crossref
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-09 01:20:11
abstract_source: Crossref
abstract_source_url: https://doi.org/10.1162/netn.a.594
text_rights_status: unverified_not_redistributed
authors:
Bhavaraju Krishna Prasad, Mason Natasha L., Mallaroni Pablo, Heinke Dietmar, Toennes Stefan W., Ramaekers Johannes G., Amico Enrico

source_provenance_json:
{"source_name":"Crossref","source_record_id":"DOI:10.1162/netn.a.594","source_url":"https://doi.org/10.1162/netn.a.594","doi":"10.1162/netn.a.594","pmid":"","publication_date":"2026-07-01","importer_version":"2.1.3","text_redistributed":false}


journal: Neurology
publication_date: 2026-06-08
doi: 10.1212/wnl.0000000000212934
source_url: https://doi.org/10.1212/wnl.0000000000212934
source_record_id: DOI:10.1212/wnl.0000000000212934
substance_tags: psilocybin
topic_tags: Chronic Pain,Randomized Controlled Trial,Safety
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1212/wnl.0000000000212934
text_rights_status: unverified_not_redistributed
title:
Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)

authors:
Alexander Bryson, Chiranth Bhagavan, O. Carter, Glenn Nielsen, David Berlowitz, Sara Issak, Zachary Attard, Dina Eleftheriadis, Gina Oliver, Deanne Mayne, Greg Roebuck, James Rucker, Matthew Butler, Richard Kanaan

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1212/wnl.0000000000212934","source_url":"https://doi.org/10.1212/wnl.0000000000212934","doi":"10.1212/wnl.0000000000212934","pmid":"","publication_date":"2026-06-08","importer_version":"2.1.3","text_redistributed":false}


authors: Yosr Ziadi, Taehwan Park
journal: Value in Health
publication_date: 2026-05-31
doi: 10.1016/j.jval.2026.03.635
source_url: https://doi.org/10.1016/j.jval.2026.03.635
source_record_id: DOI:10.1016/j.jval.2026.03.635
substance_tags: psilocybin
topic_tags: Depression,Personality Change,Treatment-Resistant Depression
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
title:
EE341 COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jval.2026.03.635","source_url":"https://doi.org/10.1016/j.jval.2026.03.635","doi":"10.1016/j.jval.2026.03.635","pmid":"","publication_date":"2026-05-31","importer_version":"2.1.3","text_redistributed":false}


title: Demoralization in Psilocybin-Assisted Therapy for Advanced Cancer: An Exploratory Network Analysis
journal: Journal of Pain and Symptom Management
publication_date: 2026-05-11
doi: 10.1016/j.jpainsymman.2026.04.025
source_url: https://doi.org/10.1016/j.jpainsymman.2026.04.025
source_record_id: DOI:10.1016/j.jpainsymman.2026.04.025
substance_tags: psilocybin
topic_tags: End-of-Life Distress,Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
authors:
Austin Mallard, Jessica Harbour, Catherine Pappano, Mary Mancuso, Kristin Kilbourn, Stacy M. Fischer

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jpainsymman.2026.04.025","source_url":"https://doi.org/10.1016/j.jpainsymman.2026.04.025","doi":"10.1016/j.jpainsymman.2026.04.025","pmid":"","publication_date":"2026-05-11","importer_version":"2.1.3","text_redistributed":false}


authors: Matthew Sidovar, Shane J. O’Connor, Lucinda Orsini
journal: Value in Health
publication_date: 2026-05-31
doi: 10.1016/j.jval.2026.03.422
source_url: https://doi.org/10.1016/j.jval.2026.03.422
source_record_id: DOI:10.1016/j.jval.2026.03.422
substance_tags: psilocybin
topic_tags: Review Article,Toxicity
study_type: Review Article
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
title:
EE127 A REVIEW OF HEALTH ECONOMIC ANALYSES OF PSILOCYBIN, MIDOMAFETAMINE(MDMA), AND KETAMINE-BASED TREATMENTS FOR MENTAL HEALTH CARE

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jval.2026.03.422","source_url":"https://doi.org/10.1016/j.jval.2026.03.422","doi":"10.1016/j.jval.2026.03.422","pmid":"","publication_date":"2026-05-31","importer_version":"2.1.3","text_redistributed":false}


journal: Drug Science Policy and Law
publication_date: 2026-05-31
doi: 10.1177/20503245261459447
source_url: https://doi.org/10.1177/20503245261459447
source_record_id: DOI:10.1177/20503245261459447
substance_tags: psilocybin
topic_tags: Pharmacology,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
title:
Corrigendum to “From Prohibited to Prescribed: The Rescheduling of MDMA and Psilocybin in Australia”

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1177/20503245261459447","source_url":"https://doi.org/10.1177/20503245261459447","doi":"10.1177/20503245261459447","pmid":"","publication_date":"2026-05-31","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Drug Delivery Science and Technology
publication_date: 2026-03-09
doi: 10.1016/j.jddst.2026.108228
source_url: https://doi.org/10.1016/j.jddst.2026.108228
source_record_id: DOI:10.1016/j.jddst.2026.108228
substance_tags: psilocybin
topic_tags: Clinical Trial
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1016/j.jddst.2026.108228
text_rights_status: unverified_not_redistributed
title:
Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase development

authors:
Vorawut Wongumpornpinit, K Ingkaninan, Prapapan Temkitthawon, Neti Waranuch, Rhannanda Copetti Pivetta, Jieyu Zuo, Gabriel Lima Barros de Araújo, Nádia Bou-Chacra, Vijay Somayaji, Raimar Löebenberg

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jddst.2026.108228","source_url":"https://doi.org/10.1016/j.jddst.2026.108228","doi":"10.1016/j.jddst.2026.108228","pmid":"","publication_date":"2026-03-09","importer_version":"2.1.3","text_redistributed":false}


authors: Alex Hood, Gary ELKINS
journal: Journal of Psychedelic Studies
publication_date: 2026-05-28
doi: 10.1556/2054.2026.00507
source_url: https://doi.org/10.1556/2054.2026.00507
source_record_id: DOI:10.1556/2054.2026.00507
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1556/2054.2026.00507
text_rights_status: unverified_not_redistributed
title:
Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis

topic_tags:
Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1556/2054.2026.00507","source_url":"https://doi.org/10.1556/2054.2026.00507","doi":"10.1556/2054.2026.00507","pmid":"","publication_date":"2026-05-28","importer_version":"2.1.3","text_redistributed":false}


title: Single-dose psilocybin with CBT more effective than nicotine patch for smoking cessation
journal: The Brown University Psychopharmacology Update
publication_date: 2026-05-28
doi: 10.1002/pu.31467
source_url: https://doi.org/10.1002/pu.31467
source_record_id: DOI:10.1002/pu.31467
substance_tags: psilocybin
topic_tags: Addiction,Pharmacology,Receptor Pharmacology,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/pu.31467","source_url":"https://doi.org/10.1002/pu.31467","doi":"10.1002/pu.31467","pmid":"","publication_date":"2026-05-28","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin shows mixed results for patients with treatment-resistant depression
journal: The Brown University Psychopharmacology Update
publication_date: 2026-05-28
doi: 10.1002/pu.31461
source_url: https://doi.org/10.1002/pu.31461
source_record_id: DOI:10.1002/pu.31461
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1002/pu.31461
text_rights_status: unverified_not_redistributed
topic_tags:
Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/pu.31461","source_url":"https://doi.org/10.1002/pu.31461","doi":"10.1002/pu.31461","pmid":"","publication_date":"2026-05-28","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin shows rapid relief for depression symptoms
authors: Valerie A. Canady
journal: Mental Health Weekly
publication_date: 2026-05-28
doi: 10.1002/mhw.34890
source_url: https://doi.org/10.1002/mhw.34890
source_record_id: DOI:10.1002/mhw.34890
substance_tags: psilocybin
topic_tags: Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1002/mhw.34890
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/mhw.34890","source_url":"https://doi.org/10.1002/mhw.34890","doi":"10.1002/mhw.34890","pmid":"","publication_date":"2026-05-28","importer_version":"2.1.3","text_redistributed":false}


authors: Lin Wei, Hong Chen, Yuanyuan Li
journal: Journal of Raman Spectroscopy
publication_date: 2026-05-27
doi: 10.1002/jrs.70178
source_url: https://doi.org/10.1002/jrs.70178
source_record_id: DOI:10.1002/jrs.70178
substance_tags: psilocybin,psilocin
topic_tags: Aging,Toxicity
study_type: Qualitative Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:49:23
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1002/jrs.70178
text_rights_status: unverified_not_redistributed
title:
Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman Spectroscopy

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1002/jrs.70178","source_url":"https://doi.org/10.1002/jrs.70178","doi":"10.1002/jrs.70178","pmid":"","publication_date":"2026-05-27","importer_version":"2.1.3","text_redistributed":false}


journal: PsyArXiv
publication_date: 2026-03-29
source_url: https://osf.io/preprints/psyarxiv/8s7xk_v1
source_record_id: https://osf.io/preprints/psyarxiv/8s7xk_v1
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Treatment-Resistant Depression
study_type: Other
source_name: PsyArXiv
publication_status: preprint
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-01 11:22:30
abstract_source: PsyArXiv
abstract_source_url: https://osf.io/preprints/psyarxiv/8s7xk_v1
text_rights_status: unverified_not_redistributed
title:
Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”

source_provenance_json:
{"source_name":"PsyArXiv","source_record_id":"https://osf.io/preprints/psyarxiv/8s7xk_v1","source_url":"https://osf.io/preprints/psyarxiv/8s7xk_v1","doi":"","pmid":"","publication_date":"2026-03-29","importer_version":"2.1.3","text_redistributed":false}


title: Psilocybin.
authors: Mulkey D.
publication_date: 1972-06-30
pubmed_id: 5039020
source_url: https://europepmc.org/article/MED/5039020
source_record_id: PMID:5039020
substance_tags: psilocybin
topic_tags: General
study_type: Other
source_name: Europe PMC
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-01 11:22:07
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"Europe PMC","source_record_id":"PMID:5039020","source_url":"https://europepmc.org/article/MED/5039020","doi":"","pmid":"5039020","publication_date":"1972-06-30","importer_version":"2.1.3","text_redistributed":false}


journal: Neuroethics
publication_date: 2026-05-12
doi: 10.1007/s12152-026-09645-5
source_url: https://doi.org/10.1007/s12152-026-09645-5
source_record_id: DOI:10.1007/s12152-026-09645-5
substance_tags: psilocybin
topic_tags: Anxiety,Clinical Trial,Safety,Toxicity
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1007/s12152-026-09645-5
text_rights_status: unverified_not_redistributed
title:
Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study

authors:
Christina Chwyl, Alissa Bazinet, Adrianne R. Wilson-Poe, Kim Hoffman, Kellie Pertl, R. Cameron Wolf, P. Todd Korthuis, Jason B. Luoma

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1007/s12152-026-09645-5","source_url":"https://doi.org/10.1007/s12152-026-09645-5","doi":"10.1007/s12152-026-09645-5","pmid":"","publication_date":"2026-05-12","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Pre-Clinical and Clinical Research
publication_date: 2026-05-11
doi: 10.26444/jpccr/221219
source_url: https://doi.org/10.26444/jpccr/221219
source_record_id: DOI:10.26444/jpccr/221219
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.26444/jpccr/221219
text_rights_status: unverified_not_redistributed
title:
Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin

authors:
Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń

topic_tags:
Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.26444/jpccr/221219","source_url":"https://doi.org/10.26444/jpccr/221219","doi":"10.26444/jpccr/221219","pmid":"","publication_date":"2026-05-11","importer_version":"2.1.3","text_redistributed":false}


title: Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer study
publication_date: 2026-05-07
doi: 10.21428/8e6ba8ef.1db8272c
source_url: https://doi.org/10.21428/8e6ba8ef.1db8272c
source_record_id: DOI:10.21428/8e6ba8ef.1db8272c
substance_tags: psilocybin
topic_tags: Chronic Pain,Consciousness,Healthy Volunteers
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
authors:
Lorenzo Pasquini, Manesh Girn, Hannes Kettner, Avery Ostrand, Kate Allison, Christian Valtierra, Will Lucas, Patrick McConnell, Catriona Miller, Sydney Griffith, Dawn Weinstein, B L Anderson, Andrea Rosati, Jennifer Mitchell, Robin Carhart-Harris

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.21428/8e6ba8ef.1db8272c","source_url":"https://doi.org/10.21428/8e6ba8ef.1db8272c","doi":"10.21428/8e6ba8ef.1db8272c","pmid":"","publication_date":"2026-05-07","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Education Health and Sport
publication_date: 2026-05-06
doi: 10.12775/jehs.2026.91.70672
source_url: https://doi.org/10.12775/jehs.2026.91.70672
source_record_id: DOI:10.12775/jehs.2026.91.70672
substance_tags: psilocybin
study_type: Randomized Controlled Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.12775/jehs.2026.91.70672
text_rights_status: unverified_not_redistributed
title:
Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review

authors:
Kinga Zachar, Maksymilian Sito, Filip Jurkowski, Łukasz Wójcik, Natalia Gawron, Hubert Tomasz Bojanowski, Aleksandra Dobracka, Zuzanna Marczak, Monika Jarowicz, Jędrzej Czmyr

topic_tags:
Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.12775/jehs.2026.91.70672","source_url":"https://doi.org/10.12775/jehs.2026.91.70672","doi":"10.12775/jehs.2026.91.70672","pmid":"","publication_date":"2026-05-06","importer_version":"2.1.3","text_redistributed":false}


authors: Ceyda Sayalı, Eli Weisman, Frederick Barrett
publication_date: 2026-05-01
doi: 10.21428/8e6ba8ef.31e358f9
source_url: https://doi.org/10.21428/8e6ba8ef.31e358f9
source_record_id: DOI:10.21428/8e6ba8ef.31e358f9
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Chronic Pain,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
title:
Effects of Psilocybin Treatment on Cognitive Effort Avoidance in Major Depressive Disorder and Co-Occurring Alcohol Use Disorder

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.21428/8e6ba8ef.31e358f9","source_url":"https://doi.org/10.21428/8e6ba8ef.31e358f9","doi":"10.21428/8e6ba8ef.31e358f9","pmid":"","publication_date":"2026-05-01","importer_version":"2.1.3","text_redistributed":false}


authors: Gyandev Gupta, Ravina Yadav
journal: JOURNAL OF ADVANCE AND FUTURE RESEARCH
publication_date: 2026-04-30
doi: 10.56975/jaafr.v4i5.509087
source_url: https://doi.org/10.56975/jaafr.v4i5.509087
source_record_id: DOI:10.56975/jaafr.v4i5.509087
substance_tags: psilocybin
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.56975/jaafr.v4i5.509087
text_rights_status: unverified_not_redistributed
title:
Role of Psychological support in sustaining Antidepressants effects in Psilocybin - Assisted Clinical

topic_tags:
Depression,Anxiety,Chronic Pain,Pharmacology,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Animal Study,Treatment-Resistant Depression,Healthcare Workers,Adverse Events,Toxicity

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.56975/jaafr.v4i5.509087","source_url":"https://doi.org/10.56975/jaafr.v4i5.509087","doi":"10.56975/jaafr.v4i5.509087","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


authors: Denise Vidot, Bria-Necole Diggs, Amrit Baral, Michelle Thompson, Girardin Jean-Louis
journal: SLEEP
publication_date: 2026-04-30
doi: 10.1093/sleep/zsag091.0408
source_url: https://doi.org/10.1093/sleep/zsag091.0408
source_record_id: DOI:10.1093/sleep/zsag091.0408
substance_tags: psilocybin
topic_tags: Depression,Observational Study,Toxicity
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1093/sleep/zsag091.0408
text_rights_status: unverified_not_redistributed
title:
0408 Insomnia Severity Differences by Psilocybin, LSD, and DMT Use Status Among Young Adult Daily Cannabis Consumers in the Herbal Heart Study

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1093/sleep/zsag091.0408","source_url":"https://doi.org/10.1093/sleep/zsag091.0408","doi":"10.1093/sleep/zsag091.0408","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


journal: RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia
publication_date: 2026-04-30
doi: 10.51126/revsalus.v8isupii.46839
source_url: https://doi.org/10.51126/revsalus.v8isupii.46839
source_record_id: DOI:10.51126/revsalus.v8isupii.46839
substance_tags: psilocybin,psilocin
topic_tags: Pharmacology,Toxicity
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
title:
Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening Study

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.51126/revsalus.v8isupii.46839","source_url":"https://doi.org/10.51126/revsalus.v8isupii.46839","doi":"10.51126/revsalus.v8isupii.46839","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


authors: Broc Pagni, Stephen Ross, Yuna Kim, Michael Bogenschutz
journal: Biological Psychiatry
publication_date: 2026-04-24
doi: 10.1016/j.biopsych.2026.03.240
source_url: https://doi.org/10.1016/j.biopsych.2026.03.240
source_record_id: DOI:10.1016/j.biopsych.2026.03.240
substance_tags: psilocybin
topic_tags: Addiction,Safety
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
title:
6. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-Efficacy

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.biopsych.2026.03.240","source_url":"https://doi.org/10.1016/j.biopsych.2026.03.240","doi":"10.1016/j.biopsych.2026.03.240","pmid":"","publication_date":"2026-04-24","importer_version":"2.1.3","text_redistributed":false}


journal: Journal of Hepatology
publication_date: 2026-04-30
doi: 10.1016/s0168-8278(26)01861-1
source_url: https://doi.org/10.1016/s0168-8278(26)01861-1
source_record_id: DOI:10.1016/s0168-8278(26)01861-1
substance_tags: psilocybin
topic_tags: Chronic Pain,Pharmacology,Receptor Pharmacology,Animal Study
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
title:
SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH models

authors:
Anna Signor, Martina Colognesi, Giovanna Finzi, Daniela Gabbia, Andrea Mattarei, Stefano Comai, Gianfranco Pasut, Franco Folli, Paolo Manfredi, Sara De Martin

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/s0168-8278(26)01861-1","source_url":"https://doi.org/10.1016/s0168-8278(26)01861-1","doi":"10.1016/s0168-8278(26)01861-1","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


title: 1080 Psilocybin Elicits Non-Linear Night to Night Changes in Sleep Spectral Power
authors: Matthew Reid, Eli Weisman, Luis Luna Martinez, William Coon, Frederick Barrett
journal: SLEEP
publication_date: 2026-04-30
doi: 10.1093/sleep/zsag091.1079
source_url: https://doi.org/10.1093/sleep/zsag091.1079
source_record_id: DOI:10.1093/sleep/zsag091.1079
substance_tags: psilocybin
topic_tags: Depression,Anxiety,Addiction,Chronic Pain,Brain Imaging,Pharmacology,Consciousness,Clinical Trial
study_type: Clinical Trial
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1093/sleep/zsag091.1079
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1093/sleep/zsag091.1079","source_url":"https://doi.org/10.1093/sleep/zsag091.1079","doi":"10.1093/sleep/zsag091.1079","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


title: Preclinical evaluation of psilocybin and related compounds: Inhibition of cytochrome P450 isoforms
journal: RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia
publication_date: 2026-04-30
doi: 10.51126/revsalus.v8isupii.46635
source_url: https://doi.org/10.51126/revsalus.v8isupii.46635
source_record_id: DOI:10.51126/revsalus.v8isupii.46635
substance_tags: psilocybin
topic_tags: Pharmacology,Animal Study,Toxicity
study_type: Animal Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.51126/revsalus.v8isupii.46635","source_url":"https://doi.org/10.51126/revsalus.v8isupii.46635","doi":"10.51126/revsalus.v8isupii.46635","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


authors: Joseph Hennessey, John Mantsch, John McCorvy
journal: Journal of Pharmacology and Experimental Therapeutics
publication_date: 2026-04-30
doi: 10.1016/j.jpet.2026.104291
source_url: https://doi.org/10.1016/j.jpet.2026.104291
source_record_id: DOI:10.1016/j.jpet.2026.104291
substance_tags: psilocybin
topic_tags: Depression,Pharmacology,Receptor Pharmacology
study_type: Other
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
text_rights_status: not_applicable_no_text
title:
Effects of Psilocybin on Attentional Set-Shifting Following Chronic Unpredictable Stress in Rats (Abstract ID: 231339)

source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.jpet.2026.104291","source_url":"https://doi.org/10.1016/j.jpet.2026.104291","doi":"10.1016/j.jpet.2026.104291","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


title: Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA
authors: R Andrew Yockey, Amber Amis, Elise Devier, Aminul Apu, Rachel Hoopsick
journal: AJPM Focus
publication_date: 2026-04-30
doi: 10.1016/j.focus.2026.100518
source_url: https://doi.org/10.1016/j.focus.2026.100518
source_record_id: DOI:10.1016/j.focus.2026.100518
substance_tags: psilocybin
topic_tags: Addiction,Observational Study,Adolescents,Safety,Toxicity
study_type: Observational Study
source_name: OpenAlex
publication_status: published
date_added: 2026-07-01 06:52:05
last_checked: 2026-07-04 07:00:31
abstract_source: OpenAlex
abstract_source_url: https://doi.org/10.1016/j.focus.2026.100518
text_rights_status: unverified_not_redistributed
source_provenance_json:
{"source_name":"OpenAlex","source_record_id":"DOI:10.1016/j.focus.2026.100518","source_url":"https://doi.org/10.1016/j.focus.2026.100518","doi":"10.1016/j.focus.2026.100518","pmid":"","publication_date":"2026-04-30","importer_version":"2.1.3","text_redistributed":false}


